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Introduction
Welcome to the ‘Substance Misuse in Pregnancy’ resource pack for 
professionals working in Lothian. Many different professionals and service 
providers are now involved in the care of women who use drugs and/or 
alcohol during the course of their reproductive life. All professionals have 
an equally important role to play in ensuring a high standard of care is 
delivered. The pack aims to establish a ‘framework for care’ so that all 
women who use drugs can be offered appropriate support before, during 
and after the birth of their child.
The framework for care consists of a philosophy of approach and 
guidelines on good practice. These are outlined in the pack and provide a 
basis from which the best possible outcomes can be achieved for both 
mother and baby. The pack takes a predominantly community perspective,
as Lothian now provides most alcohol, drug and maternity services within 
the community setting.
A broad view of drug use is taken that includes alcohol and nicotine. This 
is because the risks of these drugs in pregnancy are well established and 
they are often used in combination with illicit and prescribed drugs 
(Johnstone 1998). Having said this, the pack refers mainly to the care of 
women who have significant problems related to drug and alcohol use. This 
is because social and lifestyle factors often complicate the delivery of 
care to these women. Their care often provides the biggest challenge for 
professionals and much co-ordination and understanding between services 
is needed.
The need for this resource pack was highlighted in the McIntosh (2001) 
needs assessment report ‘The Care of Pregnant Drug and Alcohol Misusers 
in Lothian’. Writing a new resource pack for all professionals (to replace 
the midwifery ‘Substance Misuse in Pregnancy and Childbirth Resource 
Pack’ 1996) was one of a number of strategies recommended to improve 
the care of pregnant women with drug and alcohol misuse problems in 
Lothian. Disseminating the resource pack was seen as a useful way of 
improving joint working, outlining good practice and facilitating 
multidisciplinary training. Other recommendations included improving
liaison by establishing a system of ‘link midwives for substance misuse’
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throughout Lothian. This system has now been set up and is described in 
the pack. Obtaining more reliable data on the nature and extent of the 
problem in Lothian was also recommended. This has been achieved by 
designing new ‘liaison forms’ that midwives and other health care 
professionals can now use to record important information as the woman 
progresses through maternity care. Producing good quality information
leaflets for service users was identified as an important resource that 
needed to be developed. Two leaflets, written with the help of women 
service users, are included in the pack. 
Currently in Lothian, there is no specialist midwifery service for pregnant 
women who have drug and/or alcohol related problems and no plans to 
establish one in the near future. Other areas (notably Glasgow, Liverpool, 
Manchester and London) have developed specific midwifery services for 
this client group. Whilst it has been useful to learn from these other 
areas, it is important to remember that Lothian is different for a number 
of epidemiological, geographical, organisational, professional and cultural 
reasons.
Lothian has a long history of providing drug, alcohol and maternity care 
within the community setting. Harm reduction and normalisation has been 
at the heart of our approach since the 1980’s. A number of professionals 
in Lothian have taken a special interest in this field and we have built up 
considerable expertise over the years, taking care not to establish 
services that might segregate or stigmatise women with substance misuse 
problems. Areas of good practice exist within Lothian, for instance in 
Craigmillar, where antenatal services are jointly managed by midwifery 
and obstetric staff, general practitioners, health visitors, and drug 
specialists who all work together in the one centre. The majority of health 
and social care workers in Lothian have integrated work with this client 
group into their normal client population despite the additional needs with 
which they often present. Midwifery and other services have recognised 
the special needs of this client group and have developed strategies 
designed to improve access to care as well as communication and joint 
working. This resource pack reflects the ideals of care that can be 
achieved.
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Please note:
1. The terminology used in this resource pack has been carefully chosen so 
as to avoid language that implies value judgements or has negative 
connotations. For instance, the terms ‘drug and alcohol dependency’, ‘drug
and alcohol related problems’, ‘drug use’ or ‘substance misuse’ are used in 
preference to terms such as ‘addiction’, ‘drug addict’, ‘alcoholic’, ‘drug
habit’ or ‘drug abuse’. The use of currently preferred terminology is 
especially important when working with substance-misusing women who are 
particularly sensitive to public and professional judgements.
2. The information and advice in this resource pack is based on current 
best practice and available evidence. Sources include: governmental policy 
documents, contemporary social theory and health care practice, good 
practice guidelines, expert opinion and recent publications from 
experienced practitioners in the field as well as a literature and 
publications search. 
3. The resource pack is not fully referenced but those references that 
are cited are recommended for further reading. Other helpful sources of 
information, addresses and websites are included in the pack. A glossary
provides definitions of terms and a list of Lothian services is also 
included.
4. The resource pack is not designed to be read cover to cover but it is 
worth taking a little time to familiarise yourself with the layout and 
contents so that you can access information easily when you need to. It is 
worthwhile reading the ‘key points’ and ‘philosophy of approach’ before 
other sections.
5. This resource pack is copyrighted. Professionals are welcome to 
reproduce the contents in full or in part, as long as the source is 
acknowledged. Many of the appendices are designed for photocopying.
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Key points 
z Most pregnant women with substance misuse problems will have a 
normal pregnancy, labour, delivery and a full-term normal birth-weight 
baby. Most will embrace motherhood and cope well with caring for 
their children. 
z Many conditions carry with them an element of risk or uncertainty 
during pregnancy and require greater care. Increased risks are 
associated with smoking, alcohol use and drug use in pregnancy. 
Agencies should work together to offer information, advice, treatment 
and care that will help reduce these risks.
Philosophy of approach 
z Many factors affect pregnancy outcome and the health and 
development of infants and children. Substance misuse is just one 
factor. A holistic assessment and package of care needs to be 
offered. The woman’s lifestyle and social circumstances, her physical 
and psychological needs, her support needs, as well as the needs of her 
unborn child should be taken into account.
z The approach taken by professionals is a crucial factor in the delivery 
and outcome of care. Pregnant women with substance misuse problems 
are subject to social disapproval and judgemental attitudes. 
Discriminatory professional practice deters women from seeking help. 
Professionals need to encourage women to engage with helping 
agencies and ensure that their approach to care is based on good 
evidence and best practice.
z The guiding principle of management should be a pragmatic approach 
that emphasises harm reduction and aims to achieve the best possible 
outcome for both mother and baby. This means taking account of the 
woman’s wishes, recognising her vulnerabilities and needs and focusing 
on what could be done rather than what should be done. 
z A well co-ordinated multi-disciplinary and multi-agency approach will 
ensure that a comprehensive package of care can be offered. All 
professionals involved in a woman’s care need to communicate with one 
another to ensure that they share a common approach, offer 
consistent advice and are working towards the same goals. 
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Pre-conceptual care 
z Agencies in contact with substance-misusing women should routinely 
enquire if they plan to have children. All agencies have a part to play in 
offering pre-conceptual advice and care. 
Antenatal care 
z All pregnant women with substance misuse problems and their partners 
should be told about the benefits of antenatal care and encouraged to 
attend early in pregnancy. 
z Specific information and advice about the effects of drug use 
(including tobacco and alcohol) on pregnancy should be routinely given 
to all women identified as having a substance misuse problem. 
z Drug dependent women should be given information and advice on 
Neonatal Abstinence Syndrome and helped to prepare for the care of 
their newborn baby. 
z Pregnant women and their partners should be given priority access to 
drug and alcohol treatment services. Treatment goals should be 
realistic and tailored to their individual needs.
Assessing risk in pregnancy 
z Professionals should undertake a continuous risk assessment 
throughout pregnancy to identify any problems that could affect the 
mother, her pregnancy and the well-being of the baby.
z Substance misuse is not sufficient reason in itself, to assume that 
parenting or child care will be inadequate. However, the safety and 
welfare of the newborn baby is paramount and professionals should 
follow child protection guidelines if ‘significant harm’ is likely.
Intrapartum care 
z Although most women with substance misuse problems will have a 
normal labour and delivery, they may need help to prepare for hospital 
admission. Drug dependent women should be reassured that they will 
be given adequate pain relief during childbirth.
z Following delivery, parents should care for their baby as normal in the 
postnatal ward. Separating mother and baby should be avoided 
wherever possible. Like other women, they should be encouraged to 
breastfeed, bond and care for their baby.
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Postnatal care 
z Parents with substance misuse problems may need considerable help 
and support to cope with the transition into parenthood. Planned 
support that continues into the postnatal period is crucial.
z The postnatal period can be a stressful time for parents. For mothers 
who have managed to reduce their drug and alcohol use during 
pregnancy, the risk of relapse to former levels of drug taking is high. 
Relapse prevention work, careful drug management and intensive 
psychosocial support may be required for some time.
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Setting the scene 
The extent of the problem 
The true extent of drug taking in women is largely unknown as reliable 
figures are hard to obtain. It is clear, however, that smoking, alcohol use 
and illicit drug use in women of reproductive age is increasing and the 
continued use of drugs during pregnancy is common. Approximately one-
third of pregnant women smoke and approximately 60% continue to 
consume alcohol (Taylor 2003). The use of illicit drugs in pregnancy such 
as cannabis, amphetamines, heroin and cocaine is thought to be fairly 
widespread, especially in large urban areas. For many women, drug use is a 
‘lifestyle choice’ and a fundamental part of their lives.
Although nicotine and alcohol are legally available it is important not to 
confuse legality with safety. Maternal use of tobacco is well researched 
and known to have significant harmful effects on pregnancy. Although 
approximately 20% of women who smoke manage to give up during 
pregnancy, nicotine remains the most problematic drug of use in pregnancy 
at a population level (Johnstone 1998). Alcohol has the clearest 
association with teratogenesis (congenital birth defects), with well-
documented adverse effects associated with high maternal intake. 
Approximately 20% of women of reproductive age exceed the 
recommended weekly limit of alcohol consumption (Scottish Executive 
2002). Nicotine and alcohol are often used in combination with other 
drugs and most women who present to drug and alcohol treatment services 
report ‘polydrug use’.
National statistics and local data sources provide some indication of the 
prevalence of pregnant women who have significant drug and alcohol 
related problems. The Information and Statistics Division (ISD Scotland) 
collects national statistics on drug misuse during pregnancy. The source of 
the data is maternity in-patient and day case records (SMR02) and 
neonatal discharge records (SMR11). Drug misuse is recorded using codes 
from the International Classification of Diseases (ICD-10) criteria. A 
revised SMR02 now includes data items for documenting alcohol 
consumption and SMR11 is currently being replaced by the Scottish Birth 
Record (SBR), which has the potential to collect more detailed information 
about maternal drug and alcohol use.
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These data sources have traditionally suffered from under-reporting and 
the statistics are thought to grossly underestimate the prevalence of 
drug misuse. Nevertheless, some useful information has been gathered 
which shows that the majority (approx 80%) of live births to women with 
a recorded history of drug misuse, have resulted in the spontaneous 
delivery of full-term normal birth weight babies (Drug Misuse Statistics 
Scotland 2002).
In Lothian, a significant number of women (approximately 1000) are now 
on prescribed drugs for the treatment of their drug dependency and most 
are of reproductive age. Informal recording methods (using midwifery 
‘liaison sheets’) have estimated: approximately 100 pregnancies per year in 
women who have significant substance misuse problems; approximately 40 
babies per year receive treatment for conditions related to maternal 
substance misuse. This number is likely to increase as the overall 
prevalence of substance misuse increases. Improved local data collection 
methods have recently been implemented in Lothian. Maternity staff now 
complete substance misuse liaison forms for all pregnant women who 
report problem drug and alcohol use. The liaison forms are included in 
appendix 9.
The nature of the problem 
Many factors affect the outcome of pregnancy and the health and well-
being of mother and baby. Many conditions carry with them an element of 
risk or uncertainty and require greater care during pregnancy. Drug use is 
just one factor. Other factors include lifestyle and social circumstances, 
physical and psychological health, nutrition, breastfeeding, sexually 
transmitted and communicable diseases, antenatal and postnatal care.
Women who seek help for drug and alcohol related problems are more 
likely to be unemployed and living in areas of social deprivation. Pregnant 
women with substance misuse problems often present with a multiplicity
of needs that require the involvement of many different professionals and 
agencies. The organisation and delivery of care therefore, is an important 
factor in outcome. 
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Organisational difficulties 
Professionals who are experienced in working with this client group often 
report a number of problems. These include:
• No common or ‘shared’ approach to care 
• Lack of understanding of professional roles and responsibilities 
• Poor liaison and communication between professionals 
• Little consultation or ‘joint’ assessments
• Limited ‘partnership’ of care with the woman 
• Unrealistic expectations and treatment goals 
• Inconsistent and contradictory advice 
• Difficulty organising care plan meetings or reviews 
• Little engagement or involvement of the partner
• No one professional taking responsibility for co-ordinating care 
For midwives, delivering care to this client group can be very time 
consuming. In Lothian, community midwives each manage approximately 80 
pregnancies per year in their geographical area. Committed midwives can 
often spend considerable time co-ordinating care, liaising with other 
professionals, organising antenatal and postnatal care planning meetings, 
organising the additional antenatal care requirements that these women 
often need, and visiting in excess of 10 days postpartum.
In addition to the organisational and service delivery difficulties there 
are a number of other reasons why the care of pregnant women with drug 
and/or alcohol related problems has been difficult for health and social 
care providers. 
Ideology
The prevailing societal view of women with substance misuse problems is a 
negative one. Drug and alcohol dependent women have been characterised 
as irresponsible, inadequate, deviant, immoral and unfit for motherhood. 
Research shows that women who are drug or alcohol dependent get 
significantly more social disapproval than men (Klee, Jackson & Lewis 
2002). In pregnancy, this view is heightened as the welfare of the unborn 
child is emphasised and assumptions are made about the harmful 
consequences of the mother’s drug/alcohol use and her ability to be a 
‘good mother’ and care adequately for her child (Macrory & Crosby 1995). 
This gender bias has led to punitive responses, unacceptable levels of 
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surveillance and restricted options for treatment and care (Klee, Jackson 
& Lewis 2002). Negative societal views and professional attitudes coupled 
with discriminatory practice have deterred women from seeking help. 
They may appear to neglect their condition and that of their babies but in 
reality it may be the service’s attitudes and approach that have excluded 
them from care (Morrison 1999).   
 
Research evidence 
Lack of good data and research evidence on the effects of illicit drug use 
on the fetus and baby has led to some confusion and exaggeration of risk. 
Providing balanced and factual information to women so that they can 
make informed choices in pregnancy has proved difficult and women 
continue to receive inconsistent and contradictory advice.  
 
Women’s fears 
Not surprisingly, pregnant women who have substance misuse problems 
• 
• Fear that her baby will be taken into care 
• Fear and confusion over whether her drug use will cause fetal damage  
• Fear that she will be blamed if anything goes wrong with her 
pregnancy 
• Fear of being thought of as un uncaring or ‘unfit’ mother if she doesn’t 
manage to come off or reduce her drug use  
• Feeling guilty and ‘to blame’ for her baby experiencing withdrawal 
symptoms 
 
Poor social circumstances 
Drug and alcohol related problems are commonly associated with socio-
economic deprivation and poor social circumstances. These include: 
• Poor support from family and friends 
• Poor support from a substance-misusing partner 
• Drug related criminal activity and legal problems (e.g. outstanding 
charges, impending court cases, community service order, probation, 
prison history, drug treatment and testing orders) 
• Violence (e.g. substance misuse-related or domestic abuse) 
 
  
frequently report a number of concerns (Scottish Executive 2003) including: 
Fear that child protection agencies will be contacted automatically
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• Financial problems (including debts, fines and problems with welfare 
benefits)
• Housing problems (including homelessness, insecure or unsuitable 
housing)
Maternal health problems
Injecting drug use and harmful levels of drinking are associated with poor 
maternal health. This may include:
• Malnutrition and anaemia 
• Respiratory problems
• Poor dental hygiene
• Blood borne virus infections (HIV, hepatitis B, hepatitis C) 
• Complications from injecting (such as abscesses, endocarditis, 
septicaemia etc) 
• Liver disease 
• Accidental injury
• Overdose and maternal death 
• Mental health problems (such as anxiety, depression, self harm, 
psychosis)
Chaotic lifestyle
Drug and alcohol related problems are commonly associated with a chaotic
lifestyle and may result in the woman receiving poor maternity care. For 
example:
• Late pregnancy booking 
• Poor attendance for antenatal care 
• Not registering with a general practitioner 
• Poor attendance for parenthood education 
• Late presentation during labour 
• Early discharge home after delivery
Obstetric and paediatric problems 
Drug use (including alcohol and tobacco) impacts on obstetric and 
paediatric morbidity and mortality. Increased rates of low birth weight,
pre-term delivery, Sudden Infant Death Syndrome (SIDS or ‘cot death’) 
and Neonatal Abstinence Syndrome in babies are the most commonly 
reported problems. The effects of specific substances on the developing 
fetus and baby are outlined later in the pack (see page 35).
Substance Misuse in Pregnancy 20
It is well established that many obstetric problems associated with 
substance misuse are also associated with social deprivation, poor 
antenatal care, poor maternal health and nutrition (Mounteney 1999). A 
number of case controlled studies have found comparable outcomes in 
women (who are matched by age, parity, social deprivation category etc) 
who do not have substance misuse problems (Siney 1999). Social factors, 
as well as the quality of health and social care provision, significantly 
influence the health and well-being of both mother and baby.
Because of such complications, substance misuse in pregnancy has become 
one of the leading conditions requiring specific guidelines and strategies.
The next section outlines the principle guidelines that form a ‘framework
for care’.
Introduction
Key points
Setting the scene
Framework for care
Guidelines on good practice
Framework for care
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Framework for care 
A number of recent governmental publications have provided a broad set 
of principles and guidelines on good practice for working with pregnant 
women and families affected by drug and alcohol related problems. These 
include:
z ‘Drug Misuse and Dependence – Guidelines on Clinical Management’, 
Annex 5: ‘Pregnancy and Neonatal Care’, Department of Health (1999)
z ‘A Framework for Maternity Services in Scotland ‘, Scottish Executive
(2001)
z ‘Integrated Care for Drug Users’, Effective Interventions Unit (2002)
z ‘Plan for Action on Alcohol Problems’, Scottish Executive (2002)
z ‘Getting Our Priorities Right’, Scottish Executive (2003)
z ‘Hidden Harm: responding to the needs of children of problem drug 
users’, The Advisory Council on the Misuse of Drugs report (2003)
Philosophy of approach 
The philosophy of approach outlined here reflects the central themes 
from these policy documents as well as recommendations from leading 
experts in the field.
Overall, the approach to care needs to be: 
 women and family centred
 non-judgemental
 pragmatic, with an emphasis on harm reduction
 holistic
 provided by a multi-disciplinary and multi-agency team
Women and family centred approach 
Pregnancy and the transition into parenthood is a significant life event. 
For women who have problems related to alcohol and drug misuse it offers 
opportunities as well as risks. These women have the same hopes and 
aspirations for family life and the same anxieties about pregnancy, 
childbirth and motherhood as other women (Ford & Hepburn 1997). For 
service providers, the challenge is to offer the right kind of support that 
will allow them to minimise the risks as much as possible and to make the 
most of available opportunities. This means that treatment and care needs 
to be women and family centred.
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The important role of partners needs to be recognised, and professionals 
need to ensure that, where appropriate, they are encouraged and 
supported to take a full and active role in pregnancy, childbirth and 
postnatal care. Women and their partners need to be able to make fully 
informed choices about their care. They need timely, relevant and easily
accessible information to help them make the choices they face. They also 
need prompt access to any treatment and care that they might need. 
Maternity care should be tailored to the needs of the individual woman 
and her family, focusing on the safety of mother and baby. It should 
take into account: 
 the needs and wishes of the woman and her family
 her right to privacy and dignity throughout her pregnancy
 her cultural values, beliefs, attitudes, and chosen lifestyle
A family centred approach will create an atmosphere of normalisation and 
partnership that will engage the woman and her partner and foster the 
best possible outcome for mother and baby. 
Non-judgemental approach 
Service providers need to adopt a truly professional approach that is not 
led by views which are distorted by prejudice or limited by conventional 
stereotypes (Klee, Jackson & Lewis 2002). Professionals need to 
continually examine their approach to care so that they can account for 
their practice in terms of what is in the best interests of the woman and 
her baby and what is in accordance with the best available evidence and 
best practice.
Establishing early contact with pregnant women who have substance 
misuse problems and retaining them in treatment and care is vital. This 
can best be achieved by creating a non-judgemental environment. Providing 
care with compassion, reassurance and encouragement will facilitate good 
contact. A non-judgemental approach is also a pre-requisite for obtaining 
the necessary details of the woman’s substance misuse and social 
circumstances. The woman needs to feel supported throughout her 
pregnancy and beyond. This means that professionals need to create a 
positive pregnancy experience for the woman, irrespective of risk and 
despite any difficulties that she may have.
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Harm reduction approach 
Substance misuse in pregnancy is associated with increased risks. 
Pregnancy therefore provides an excellent opportunity for professionals 
to provide education and care within a harm reduction framework 
(Johnstone 1998). Harm reduction is a pragmatic approach to care which 
aims to reduce the harm to individuals and society whether or not it is 
possible to reduce the substance use per se. It is essentially a public
health policy designed to minimise risk. It is a reality-based approach that 
focuses on what could be done rather than what should be done. A harm 
reduction approach includes providing the means, information and 
education to enable people to make informed choices about their lifestyle. 
Treatment and care goals must be realistic and tailored to the needs of 
the individual woman. Pressurising pregnant women into reducing or coming 
off drugs may lead to more harm than good. A flexible service that is able 
to take account of the wishes of the woman and support her to make her 
own decisions and be guided by what she feels she can achieve, will be 
most successful (McIntosh 2001).
It is important to remember that a harm reduction approach includes
abstinence. Abstinence can be helpfully thought of as the ‘final goal’ of 
harm reduction and one which many people with substance misuse 
problems may wish to achieve. Drug and alcohol dependency however, is 
considered a chronic relapsing condition. People may use drugs and alcohol 
in potentially harmful ways for many years before achieving abstinence. 
Long-term support to help people minimise the harm associated with 
substance misuse is normally required and may include such interventions 
as: substitute prescribing; needle exchange; and safer drug use / sensible 
drinking advice and support.
Holistic approach 
Pregnant women with substance misuse problems often present with a 
multiplicity of needs and their substance misuse is just one aspect of 
their lives. A holistic approach to care, from preconception to parenthood, 
needs to be offered. A holistic assessment should aim to identify their 
physical, psychological and social needs. It encompasses the context and 
causes of their problems and addresses the needs of other family 
members (Scottish Executive 2002). A holistic package of care
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recognises that a woman’s needs are inter-related and aims to provide a 
service that can address not just one aspect of her care, but all her needs 
and current strengths. 
Multi-disciplinary and multi-agency approach 
Pregnant women, whose drug or alcohol use is likely to impact on the 
outcome of their pregnancy, will need a comprehensive service provided by 
a multi-professional team. This service should provide consistent advice 
and support and continuity of care and aim to ensure safety for both 
mother and baby.
Many women will benefit from receiving care from a range of health and 
social care providers. This ‘multi-agency’ approach to care needs to be well
co-ordinated and integrated. Good communication between professionals 
is central to the provision of good quality care. Integrated care is where 
everyone involved in the provision of care has a shared philosophy of 
approach, knows what each other is doing and saying, and also knows what 
the woman herself wants.
A clear understanding of professional roles and responsibilities is needed 
to maximise the quality of care. Collaborative working should minimise the 
opportunities for contradictory or opinion-based advice and practice. 
Professionals delivering care need to have the knowledge and skills
necessary for the type and level of service they provide. They should be 
aware of the expertise of other professionals and be prepared to draw 
upon that expertise where needed.
Pregnant women with substance misuse problems should receive the 
same quality of care, respect and dignity as any other pregnant 
woman throughout their pregnancy. The philosophy of approach 
outlined above and the guidelines on good practice that follow should 
ensure that this can be achieved.
Introduction
Key points
Setting the scene
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Guidelines on good practice 
This section of the resource pack outlines guidelines on good practice for 
working with pregnant women who have substance misuse problems.
The care process 
It is important that all professionals involved with substance-misusing 
women follow a clear ‘pathway of care’, from pre-conception through to 
parenthood. A model ‘care pathway’ is included in appendix 4.
The care process involves assessment, planning care and agreeing an 
individual care plan, implementing care, and reviewing care. These key 
tasks in the care process are outlined below, along with a checklist of 
topics that are relevant to each stage of the process, many of which are 
covered in the course of routine health care as well as drug and alcohol 
treatment and social care service provision. 
Assessment
Assessment should be holistic and continuous throughout pregnancy. It 
should take into account the woman’s physical and psychological health 
needs, her social circumstances, her partner’s drug and alcohol use, an 
assessment of risk as well as her own drug use (including alcohol and 
tobacco). It may involve a number of different professionals contributing 
to the assessment process over time, including the General Practitioner, 
midwifery, obstetric and paediatric staff, the Health Visitor, Drug and 
Alcohol Worker and Social Worker.
An assessment of physical health needs should include such topics as:
 Past obstetric / gynaecological history 
 General health status
 Nutrition (e.g. diet, weight, anaemia)
 Dental health
 Exposure to infections (e.g. Blood Borne Viruses, Sexually Transmitted 
Infections)
 Complications from injecting (including venous access) 
 Accidents or injuries 
 Difficulty getting registered with GP
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An assessment of psychological needs should include such topics as:
 Worries or concerns about pregnancy (e.g. fear baby will be taken into 
care, fear of damage to the fetus)
 Current or past anxiety related problems
 Current low mood or history of depression / self harm 
 History of eating disorder (e.g. anorexia or bulimia) 
 Low self esteem or self worth
 History of physical, emotional or sexual abuse 
 Bereavement issues 
 Woman’s perception of her own circumstances, needs and coping ability 
An assessment of social needs should include:
 Housing situation (e.g. homelessness, insecure or unsuitable 
accommodation)
 Financial situation (e.g. debts, rent arrears, unpaid bills or fines) 
 Legal situation (e.g. current charges, impending court cases, community 
service or probation orders, drug treatment and testing orders) 
 Employment or training & education issues
 Care of any existing children 
 Parenting skills
 Relationships with partner, family, friends 
 Available social support network 
 Contact with other health and social care workers 
An assessment of drug use should include the following:
 Smoking
 Alcohol use 
 Illicit (street) drug use 
 Injecting drug use 
 Prescribed drug use 
 Use of ‘over the counter’ medications 
 Current contact with specialist drug/alcohol services 
 Current treatment and care goals 
 Previous contact with drug/alcohol services 
Information on the effects of drugs on the developing fetus and baby, as 
well as the assessment and management of drug use in pregnancy is 
described in detail later in the pack (see pages 31-63).
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An assessment of the partner’s drug use should include:
 Partner’s current use of tobacco, alcohol and drugs 
 Level of stability if drug dependent 
 Is partner currently injecting drugs? 
 Blood borne virus (HIV, HCV, HBV) status? 
 Partner’s current contact with health and social care agencies
A risk assessment should include: 
 Obstetric / gynaecological problems 
 Current maternal health problems
 Domestic abuse
 Previous history of child care problems 
 Impact of substance misuse on lifestyle
 Impact of drug culture environment 
 Social isolation / unsupported pregnancy 
Care planning 
Care should be planned in partnership with the woman and, where 
appropriate, her partner. Care planning involves developing a ‘package of 
care’ that meets the woman’s needs and takes account of her views and 
wishes. It includes what treatment and care will be provided, and by 
whom, as well as the desired outcomes. Care plans need to be realistic and 
achievable and they should include a date for review (Whittaker & McLeod 
1998). This should be arranged for between 28-32 weeks gestation. 
A care plan would include some or all of the following:
 Antenatal care including screening tests, scans, monitoring of fetal 
growth
 Treatment and care of substance misuse (realistic harm reduction 
goals and strategies) 
 Plan to address any social needs 
 Plan to meet and involve the partner in care (where appropriate) 
 Preparation for parenthood (including parent education classes) 
 Preparation for childbirth (labour and delivery) 
 Preparation for Neonatal Abstinence Syndrome (if drug dependent)
 Preparation for infant feeding (support & encouragement to 
breastfeed)
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 Plan for postnatal care (including preparations for infant and social 
support)
 Plan to address any risks or concerns associated with parenting skills or 
child care
 Plan to involve other professionals and referral to other agencies
 Plan for multi-disciplinary / multi-agency meeting / child protection 
case conference
Reviewing the care plan 
The care plan and progress of care need to be reviewed at regular
intervals throughout the pregnancy (for example at each antenatal 
appointment).
Women with identified risks or multiple social needs may benefit from 
attending an organised ‘care plan review’ meeting. All parties involved in 
the delivery of care should be encouraged to attend review meetings or 
submit a brief report. If the care plan review meeting takes place around 
28 weeks gestation then there will be enough time for services to be put 
in place in time for the arrival of the baby. 
The review process should include a discussion on the following topics: 
 Attendance for antenatal care? 
 Fetal health and development? 
 Maternal health? (including mental health) 
 Current smoking/alcohol/drug use? 
 Attendance for other health care appointments? (e.g. GP, Health 
Visitor or Community Mental Health Nurse) 
 Attendance at specialist drug/alcohol service? 
 Attendance for social care appointments? (e.g. social work, voluntary 
sector agencies) 
 Involvement and support of partner? 
 Stability of lifestyle? 
 Improvement in social circumstances? 
 Current or potential risks? 
 Future needs to address?
 Future goals to work towards? 
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Care management 
Some women with substance misuse problems and their families will have 
complex health and social care needs and will require a care management 
approach and a comprehensive package of care during pregnancy and well 
into the postnatal period. In these cases, one professional needs to be 
identified as the ‘care co-ordinator’ to take responsibility for managing 
the care process. The role of this ‘lead professional’ is to ensure that the 
care process is fully documented, implemented and reviewed. This requires 
good liaison, communication and organisational skills to ensure a continuum 
of care is delivered in accordance with the agreed care plan for the 
family.
Consent to share information with other professionals
All professionals working with pregnant women who have substance misuse 
problems need to work collaboratively with other professionals and 
agencies in order to provide good quality care. It is important to discuss 
‘joint working’ with the woman at an early stage so that informed consent
can be obtained to allow information sharing. Most women are happy to 
agree to this once the benefits of inter-agency collaboration are 
explained. Information regarding her assessment, care plan and progress 
can then be exchanged between professionals.
Although the woman may consent to ‘joint working’ she may still need 
reassurance about her right to privacy and should be given guidance on the 
Data Protection Act (1998) and the terms of professional ‘confidentiality’.
This will include advice about circumstances whereby confidentiality may 
be breached e.g. for child protection, mental health or legal reasons. A 
proforma consent form is included in appendix 5. The consent form can be 
photocopied and sent to all professionals involved in the woman’s care (i.e. 
the Midwife, GP, Health Visitor, Drug/Alcohol worker, Social Worker etc).
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Information and guidelines on drug use 
Ideally, all professionals who provide care to pregnant women with 
substance misuse problems should be able to:
 Provide information on the risks associated with drug use in pregnancy 
 Assess drug and alcohol related problems in pregnancy 
 Provide advice about how to manage drug use in pregnancy 
 Discuss substance misuse treatment and care options for pregnancy 
If professionals cannot provide the above then they should ensure that 
they refer women to services that can. 
The next section of the resource pack provides information and guidelines
on good practice on these topics. 
Trends in substance use (illicit and prescribed) 
This section of the resource pack includes basic information on commonly 
used drugs in Lothian for those professionals not familiar with illicit (non-
prescribed) and prescribed drug use.
Commonly used drugs in Lothian include: 
• cannabis (‘hash’ and marijuana) 
• stimulants (such as amphetamine, cocaine, ecstasy)
• hallucinogens (e.g. LSD & ‘magic mushrooms’) 
• opioids (e.g. heroin, methadone, dihydrocodeine, buprenorphine) 
• benzodiazepines (e.g. diazepam & temazepam)
• volatile substances (e.g. ‘gas’ and ‘glue’)
• other drugs (such as cyclizine, ketamine, gammahydroxybutrate or 
‘GHB’, ‘poppers’, steroids, anti-depressants). 
Most women in Lothian who use drugs do not inject them. Oral ‘polydrug’
use is more common. Cannabis is the most widely used illicit drug and is 
normally mixed with tobacco and smoked in a ‘joint’ or ‘spliff’. Central 
nervous system (CNS) stimulant drugs, such as amphetamine, ecstasy and 
cocaine, are commonly used for ‘recreational’ purposes and are popular in 
the dance club social scene. Anti-depressants (mostly SSRI’s) are also in 
widespread use. They are prescribed for the treatment of depression and 
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anxiety related problems and can interact with other CNS depressant 
drugs and CNS stimulant drugs.
Effects of commonly used drugs 
Benzodiazepine drugs, such as diazepam (Valium®) and temazepam, are 
commonly called ‘minor tranquillisers’ or ‘sleeping tablets’ (hypnotics) and 
are CNS depressant drugs. They are easily available on the black market 
and are in widespread use. People can become dependent on 
benzodiazepines in a very short period of time if they are used 
continuously (ISDD 1999). Sudden withdrawal from benzodiazepines can 
result in severe anxiety symptoms, hallucinations and seizures (similar to 
alcohol dependency withdrawal symptoms). 
Opioid drugs are CNS depressant drugs that have an analgesic (‘pain 
killer’) effect. They include: 
• opiates… derived from the opium poppy e.g. morphine and codeine, and 
their
• synthetic analogues… e.g. methadone (‘meth’), diamorphine (‘heroin’), 
dihydrocodeine (DF118 or ‘difs’), dipipanone (Diconal®), pethidine.
Opioids produce a range of physical effects apart from analgesia. They 
depress nervous system activity, including reflex functions such as 
coughing, respiration and heart rate. They also depress bowel activity, 
resulting in constipation. At higher doses sedation results and the user 
becomes drowsy and contented. Excessive doses produce stupor and coma. 
Tolerance and physical dependence develops with regular continued use. 
The physiological effects of long-term opiate use are rarely serious in 
themselves. They include respiratory complaints, constipation and 
menstrual irregularity (ISDD 1999).
Opioid intoxication… ‘gouching’ is the colloquial term used in Lothian to 
describe being intoxicated or ‘stoned’ on opiate drugs (i.e. the person 
takes a dose which is above their tolerance level). An intoxicated person 
may be unresponsive, have pinpoint pupils, respiratory depression (shallow 
and infrequent breathing), a weak and rapid pulse, and they may appear 
pale and have cold extremities.
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Opioid overdose… is life threatening. Immediate medical attention and 
treatment is required (normally naloxone is administered to reverse the 
effects of overdose). A person who has taken an overdose will have blue 
lips and cold skin, will lose consciousness and not respond to stimuli, 
develop respiratory failure and die (sometimes through asphyxia after 
vomiting).
Opioid withdrawal in adults… abrupt withdrawal is rarely life-threatening 
and is considered less dangerous than withdrawal from alcohol or 
benzodiazepines. Withdrawal symptoms develop in dependent opiate users 
normally 24-72 hours after their last dose. Symptoms can include: nausea, 
vomiting, diarrhoea, insomnia, muscle cramps, goose flesh, cold and clammy 
skin, dilated pupils, runny nose and eyes, abdominal pains, sweating, 
restlessness, irritability, as well as intense craving for the drug. Physical 
symptoms normally subside without treatment within 7 days. For opiate 
detoxification during pregnancy see section on ‘Management of problem 
drug use ’, page 57.
Injecting drug use 
Although most drug users in Lothian report taking drugs by oral 
administration (swallowing, snorting or smoking), injecting drug use is on 
the increase. Drugs that can be easily prepared for injection include: 
• diamorphine (‘heroin’) 
• buprenorphine (Temgesic®, Subutex®) 
• dipipanone (Diconal®) 
• cyclizine (Valoid®) 
• amphetamines (‘speed’)
• cocaine.
Injecting drug use and sharing needles & syringes and other injecting 
paraphernalia (e.g. spoons, filters, water etc) remains a major public 
health concern. Messages about the risks associated with sharing
injecting paraphernalia need to be continually emphasised by professionals 
as many young drug users do not perceive themselves to be at risk of 
blood borne viruses (HIV, hepatitis C and hepatitis B).
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Drugs and their effects on the developing baby
All women should be given information on the effects of smoking, alcohol 
use and drug use in pregnancy. Ideally, information should be given well 
before conception so that the woman has an opportunity to modify her 
drug use before she becomes pregnant (see section on ‘pre-conceptual
care’ page 65). 
The general answer to a question like ‘I took some x before I found out I 
was pregnant. Is it likely to harm the baby?’ is almost certainly ‘no’. 
However, outcomes depend on the drug used, the amount taken, over what 
time period, how it was taken, at what stage in pregnancy, and many other 
factors such as diet and social circumstances. One unfortunate aspect of 
over-emphasising the likelihood of adverse effects is that it may persuade 
some concerned women to inappropriately consider termination 
(Mounteney 1999). Others may suddenly stop their dependent drug use 
(which could be dangerous to the fetus) or avoid engaging with 
professionals because of exaggerated concerns.
Drug use is associated with increased rates of obstetric and 
paediatric mortality and morbidity and can affect pregnancy in a 
number of ways. During the 1
st
 trimester, when fetal organs are actually 
forming, teratogenic (malformation) effects are the main concern. This is 
a time when the woman may not even know she is pregnant. During the 2
nd
and 3
rd
 trimester the main concern is about growth and functional
development (Siney 1999). Impaired placental function and fetal growth 
can result in a low birth weight baby. Chaotic drug use can increase the 
risk of pre-term labour and result in early delivery. The risk of Sudden
Infant Death Syndrome (SIDS) is increased and Neonatal Abstinence 
Syndrome is common in the babies of women who are dependent on certain 
drugs.
Many women with alcohol / drug related problems feel worried and guilty
about the effects of their drug use on the baby and may appear reluctant 
to discuss these issues as a result (Klee, Jackson & Lewis 2002). 
Professionals need to give parents license to voice concerns, fears and 
questions that they are reluctant to bring up spontaneously. Very often 
parents will be relieved when a professional raises the subject and 
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encourages them to share their concerns. Allowing them to voice anxieties 
about poor outcome and their ambivalence about their current situation, 
including their substance use, treatment and so on can be therapeutic. 
Parents often complain that they are not ‘told enough’ and professionals 
comment that parents are ‘ill prepared’ or ‘ill informed’.
In Lothian, an information booklet called ‘Pregnant… and using alcohol or 
drugs?’ is available (see appendix 11). This can be given to any woman with 
a drug and/or alcohol related problem in the antenatal period. The booklet 
is ‘user friendly’, outlining the general effects associated with drug use 
and advice about how to manage drug use during pregnancy. Women (and 
their partners) should be advised to read the booklet then discuss it with 
their midwife or other professional involved in their care.
Evidence base 
It has been difficult to establish clear and reliable information about the 
effects of specific drugs on the developing fetus and baby. Much of the 
research is methodologically flawed and findings are inconsistent and 
contradictory. This is because well controlled studies are difficult to 
conduct and pregnancy outcome is multifactorial. It is the result of an 
interplay of genetic factors, physical and psychological health, nutrition, 
health and social care, social deprivation and other environmental 
influences as well as the effects of tobacco, alcohol and drug use. These 
confounding factors have made it difficult to establish cause-and-effect
relationships. This is particularly true when relating specific intrauterine 
fetal drug exposure to long-term behavioural effects as the child grows 
up (Johnstone 1998).
Drug and alcohol related problems are associated with poverty, 
unemployment, chaotic lifestyle, violence, poor physical and psychological 
health and poor uptake of health and social care. These other factors may 
therefore account for many of the findings reported in the research 
literature. There is also a moral dimension to what purports to be 
objective scientific evidence (Mounteney 1999). Reports of adverse 
effects are more likely to be published than research reporting no 
adverse effects, irrespective of the scientific validity of the research 
(Koren et al 1989). The following information on specific drug effects 
should be read with these limitations in mind.
Substance Misuse in Pregnancy 37
Effects of tobacco 
The significant risks associated with maternal use of tobacco are 
particularly well established. There are many harmful substances 
contained in cigarettes. Nicotine, carbon monoxide and cyanide are 
thought to have the greatest adverse effects, reducing blood flow and 
oxygen to the fetus.
Maternal smoking in the first 12 weeks of pregnancy (until the end of the 
1
st
 trimester) is responsible for up to 25% of all low birth weight babies 
(Scottish Executive 2001). Smoking tobacco causes a reduction in birth 
weight greater than that from heroin and is a major risk factor in Sudden
Infant Death Syndrome (Scottish Executive 2003).
Although there is no convincing evidence that smoking cigarettes causes 
congenital birth defects, many other pregnancy complications are 
associated with smoking (Johnstone 1998). These include:
• miscarriage
• pre-term (premature) delivery 
• stillbirth
• intrauterine growth restriction (IUGR) or ‘small for dates’ 
• low birth weight 
• placental abruption 
• reduction in breast milk production
• Sudden Infant Death Syndrome (SIDS or ‘cot death’).
Babies born to heavy smokers may also exhibit minor signs of withdrawal, 
including ‘jitteriness’ in the perinatal period (Scottish Executive 2003). 
Children of smokers also suffer more respiratory infections in childhood 
and adolescence.
Effects of alcohol 
Alcohol use during pregnancy may potentially affect fetal brain 
development at any gestation. At all points along the continuum from 
occasional light drinking to regular heavy drinking there is conflicting 
evidence as to the possibility of damaging effects on the fetus 
(Mounteney 1999). It is important to remember that a ‘safe’ level of 
alcohol use in pregnancy has not been established.
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Low levels (<7 units per week) of alcohol use during pregnancy appear to 
cause little harm for the baby, although in the 1
st
 trimester it has been 
associated with an increased risk of miscarriage (Taylor 2003).
Maternal consumption of 15 units or more per week has been associated 
with a reduction in birth weight.
Consumption of 20 units or more per week has been associated with 
intellectual impairment in children.
Very heavy drinking in pregnancy (including heavy ‘binge’ drinking) results 
in a small number of babies being born with Fetal Alcohol Syndrome (FAS). 
In Scotland, there are an estimated 38 babies born per year with FAS. 
Fetal Alcohol Syndrome is characterised by: 
• Fetal growth restriction (with subsequent low birth weight, reduced 
head circumference and brain size) 
• Central nervous system problems, including cognitive dysfunction 
(learning difficulties) and neurological abnormalities 
• A cluster of characteristic facial abnormalities e.g. short palpebral 
fissures (eye openings), thin upper lip, flattened midface and indistinct 
philtrum
• Failure to thrive (the child remains below the 10th centile) 
Studies that report alcohol consumption related to FAS have found high 
levels of drinking (>42 units per week). Patterns of consumption also seem 
to be important. Frequent high dose (‘binge’) drinking, to the point of 
intoxication, is thought to be a greater risk to the fetus than steady 
moderate drinking. Many other confounding factors however, may be 
important. These include general physical health, nutrition, age, parity, 
smoking and other drug use as well as social deprivation (Plant 1997, Abel 
1998).
A wide range of other alcohol-related birth defects (ARBD) appear to 
occur with heavy drinking. These ‘fetal alcohol effects’ include more 
subtle problems identified on behavioural, cognitive, psychological and 
educational tests. 
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Effects of drugs (illicit and prescribed) 
As stated earlier, studies examining the effects of drugs in pregnancy are 
fraught with methodological difficulties and multiple confounding 
variables producing inconsistent and contradictory findings.
Drug effects on the fetus are broadly similar and largely non-specific.
Intrauterine growth restriction (IUGR) and pre-term deliveries 
contribute to increased rates of low birth weight and increased perinatal 
mortality rate. These outcomes are multi-factorial and are also associated 
with socioeconomic deprivation, poor maternal health and smoking 
(Department of Health 1999). 
Cannabis (e.g. marijuana or ‘hash’)
Despite its widespread use, information on the effects of cannabis in 
pregnancy is generally poor. A review of cannabis by the World Health 
Organisation (1997) concluded that there was no good evidence that 
cannabis itself has a direct effect on pregnancy or the developing baby.
Cannabis however, is normally mixed together with tobacco and smoked in 
a ‘joint’. Tobacco causes a reduction in birth weight, increased risk of 
sudden infant death syndrome (SIDS or ‘cot death’) and many other 
pregnancy complications (see page 37).
Benzodiazepines (e.g. diazepam & temazepam) 
There is no conclusive evidence that benzodiazepine use by the mother 
causes adverse effects on the developing fetus. Most studies however, 
have studied low dose use, whereas many drug users in Lothian report high 
dose intake. There have been some reports of facial abnormalities (i.e. 
cleft lip and palate) following prolonged high dose benzodiazepine use in 
early pregnancy but these findings have not been reliably reproduced 
(Johnstone 1998). Benzodiazepines are associated with withdrawal
symptoms in the newborn baby that can be severe and prolonged (see 
section on NAS, page 43). Because of concerns about the possible 
increased risk of cleft palate, reduced growth and brain development and 
long-term outcomes for the baby, dependent women are normally advised 
to gradually reduce their benzodiazepine use during pregnancy.
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Opioids (e.g. heroin, methadone, dihydrocodeine) 
Evidence on the effects of opioids is fairly limited, particularly on the 
long-term effects on the child. Opioids are associated with an increased 
risk of:
• low birth weight
• intrauterine growth restriction (IUGR) or ‘small for dates’
• pre-term delivery (associated with fetal withdrawal in-utero, poor diet 
and maternal health) 
• Sudden Infant Death Syndrome (‘SIDS’ or ‘cot death’). 
There is no convincing evidence that opioids cause any significant or 
permanent neurological damage or increased risk of congenital 
abnormalities (Johnstone 1998). 
Abrupt withdrawal of opiates (i.e. ‘cold turkey’) has been associated with 
miscarriage in the 1
st
 trimester and stillbirth and pre-term labour in the 
3
rd
 trimester (Department of Health 1999). Sudden opiate withdrawal is 
therefore considered potentially dangerous to the fetus, although the 
risks of withdrawal have probably been exaggerated in the past and can 
be minimised by appropriate drug therapy for the mother (Johnstone 
1998). Most studies that report these findings relate to women with a 
history of injecting opiate use (primarily ‘heroin’) and chaotic illicit drug 
use. See section on ‘Management of problem drug use’ for further 
information on drug reduction and detoxification during pregnancy (page 
57).
Neonatal Abstinence Syndrome (NAS or ‘neonatal withdrawal’) is well 
documented in babies born to opiate dependent women and is the most 
commonly reported effect of opiate use in pregnancy. For more 
information see section on NAS, page 43. 
Cocaine and ‘Crack’ 
Cocaine is a powerful vasoconstrictor (restricting blood flow and oxygen 
to the fetus) and this effect is reported to increase the risk of: 
• placental abruption (placental separation with haemorrhage and fetal 
hypoxia)
• intrauterine growth restriction (including reduced brain growth)
• underdevelopment of organs and/or limbs 
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• fetal death in-utero (miscarriage and stillbirth)
• low birth weight babies
• pre-term (premature) delivery.
Adverse effects have been largely reported in heavy crack/cocaine users, 
rather than with ‘recreational’ or occasional users. Cocaine ‘binges’ can 
potentially cause fetal brain infarcts due to sudden reduced blood flow 
(Ford & Hepburn 1997). Mothers-to-be should be advised not to use 
cocaine or ‘crack’ in pregnancy if they possibly can.
High dose cocaine use in the mother can result in the newborn showing 
signs of intoxication at birth that include: ‘jitteriness’, irritability, 
hypertonia, poor feeding and an abnormal sleep pattern. Neonatal 
Abstinence Syndrome (NAS) has not been reliably reported (Scottish 
Executive 2003).
Dependent crack/cocaine users should be managed by the consultant 
obstetrician and referred to a specialist drug agency for help (see 
‘services’ list).
Amphetamines (e.g. ‘speed’ or ‘whizz’)
There is no conclusive evidence that amphetamine use directly affects 
pregnancy outcomes. However, amphetamine sulphate is a powerful CNS 
stimulant and heavy users tend to have poor health (due to poor nutrition, 
weight loss, anaemia and mental health problems). Like cocaine, 
amphetamines cause vasoconstriction and hypertension, which may result 
in fetal hypoxia.
Withdrawal symptoms in the newborn baby have not been reliably 
reported with amphetamine use. As with other drugs, in the absence of 
good data, advice should be to avoid or at least reduce intake during 
pregnancy (Johnstone 1998).
Ecstasy (‘E’)
There is no conclusive evidence that ecstasy use directly affects 
pregnancy outcomes, however information in the literature is very scarce. 
Heavy users of ecstasy may have poor physical and mental health (e.g. 
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depression) and this may affect outcome. Ecstasy use by the mother does 
not appear to cause withdrawal symptoms in the newborn baby.
Hallucinogens
(e.g. LSD (lysergic acid diethylamide or ‘acid’) and ‘Magic Mushrooms’) 
There is little evidence regarding the effects of hallucinogens in 
pregnancy. There is no evidence of congenital malformations and no 
conclusive evidence of other increased risks in pregnancy.
Solvents & volatile substances (e.g. ‘glue’ and butane gas)
There is little evidence regarding the effects of solvent and volatile 
substance use in pregnancy. However, inhaled solvents may reduce oxygen 
supply to the fetus and Neonatal Abstinence Syndrome has been reported 
in heavy users. A number of young people in Scotland die each year from 
the effects of volatile substances (usually as a result of arrhythmia) and 
women who continue to use volatile substances in pregnancy run the risk of 
sudden death (Johnstone 1998). 
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Neonatal Abstinence Syndrome (NAS) 
A group of drug withdrawal symptoms referred to as Neonatal Abstinence 
Syndrome (NAS) can occur in infants born to mothers dependent on 
certain drugs. NAS occurs because, at birth, the infant is cut off from 
the maternal drug supply to which it has been exposed in utero.
NAS is the most commonly reported adverse effect of dependent drug 
use in pregnancy. In Lothian, approximately 40 babies present with NAS 
each year and this number is likely to increase with the increasing 
prevalence of substance misuse.
The classes of drugs that are known to cause NAS include the opioids, 
benzodiazepines, alcohol, and barbiturates. Classical symptoms of NAS 
have not been consistently reported with solvents, hallucinogens, cannabis 
and most stimulants (Scottish Executive 2003). NAS symptoms are 
generally non-specific to the class of drug and differ from drug 
withdrawal symptoms seen in adults.
NAS is well described in babies born to opiate dependent women. The 
majority of infants born to dependent mothers (60-90%) will show varying 
symptoms of NAS.
Signs and symptoms of NAS 
NAS is characterised by central nervous system irritability, gastro-
intestinal dysfunction and autonomic hyperactivity.
The following signs and symptoms have been reported in babies born to 
opiate and benzodiazepine dependent women (including polydrug users) 
and describe the more severe range of symptoms that a baby may display: 
• irritability (marked tremor, easily startled, increased reflexes and 
excessive crying) 
• hyperactivity (excessive body movements, face scratching) 
• hypertonicity (increased muscle tone and rigidity)
• a fairly continuous high-pitched cry
• inability to settle or sleep after feeds 
• excessive sucking (including fist sucking) 
• increased appetite 
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• poor feeding ability (hungry but difficulty in sucking, swallowing and 
successfully completing a feed) 
• regurgitation and vomiting 
• frequent loose stools or diarrhoea (which cause peri-anal excoriation) 
• poor weight gain or weight loss 
• repetitive sneezing, yawning, hiccoughs, nasal stuffiness
• tachypnoea (rapid shallow breathing) 
• respiratory depression 
• increased pulse and heart rate 
• temperature instability, fever (>37.5 C), sweating and dehydration
• mottling (discolouration of skin) 
• excoriation (skin abrasions) from excessive movement (usually seen 
around the buttocks, back of the head, shoulders, and heels)
• seizures (fits) 
Seizures occur rarely (in approximately 5% of infants) and may manifest 
up to 30 days after birth (mean age of onset is 10 days). 
The onset, duration and severity of NAS symptoms vary greatly and 
depend on many factors, including the:
• type of drugs used
• duration of mother’s dependency
• timing and amount of the mother’s last dose
• metabolism and elimination of the drug by the infant, as well as the 
• gestational age of the infant.
Data on possible dose related effects of methadone are inconclusive 
(Johnstone 1998). Some studies show no correlation between maternal 
methadone dose and the development or severity of NAS. Others have 
found a weak positive correlation. Little data exists on the dose related 
effects of maternal benzodiazepine use.
Symptoms normally present within the first 24 - 72 hours of birth (in 
approximately 75% of cases). Methadone withdrawal in the neonate can 
present later than heroin withdrawal. Methadone withdrawal symptoms 
can also last longer and be more severe (Sparey & Wilkinshaw 1999). The 
onset of benzodiazepine withdrawal in neonates can also be delayed (due 
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to slow metabolism in the neonate) presenting at 5-10 days of age (Coghlan 
et al 1999).
Acute symptoms of NAS may persist for several weeks and irritability can 
last for some months (particularly from benzodiazepines). Pharmacological
treatment is required for some infants with acute symptoms 
(approximately 25% - 40%). Most studies show that babies who require 
treatment develop symptoms within 72 hours of birth, including babies 
born to methadone dependent women (Shaw & McIvor 1994).
Withdrawal symptoms in pre-term infants tend to occur later than full-
term infants and are generally milder and require less treatment 
(Doberczak et al 1991). This is thought to be due to a number of different 
factors, including: their reduced total drug exposure in utero, the 
developmental immaturity of their central nervous system, the different 
metabolism of pre-term infants, and reduced ability to communicate the 
distress of withdrawal.
Some babies may present with symptoms of NAS with no reported history
of maternal drug use. If NAS is suspected then the neonatal paediatrician 
can confirm the diagnosis by toxicology and will discuss the results 
sensitively with the parents.
Assessment of NAS 
Assessment of the infant is best done using a standardised tool or formal
assessment score chart as this provides the most objective measure of 
symptoms and the best guide for making decisions about treatment and 
care (Shaw 1999).
In Lothian, assessment is normally carried out using either the ‘Lipsitz
tool’ or a modified version of the Finnegan chart (see appendix 10), where 
numerical values are allocated on the basis of the presence and severity 
of various symptoms. The main dimensions that are measured include 
irritability symptoms (high-pitched cry, sleep pattern, body movements 
etc) and gastrointestinal symptoms (feeding pattern, weight, skin 
excoriation etc). A score is allocated to each symptom for each time 
period (e.g. 9am - 1pm, 1pm – 5pm, etc). Total scores for each time period 
are then calculated and trends in the severity of the baby’s condition are 
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monitored. Any drug treatment administered is also recorded on the 
chart. This allows the medical staff to monitor the effectiveness of the 
drug treatment and to titrate the dose according to the infant’s 
presenting symptoms, weaning the baby off gradually.
Applying the NAS score chart to pre-term infants can cause difficulties 
as symptoms such as high pitched cry, poor feeding and tachypnoea could 
be over scored, whilst other symptoms such as sleep pattern, muscle tone 
and fever could be underscored. Pre-term infants are cared for in hospital 
so staff should seek advice from the neonatal paediatrician.
All maternity staff should make themselves familiar with the current 
NAS score chart in use and be able to explain its use to parents. Contact 
your Link Midwife for Substance Misuse for advice if in doubt (see list in 
appendix 2).
Preparing parents for NAS 
It is important to prepare parents for the possibility that their baby 
might develop NAS (even if they are dependent on very low doses of 
medication) and to communicate this information to them sensitively, using 
a non-judgemental approach.
Parents who have an infant with NAS experience the same range of 
emotions as any other parent of a newborn baby who is poorly. Anxiety, 
helplessness, fear and grief are commonly reported feelings. In addition 
they often feel guilty and ‘to blame’ for their baby’s condition and will 
require considerable support, reassurance and encouragement. Caring for 
a baby with NAS can be very stressful and parents will require a lot of 
patience. Involving the parents in all the decisions and choices about their 
infants care and keeping them fully informed of the baby’s progress is 
important.
Ideally, parents will have been given clear and accurate information about 
NAS in the antenatal period so that they are well prepared. At around 32 
weeks, midwives should give all drug and alcohol dependent parents the 
information leaflet ‘Caring for a baby with drug withdrawal symptoms’
(see appendix 12). This leaflet outlines in ‘user friendly’ language, what 
parents can expect and how they can help. The woman and her partner 
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should be advised to read the leaflet then discuss any questions or 
anxieties that they may have with the midwife.
Management of neonatal withdrawal symptoms 
The focus of care should be to: 
 foster the maternal/infant bond
 ensure the safe adaptation of the baby to extra-uterine life 
 detect any evidence of NAS symptoms and to offer appropriate 
treatment and care
Unnecessarily prolonged hospitalisation or placement away from the 
parents should be avoided if at all possible in an effort to keep mother 
and baby together, to enable effective breastfeeding and to promote 
good bonding (Scottish Executive 2003). 
All known drug dependent women should be asked to stay in hospital for a 
minimum of three days (72 hours) following delivery so that the neonate 
can be observed for signs and symptoms of NAS. Most babies with mild to 
moderate symptoms will be cared for in the postnatal ward. Staff in the 
postnatal ward should show parents how to use the NAS assessment score 
chart (see appendix 10) and encourage them to get involved in their baby’s 
care from the very beginning. Parents should be advised to keep a close 
eye on their baby and report any concerns to staff.
Babies with mild symptoms will not require medical intervention and can be 
looked after using supportive ‘comfort’ measures.
Supportive ‘comfort’ measures include: 
 Provide a supportive environment (ensure minimal stimulation to the 
infant by decreasing stimuli in a quiet room with dim lighting, mild 
temperature, soft gentle music, no smoking near baby). If appropriate 
the mother should be offered a single room in hospital so that a 
suitable environment can be created for the baby. 
 Recommend ‘skin-to-skin’ contact with mother to help regulate the 
baby’s breathing and body temperature, relaxation and feeding. The 
mother should be asked to read the ‘skin-to-skin’ leaflet. 
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 Swaddling of the baby will help with tremors, jerks and restlessness. 
When handling, wrap limbs (with arms and knees bent into a 
comfortable position) with a light soft flannel blanket, perhaps use a 
cotton baby sling. 
 Ensure gentle handling of the baby, gentle wakening, gentle rocking, 
humming, perhaps try gentle baby massage and deep relaxation bath. 
Before disturbing the baby for changing, prepare everything that is 
needed.
 Provide a dummy or pacifier for non-nutritive sucking (except when 
breastfeeding). Cover the infant’s hands with mittens to prevent 
trauma to fingers and fists.
 Ensure frequent changes of the baby’s nappy. Use barrier creams to 
the skin around buttocks to prevent skin damage from frequent loose 
stools and excessive body movements.
 Feed the infant on demand, small frequent feeds are normally better 
and will reduce regurgitation and vomiting and prevent dehydration. 
Burp the infant frequently as infants often swallow air due to their 
uncoordinated and poor sucking reflex.
 If the baby’s sucking and swallowing reflex is poor then support the 
cheeks and lower jaw to enhance feeding. 
 If the baby is being breast fed, feed in quiet, calm surroundings with 
minimal noise and disturbance and allow time for resting in-between 
sucking.
 Observe baby’s temperature and remove blankets if fever is present. 
Clean skin and change clothes frequently if baby is sweating.
The use of supportive therapy has been shown to reduce the effects of 
withdrawal in neonates and should be implemented as soon as possible 
following birth. Parents should be encouraged to take a lead role in their 
infants care and should be provided with this information so that they can 
care for their baby appropriately. 
Please note: naloxone (an opiate antagonist) should not be used to reverse 
opioid induced respiratory depression in neonates as this will induce an 
abrupt opiate withdrawal crisis.
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Care in the community 
After 72 hours stay on the postnatal ward, babies with mild to moderate 
symptoms can be discharged home where they can be cared for by their 
parents with community midwifery and health visiting support. The 
midwife will offer advice and support on a daily basis and will arrange for 
readmission to hospital if the baby’s symptoms worsen. As part of the 
infant’s ongoing care, parents should be advised to continue using the NAS 
assessment score chart and supportive therapy measures until the baby’s 
symptoms have resolved. Parents should be advised to record all feeds 
(amounts taken and times) so that the midwife and health visitor can 
monitor the baby’s daily calorie intake. The community midwife and health 
visitor will also weigh the baby to ensure weight gain is satisfactory.
If the baby’s symptoms get significantly worse at home (i.e. sleeps less 
than 1 hour/ cries 1 hour after feeds/ weight loss after day 7) then it is 
better to admit the baby to hospital earlier rather than later. If the baby 
has been home for less than a week, or is less than 10 days old they may 
be admitted to the Neonatal Unit at RIE, Little France or Special Care 
Baby Unit (SCBU) at St John’s Hospital, West Lothian. If the baby is 
more than 10 days old they are likely to be admitted to Sick Children’s 
Hospital (RHSC) or the Children’s Ward at St John’s Hospital. Community 
staff should discuss admission with the Neonatal Unit / SCBU first. 
Care in hospital 
Parents need to know that admission to the Neonatal Unit at Little France 
or the SCBU at St John’s Hospital is necessary if their baby develops 
severe withdrawal symptoms.
Babies with severe symptoms often require ‘tube’ feeding, pharmacological 
(drug) treatment and 24-hour care and supervision from specialist 
paediatric medical and nursing staff.
The aim of treatment is to: 
 reduce irritability and motor instability 
 establish an appropriate feed/sleep/wake cycle 
 maintain a normal body temperature, and 
 ensure adequate weight gain. 
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Babies with severe symptoms usually stay in the unit for about 10-14 days, 
but sometimes for much longer. Mothers are encouraged to ‘board’ (rooms 
permitting) in the hospital whilst their baby is in the unit (particularly if 
they are breastfeeding) or at least have daily contact to continue the 
bonding process.
In Lothian, pharmacological management is decided by the attending 
physician but normally includes the use of one or more of the following 
drugs: oral morphine, diazepam, clonazepam, clonidine, phenobarbitone, 
chlorpromazine or chloral hydrate. The best drug appears to be morphine 
if the main drug used by the mother has been an opioid. Where other 
drugs (e.g. benzodiazepines) have been used alone or in combination, drug 
therapy needs to be individually tailored towards a longer or biphasic 
pattern of withdrawal (Shaw 1999). Care is taken not to sedate the baby 
and to wean them off medication as soon as possible. Babies can be 
discharged home as soon as they are well enough to be cared for by their 
parents.
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Management of substance use in pregnancy 
Many women who are not truly dependent on alcohol or drugs will stop 
spontaneously as soon as they know they are pregnant. This applies to 
approximately 20% of women who smoke and to many women who use 
cannabis and other drugs ‘recreationally’. It also applies to some 
‘controlled’ opiate and benzodiazepine users (Johnstone 1998). For most 
drug use (excluding opiates) the immediate goal would be one of 
abstinence, although in reality this may be difficult to achieve for many 
women. Much support and drug counselling may need to be offered to help 
the woman work towards this goal.
In addition, research shows that women who have substance misuse 
problems are more likely to have substance-misusing partners (Effective 
Interventions Unit 2002). Substance-misusing sexual partners can exert a 
powerful influence over a woman’s drug use. It is very important 
therefore, to include the woman’s partner (where appropriate) in any 
treatment and care plan so that the most supportive environment can be 
created. Evidence suggests that women, who engage in treatment with,
rather than without, their partner, have better outcomes (Effective 
Interventions Unit 2002). 
Smoking cessation
All women should be advised to stop smoking or given help to cut down, 
preferably before they conceive. General Practitioners can prescribe 
nicotine replacement therapy (NRT) and can refer to smoking cessation 
programmes. Bupropion (Zyban®) can also help with nicotine cravings, 
however women who are pregnant or breastfeeding should not use 
bupropion (NICE 2002).
During pregnancy a pro-active approach to smoking cessation is required. 
Smoking cessation advice given in the antenatal period has been shown to 
be effective and can result in significant gains in birth weight (Johnstone 
1998).
Many drug and alcohol dependent women however, may find it difficult to 
stop smoking. Pregnant women who are strongly nicotine dependent and 
unable to quit unaided, can be offered nicotine replacement therapy (NRT) 
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following discussion with a health care professional or as part of the 
‘Want 2 Quit’ programme, which includes an assessment of motivation, 
counselling and support. Although NRT is not licensed for use during 
pregnancy, a number of leading experts have put forward a rationale for 
treating pregnant smokers with NRT (Wright & Walker 2001). The use of 
NRT can benefit the mother and fetus if it leads to cessation of smoking. 
Nicotine levels in the body whilst on NRT are typically lower than those 
present during heavy smoking and the many other toxins emitted by 
cigarette smoke, such as carbon monoxide are avoided.
Many areas throughout Lothian now have smoking cessation support groups 
and practitioners who have a specific remit for smoking cessation. Contact 
the local GP surgery, local pharmacy, Health Visiting or Midwifery service 
for further information. Information leaflets on smoking cessation are 
available for women and their partners and can be given out during pre-
conceptual and antenatal consultations (available from NHS Health 
Scotland). The National Institute for Clinical Excellence (NICE) also has 
guidance on NRT in their ‘Information for Patients’ leaflet 
(www.nice.org.uk).
It is easy to forget the risks associated with smoking in pregnancy when 
working with women who are using a whole variety of other drugs. Many 
women themselves are more concerned about the effects of other drugs, 
especially opiates. Professionals need to remind themselves that providing 
information on the risks of smoking is important if they are to convey a 
balanced and consistent message on the subject.
Advice on alcohol consumption 
‘Safe’ levels of alcohol use in pregnancy have yet to be precisely 
established, so ideally women should abstain from alcohol during 
pregnancy. Alcohol differs from other drugs in that it is generally 
considered socially acceptable to drink occasionally. If a pregnant woman 
chooses not to drink during her pregnancy then she should be encouraged 
for this decision and not pressured to drink.
The Royal College of Obstetricians and Gynaecologists (RCOG) recommend 
that pregnant women be advised not to drink more than one unit of alcohol 
per day (Taylor 2003).
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Scottish Executive advice recommends no more than ‘1 to 2 units, once or 
twice a week’ (HEBS 2002). Pregnant women who are concerned about low 
levels of consumption can be reassured that one or two small drinks a day 
(i.e. <14 units per week) is unlikely to do any harm (Mounteney 1999).  
 
Please note:  
One ‘unit’ of alcohol is the equivalent to:  
 half a pint of 3.5% beer,  
 
 
See SIGN guidelines ‘The Management of Harmful Drinking and Alcohol 
Dependence in Primary Care’, Annex 1 (2003) www.sign.ac.uk for more 
detailed information on alcohol unit measures.  
 
Remember that home measures are often much larger than pub measures. 
‘Sensible drinking’ for women who are not pregnant is defined as not 
consuming more than 3 units in any day (i.e. no more than 21 units per 
week), and avoiding any heavy ‘binge’ drinking, defined as consuming double 
the recommended daily amount on one occasion i.e. 6 units or more for 
women (Scottish Executive 2002). 
 
Antenatal screening for problem drinking 
It is important that information on alcohol consumption is integrated into 
routine history taking in antenatal care. Routine antenatal care provides a 
useful opportunity to screen for hazardous levels of drinking and to 
deliver brief interventions for reducing alcohol consumption (Chang et al 
1999). Pregnant women in Lothian are routinely asked about their alcohol 
consumption at the ‘booking appointment’ when they see the midwife, but 
little follow-up questioning occurs (McIntosh 2001). Alcohol use, 
especially at the level of harmful use, often goes undetected. Women 
who drink heavily before conception are more likely to continue drinking 
heavily during pregnancy without intervention and concurrent drug and 
alcohol use is associated with poorer outcomes (Robertson 1998). It is 
important that these women are identified early in pregnancy and are 
offered help. 
 
 
one 25ml measure of spirits,  
 On e small (125ml) glass of average strength (12%) wine contains 1.5 units. 
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There is good evidence that screening questionnaires (such as TWEAK,  
T-ACE or shortened versions of AUDIT) can improve detection of problem 
drinking in pregnancy and are easy and quick to administer in antenatal and 
obstetric settings (Bradley et al 1998). The Royal College of Obstetricians 
and Gynaecologists (RCOG) recommends the ‘T-ACE’ screening test as the 
most effective way of detecting harmful levels of alcohol consumption in 
pregnancy (Taylor 2003). Routine antenatal screening, using the T-ACE 
screening test is therefore recommended in Lothian (see appendix 7). 
This simple four-question test that takes about one minute to ask will 
correctly identify the majority (approximately 70%) of hazardous 
drinkers during pregnancy. The T-ACE questions are listed below. 
 
T (tolerance) How many drinks does it take to make you feel high? 
  Answer: ‘3 or more drinks’ scores 2 points 
 
A (annoyance) Have people annoyed you by criticising your drinking? 
  Answer: ‘Yes’ scores 1 point 
 
C (cut down) Have you ever felt you ought to cut down your  
  drinking? 
  Answer: ‘Yes’ scores 1 point 
 
E (eye-opener) Have you ever had a drink first thing in the morning to 
steady your nerves or to get rid of a hangover? 
 Answer: ‘Yes’ scores 1 point 
 
A total score of greater than or equal to two points is considered positive. 
 
Management of problem alcohol use 
Most women will cut down their alcohol consumption when they find out 
they are pregnant or when they are given advice to do so. Brief 
interventions, harm reduction advice, motivational interviewing and relapse 
prevention techniques are effective methods of reducing low to moderate 
levels of drinking. For further information on these interventions see 
www.alcoholconcern.org.uk, refer to ‘The Management of Harmful Drinking 
and Alcohol Dependence in Primary Care’ (SIGN guideline 2003) and ‘Brief 
Interventions’ factsheet (Alcohol Concern 1997). 
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If a ‘hazardous’ drinking score is obtained using the T-ACE test then 
professionals should consider offering the woman one or more of the 
following interventions: 
 Give the woman clear advice to cut down her alcohol consumption; 
refer her to page 8 of the ‘Ready Steady Baby’ book
 Ensure the woman is educated about the increased risks associated 
with moderate to high levels of drinking in pregnancy
 Give the woman the self-help booklet ‘So you want to cut down your 
drinking?’ (HEBS 1998) 
 Complete a ‘drink diary’ (see appendix 8) by asking the woman to detail 
what she had to drink on each of the previous seven days 
 Ask the woman to describe in more detail her pattern of drinking and 
alcohol consumption before conception and since conception
 Discuss your concerns with the woman’s midwife, consultant 
obstetrician, GP or other ‘key worker’ (preferably with the client’s 
consent)
 Arrange an appointment for the woman to see the consultant 
obstetrician or GP
 Consider referral to an alcohol service for specialist assessment and 
advice (gently broach this subject with her and obtain consent before 
referral)
Alcohol detoxification 
Dependent alcohol use is such a serious risk to the fetus that 
detoxification should be considered at any gestation. Tolerance to alcohol 
normally develops at high levels of consumption; however tolerance may 
develop at lower levels of consumption in some women using multiple drugs. 
Sudden cessation of heavy drinking is potentially dangerous to the mother 
(because of seizures) and may cause fetal distress. Alcohol dependent 
pregnant women should be advised not to suddenly stop drinking but to 
consult their GP as soon as possible. Alcohol detoxification requires close 
monitoring of mother and fetus under specialist medical supervision that 
includes collaboration with an obstetrician and alcohol specialist and is 
normally conducted in an inpatient setting (Plant 2001). Since the effects 
of alcohol are associated with dietary deficiencies, the importance of a 
balanced diet and vitamin supplementation should be discussed. Liver 
function tests, including prothrombin time should be measured. Disulfiram 
(Antabuse®) is contraindicated for women who are pregnant or 
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breastfeeding because of the risk of teratogenic effects. Women who 
conceive whilst taking this drug should receive counselling before deciding 
to continue with the pregnancy (Plant 2001).
Those women who report that they are unable to reduce high levels of 
consumption should be referred to the Alcohol Problems Service (APS) at 
the Royal Edinburgh Hospital for specialist assessment and help (see 
‘services list’ for details). Pregnant women who are drinking heavily are 
seen as a high priority for the APS. Any referral will be dealt with 
promptly and the woman would be offered in-patient and/or out-patient 
care depending on her circumstances. Referrals should be made in writing. 
Any professional can refer and a quick assessment can be offered. 
Alternatively, contact your local APS Community Mental Health Nurse for 
advice and information.
Women who are in-patients or attending out-patients in the hospital
setting can be referred to the Department of Psychological Medicine
based at the Royal Infirmary. Two specialist alcohol liaison nurses work as 
part of this team and can offer assessment and advice. In West Lothian, a 
member of the liaison psychiatry team will see in-patients in St John’s 
Hospital (see ‘services list’ for details). Other specialist alcohol services 
are included in the services list.
Please note: Alcohol detoxification should be discussed and agreed with 
the woman’s consultant obstetrician and alcohol specialist beforehand and 
should be part of a package of care that includes relapse prevention (see 
section ‘Risk of relapse’, page 92). 
Substance Misuse in Pregnancy 57
Assessing drug related problems 
It is important to establish an accurate picture of a woman’s drug use 
during pregnancy so that appropriate interventions and care can be 
offered.
An assessment of drug use during pregnancy may include such things as: 
 taking a detailed history of the woman’s drug use 
 asking the woman to complete a ‘drug diary’ (see appendix 8)
 assessing drug-related harm (e.g. the physical, psychological, social, 
legal, financial, lifestyle consequences of the woman’s drug use)
 assessing the woman’s aspirations and motivation to change
 toxicology (to screen for recent drug use) 
 assessment of withdrawal symptoms 
 tolerance testing or supervised self-administration of methadone. 
Professionals who are involved in the assessment or care of a woman with 
a drug related problem should: 
 Discuss the woman’s care with her General Practitioner or other 
prescriber
 Refer the woman to an appropriate drug service if she is not already 
attending one so that an assessment can be made 
 Seek advice from the woman’s drug treatment specialist. 
Management of problem drug use
The key aim of professionals should be to attract women into health and 
social care treatment services, provide antenatal care and stabilise or 
reduce drug use to the lowest possible dose (Department of Health 1999). 
Much of the skill in drug management lies in planning realistic and 
achievable goals with each individual woman. Professionals need to be 
careful not to force their own ideals or ‘agenda’ on the woman. Many 
women already feel guilty and worried about the effects their drug use 
may be having on their unborn child. If women feel they are not meeting 
the perceived expectations of professionals they may under-report their 
drug use and conceal any difficulties they may be experiencing. Trying to 
persuade a woman to reduce or stop using drugs may simply alienate her, 
lead to relapse and a sense of failure and result in non-attendance. 
Different treatment options need to be considered in the light of the 
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woman’s aspirations and particular social and psychological circumstances. 
Drug use may have been an integral part of the woman’s lifestyle for many 
years and she may have no intention of changing this. She may have had a 
previous pregnancy whilst using drugs with no apparent ill effects. This 
may be reinforced by drug-using friends who have also successfully 
delivered healthy babies (Johnstone 1998).
Different drug treatment options to consider include: 
 Safer drug use advice and education 
 Needle exchange and safer injecting advice 
 Substitute prescribing 
 Stabilisation
 Slow reduction
 Detoxification
Safer drug use 
Injecting and chaotic drug use in pregnancy is associated with increased 
risks for both mother and baby. These risks include:
• sudden death through drug overdose
• transmission of blood borne viruses (including HIV, hepatitis C and 
hepatitis B)
• other complications associated with poor injecting practices and the 
contaminants contained in non-pharmaceutically prepared street drugs
• pre-term labour and delivery 
• multiple social problems 
Reducing illicit, chaotic and injecting drug use in pregnancy is 
therefore an important goal to work towards.
Pregnant women who are injecting drugs can be referred to the Harm
Reduction Team (HRT) at Spittal Street Centre for supplies of clean 
injecting equipment, specialist advice about safer injecting practices and 
the ‘low threshold’ methadone programme. Free supplies of clean needles & 
syringes can be obtained from many pharmacies throughout Lothian. 
Contact the HRT (Tele 0131 537 8300) for a list of pharmacies who 
participate in the needle exchange scheme. Alternatively, refer women to 
your local voluntary sector drug agency as most provide needle & syringe 
exchange services as well as harm reduction advice. See ‘services list’.
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Substitute prescribing 
Lothian has a longstanding history of community based drug services, 
which provide a range of treatment and care approaches. Many people 
with a drug dependency in Lothian are prescribed substitute drugs for the 
treatment of opioid and benzodiazepine dependence (approximately 3000). 
Many attend their General Practitioner and other specialist drug services. 
Pregnant women drug users are seen as high priority for the Community
Drug Problem Service (CDPS) and most other drug services in Lothian.
Lothian’s policy and guidelines on prescribing drugs for the treatment of 
drug dependence are outlined in a handbook entitled ‘Managing Drug Users 
in General Practice’ (Lothian Primary Care NHS Trust, 4
th
 Edition 2003). 
The Primary Care Facilitator Team (HIV/Drugs) oversees the ‘Scheme for 
supporting the care of drug users in general practice’ and regularly visits 
participating Primary Care Teams to discuss policy and practice. For 
further information refer to the handbook. 
Methadone maintenance for opioid dependence is recommended by the 
Department of Health (1999) and is the most generally accepted 
treatment for opiate dependent pregnant women (Kandall et al 1999). 
Methadone is normally taken orally in liquid form (methadone mixture 
1mg/1ml). It is used to help people stabilise their drug intake and 
associated lifestyle. Because methadone mixture is long-acting it offers 
stability of drug levels for both mother and fetus. 
There is strong research evidence (Department of Health 1999) for the 
benefits of methadone maintenance treatment when given consistently, in 
adequate dosage, with adequate supervision and in the context of 
psychosocial support. Five identified benefits according to the research 
literature (Ward et al 1998) include the:
 reduction of injecting behaviour 
 reduction of the risk of viral transmission (HIV, hepatitis B & C)
 reduction of drug related deaths
 reduction of illicit drug use
 reduction of offending behaviour
Follow-up studies suggest the long-term outcome in women who enter 
methadone treatment programmes during pregnancy is better in terms of 
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their pregnancy, childbirth and infant development, irrespective of 
continued illicit drug use (Department of Health 1999). Women attending 
treatment services usually have better antenatal care and better general
health than drug-using women not in treatment, even if they are still using 
illicit drugs on top of their substitute prescription. 
Dihydrocodeine (DF118) is another opiate drug that is prescribed in 
Lothian and is currently being researched for its comparative 
effectiveness with methadone. Local guidelines (Lothian Primary Care 
NHS Trust 2003) recommend prescribing a maximum of 15 x 30mg tablets 
per day. Doses above this amount should only be exceeded in consultation 
with the Community Drug Problem Service (CDPS). The CDPS also 
prescribes buprenorphine (an opiate partial agonist) for supervised drug 
detoxification programmes and for maintenance prescribing. Both 
dihydrocodeine and buprenorphine have also been used as substitute drug 
therapy in pregnancy and there is some evidence to suggest that babies 
born to these mothers may be at lower risk of Neonatal Abstinence 
Syndrome than with other opiates (Wright & Walker 2001).
Lothian also has a longstanding history of prescribing substitute drug 
treatment for benzodiazepine dependency. This treatment approach has 
changed in recent years due to lack of evidence for its effectiveness and 
concerns that long term benzodiazepine use may cause harm in the form 
of cognitive impairment and mood disturbance. Many drug users in Lothian 
however, continue to be prescribed diazepam (Valium®). The 
recommended maximum dose of diazepam is now 30mg per day. GP’s are 
advised to reduce doses larger than this and not start any new drug user 
on prescribed benzodiazepines. Women who are prescribed 
benzodiazepines are normally advised to reduce to the lowest possible 
dose in pregnancy and should be prepared for the likelihood of Neonatal
Abstinence Syndrome if they remain benzodiazepine dependent (see 
section on NAS, page 43). 
Stabilisation
Pregnant women who are opiate dependent should not be required to make 
a commitment to reduce or come off their prescribed opiate drugs. The 
emphasis instead should be on support and engagement rather than 
enforced reduction or abstinence (Wright & Walker 2001). Stabilised
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drug use should be the first goal to work towards and may take some time 
to achieve. The aim is to minimise the risks to mother and baby, not only 
during pregnancy and the neonatal period, but ideally in the long term. 
Stable drug use, a stable lifestyle and abstaining from illicit (street) drug 
use are successful outcomes of treatment.
If non-prescribed opiate use persists, the methadone dose may need to be 
increased in order to achieve stability and to help the woman abstain from 
street drug use (Department of Health 1999). However, the risk of 
overdose if other drugs are taken and the likelihood of Neonatal
Abstinence Syndrome (NAS) need to be understood by the woman (see 
section on NAS, page 43). 
Some studies show that plasma levels of methadone decrease with 
gestation (Johnstone 1998). This may be due to the increased fluid space 
and a large tissue reservoir as well as altered metabolism of the drug by 
the placenta and fetus. Lowering the dose to avoid complications may 
therefore be inappropriate and the woman may require an increase in 
methadone during gestation. Advising the woman to try dividing her daily 
dose can sometimes overcome the need for an increase (Department of 
Health 1999). Conversely, in the immediate postnatal period, a reversal of 
these effects may lead to increased methadone plasma levels with 
intoxication effects and the dose may need to be reduced. It is important 
to warn the woman about this effect as it may have implications for the 
care and safety of the baby. 
Reduction
Slow reduction in pregnancy is also an option but should be gradual, 
stepwise and tailored to the woman’s response. Generally the principle of 
incremental reductions in drug dosage to a level that minimises withdrawal 
in the fetus should be explored with the woman. If the woman is 
dependent on benzodiazepines as well as opiates, then she should be 
advised to try reducing her benzodiazepines first (Lothian Primary Care 
NHS Trust 2003). Diazepam (Valium®) is the drug of choice to prescribe, 
as it is longer acting than other benzodiazepines. Diazepam should be 
prescribed at no more than 30mg daily, reducing fortnightly-monthly in 
2mg to 5mg decrements. Methadone can be reduced weekly or fortnightly 
in 2.5ml to 5ml decrements. Dihydrocodeine (‘DF118’) can also be 
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prescribed at no more than 30mg tablets x 15 per day, reducing one tablet 
per week for 15 weeks. Women who are on buprenorphine when they 
become pregnant should be referred to the CDPS for specialist drug 
management.
The woman’s stability should be reassessed at each stage of the reduction 
before proceeding further. If the woman has not relapsed back into illicit 
drug use (this may be confirmed through toxicology) and wishes to 
continue the reduction, then proceed. If the reduction is commenced early 
in the 2
nd
 trimester (i.e. 13 weeks) it may be possible to achieve dosages 
low enough at delivery to avoid significant withdrawal symptoms in the 
neonate (e.g. a dose less than 20mg of methadone or 150mg of 
dihydrocodeine). However, the woman needs to understand that this 
cannot be guaranteed and the parents should still be prepared for NAS 
(see section on NAS, page 43). 
Detoxification
Detoxification from opiate drugs may be considered at any gestation, 
however it is normally recommended during the 2
nd
 trimester (Department 
of Health 1999). Rapid detoxification should be avoided in late pregnancy 
(Johnstone 1998). In the 1
st
 trimester it is associated with an increased 
risk of miscarriage and in the 3
rd
 trimester it has been associated with 
pre-term labour (Department of Health 1999). Opiate detoxification is 
rarely fatal for the mother and less serious than withdrawal from 
benzodiazepines or alcohol, but can be very unpleasant.
Rapid benzodiazepine detoxification should be avoided as this can lead to 
withdrawal seizures (fits) in the mother and fetal distress (Department 
of Health 1999). Detoxification treatment should be similar to that of 
alcohol detoxification. Hospital or residential admission is necessary to 
supervise a gradual titrated detoxification and to monitor the fetus. 
Detoxification should be discussed and agreed with the woman’s 
consultant obstetrician and drug specialist / prescriber beforehand and 
should be part of a comprehensive package of care that includes relapse 
prevention (see section ‘Risk of relapse’ page 92).
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A final word: 
Over the years, much emphasis has been placed on pregnancy being a 
‘catalyst for change’ or a ‘window of opportunity’ for women to either stop 
using drugs or to reduce their drug use and many pregnant women will tell 
professionals that this is what they want to do. In Lothian, as in other 
areas throughout Britain, experience has shown that this has not generally 
proved to be the case. Many women who try to reduce or come off drugs 
during pregnancy are not successful. However, all attempts that pregnant 
women make to improve their health and social circumstances should be 
supported by professionals and be regarded as a successful outcome of 
care.
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Maternity care 
The next section of the resource pack provides information and guidelines
on good practice for maternity care. Maternity care includes: 
• pre-conceptual care
• antenatal care 
• intrapartum care 
• postnatal care/parenthood
Pre-conceptual care
Good health and social circumstances before pregnancy benefits the 
woman, her unborn baby and the wider family (Scottish Executive 2001). 
All professionals should routinely ask women whether they have any plans 
to have a child in the near future, or whether they may be currently 
pregnant (Scottish Executive 2003). This questioning needs to be done 
sensitively as part of the overall assessment and care planning process. 
Helping a woman prepare and plan for pregnancy and motherhood provides 
a good opportunity to offer healthy lifestyle and harm reduction
education and advice. 
All women with drug and alcohol related problems could benefit from 
receiving information and advice on: 
 contraception
 sexual health
 reproductive health
 pre-conceptual care. 
Reproductive health and drug use 
Reliable information on how drug use affects women’s reproductive health 
has been difficult to establish and findings are often inconclusive. 
Theoretically, illicit and dependent drug use can affect fertility in a 
number of ways (Ford & Hepburn 1997).
Substance misuse is associated with poor nutrition and loss of appetite. 
Significant weight loss can cause amenorrhoea (absent periods) with 
anovulation (failure to ovulate or produce eggs). Opiates (such as heroin, 
methadone & DF118) and stimulants (such as amphetamines, cocaine & 
ecstasy) can interfere with a woman’s monthly cycle in this way.
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Amenorrhoea does not necessarily mean that the woman is unable to 
conceive (fall pregnant) as she may still be ovulating, so effective 
contraception to avoid unwanted pregnancies is still required. Irregular or 
absent periods means that some women may not realise they are pregnant 
until late in pregnancy when fetal movements are felt, or until other 
changes are noticed. 
Fertility may increase around the time when a woman reduces or comes 
off drugs or when she starts treatment with substitute drugs, such as 
methadone. Offering contraceptive advice and pre-conceptual counselling 
therefore needs to go hand in hand with the beginning of any drug 
treatment (Ford & Hepburn 1997).
All professionals can encourage women to attend health care services that 
provide contraceptive and sexual health advice and care. GPs and family 
planning clinics will discuss contraceptive options and advise women about 
how to get emergency contraception if needed.
Women with substance misuse problems may plan to conceive or may have 
an unplanned pregnancy. If pregnancy is planned then pre-conceptual care
can be offered.
Pre-conceptual advice 
Health, social and voluntary sector professionals all have a role to play in 
providing pre-conceptual care to women with substance misuse problems 
(Ford & Hepburn 1997). General Practitioners are in an ideal position to 
provide pre-conceptual care to drug-using women who are attending their 
medical practice for a substitute prescription. If the woman is attending 
the Community Drug Problem Service (CDPS) or Harm Reduction Team 
(HRT) for her prescription then specialist drug workers have an excellent 
opportunity to provide pre-conceptual care. Other workers can address 
many of the social issues and encourage women to attend to any health 
checks that they may need.
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Pre-conceptual care may include a discussion on some or all of the 
following topics:
 Information on maternity services in Lothian and the importance of 
antenatal care 
 The woman’s past obstetric history, including past pregnancy outcomes 
and the health and social circumstances of previous children 
 The importance of good nutrition and a healthy balanced diet 
 The use of folic acid to prevent neural tube defects 
 Checking for rubella immunity and vaccination if indicated
 Testing for sexually transmitted diseases if needed e.g. chlamydia 
 Cervical smear if needed 
 Screening for toxoplasmosis and cytomegalovirus (if HIV positive or 
immunosuppressed)
 The importance of good oral hygiene and dental care
 The benefits of breastfeeding
 Immunisation for hepatitis B, and possibly hepatitis A 
 Healthy lifestyle education, including physical exercise, reducing stress 
etc
 The importance of post-natal contraception and preventing unwanted 
pregnancies
 Assessment of other physical and psychological health problems that 
may affect pregnancy and parenthood i.e. significant illnesses, 
domestic abuse, past or present mental health problems etc 
 Assessment of social circumstances, including such issues as housing, 
debts and welfare benefits, employment and training, offending 
behaviour and legal circumstances etc
 Assessment of support networks, including partners, parents, other 
family members and friends
 The partner’s history of drug / alcohol related problems, including 
their current use and level of stability if drug dependent 
 Advice on relationships and the transition into parenthood 
 Advice on child development, parenting skills and information on child 
care services
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Pre-conceptual advice on drug use can include: 
 The risks associated with smoking in pregnancy and information on 
smoking cessation 
 The risks of moderate to excessive alcohol use in pregnancy and advice 
on how to cut down consumption 
 Information on alcohol services in Lothian and how to access them 
 The risks associated with illicit drug use, in particular injecting drug 
use
 The risk of Neonatal Abstinence Syndrome (NAS) in babies born to 
dependent mothers 
 Options for drug management in pregnancy and the importance of 
substitute prescribing and stability for opiate dependent women 
 Information on drug services in Lothian and how to access them 
 Testing for blood borne viruses (HIV, hepatitis C & hepatitis B)
 Information on mother-to-baby transmission of blood borne viruses 
and how this can be reduced 
All women with a poor obstetric or medical history, or a previous poor 
fetal or obstetric outcome, or a family history of significant illness should 
be offered specific pre-conception services (Scottish Executive 2001). 
The woman should be encouraged to discuss this with her General 
Practitioner in the first instance. 
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Antenatal care 
Receiving good quality antenatal care is known to improve pregnancy 
outcomes, irrespective of continued drug/alcohol use (Department of 
Health 1999). All women with substance misuse problems should be told 
about the benefits of antenatal care and advised to attend early in 
pregnancy.
Maternity care in Lothian is now essentially community based and midwife
managed. Care is ‘individualised’ and depends on the needs of the individual 
woman and her circumstances. Midwives follow an ‘Care Pathway’ for 
antenatal and postnatal care, which includes routine antenatal 
appointments, screening tests and other procedures during pregnancy 
(depending on parity), parenthood education, preparation for childbirth 
and postnatal visits.
Community midwives and GPs now successfully manage the majority of 
pregnant women with substance misuse problems. All women identified as 
having a drug or alcohol related problem should have two named midwives 
involved in their care to ensure continuity of care. The Consultant 
Obstetrician is informed of the woman’s drug and/or alcohol use and will 
jointly manage her care in the community. Most Consultant Obstetricians 
now run outreach clinics in community health centres throughout Lothian 
and can see the woman close to her place of residence. Only a small 
number of substance-misusing women need to be referred to the ‘high
risk’ clinic for management by the obstetrician, and this is normally for 
other pregnancy complications (e.g. HIV positive).
All pregnant women receive a copy of the ‘Ready Steady Baby’ book 
(produced by NHS Health Scotland), which contains comprehensive 
information on all aspects of pregnancy, childbirth and postnatal care and 
will help the woman in her decision-making. The GP will normally give a copy 
of the book to the woman at confirmation of pregnancy or the midwife will 
give it to her at booking.
Hand held maternity records 
All pregnant women now receive a unified multi-professional woman-held
maternity record. This is normally given to the woman at around 16 weeks 
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gestation and she keeps it until she is admitted into hospital for delivery. 
The woman is encouraged to contribute to her notes if she wishes. Record
keeping is an integral part of care. All professionals involved in a 
woman’s care should ensure that important information is put in writing
and included in the woman’s maternity record. Guidance on the terms of 
the Data Protection Act 1998 (see leaflet ‘Protecting personal health 
information’) and confidentiality, need to be explained to the woman. The 
consent form for sharing information between professionals involved in 
the woman’s care should also be included in the woman’s notes (see 
appendix 5).
The ‘booking appointment’ 
As early as 6 weeks of pregnancy the woman can attend for a ‘pre booking’ 
appointment with the community midwife to start her antenatal care, 
although this is not routinely offered. Pregnant women can either self 
refer to the midwifery team, or be referred by their GP or other agency. 
The booking appointment is normally arranged for 12 weeks gestation and 
is a very important appointment for the woman to attend. At the booking 
appointment the midwife completes a comprehensive assessment of the 
woman’s needs and will plan pregnancy care with the woman. The midwife 
also undertakes a risk assessment to take into account any factors that 
might affect pregnancy outcome and the woman’s ability to care for her 
baby. All women receive their care in the community unless they have been 
identified as ‘high risk’, in which case they will have their care managed by 
a Consultant Obstetrician who may arrange for their care to be delivered 
in the hospital. 
At the booking appointment the midwife routinely asks about all drug use, 
including smoking, alcohol use, illicit drug use and prescribed drug use. 
Drug taking details are recorded in the woman’s hand held maternity 
record, unless she requests otherwise.
Women who have a drug or alcohol related problem are asked to provide 
information for the ’Antenatal liaison form (Substance Misuse)’ (see 
appendix 9) which provides maternity staff with more detailed 
information on the woman’s drug/alcohol use and social circumstances. 
This form is included in the woman’s records and will follow her through 
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the antenatal ward, labour ward, and postnatal ward. This enables 
intrapartum and postpartum care to be co-ordinated and tailored to the 
special needs of the woman and baby whilst in hospital. If the woman does 
not want the form to be included in her hand held records (for instance 
because of concerns about confidentiality) then it should be filed in the 
supplementary notes file which is held in hospital admissions (RIE).
At booking, the community midwife should give all pregnant women with 
drug and alcohol related problems a copy of the information booklet
called ‘Pregnant… and using alcohol or drugs?’ (see appendix 11). The 
woman and her partner should be advised to read the information booklet 
then discuss any questions or anxieties that they may have at their next 
antenatal appointment. 
It is important to remember that for some women their drug and alcohol 
use may come to light for the first time because of their pregnancy care. 
If this happens there is an excellent opportunity for harm reduction 
advice and education to be offered and may lead to a change in the 
woman’s drug use. Other women may know they have a drug or alcohol 
related problem but choose not to disclose this information to health and 
social care professionals. Some women may acknowledge that they use 
alcohol or drugs but grossly under-report their use. These women are 
sometimes identified when problems manifest in the neonate, at which 
point help can be offered.
Many women with drug related problems in Lothian are already known to 
drug services and will be on prescribed methadone or dihydrocodeine 
(DF118) and perhaps diazepam as well. Some will be receiving their 
prescription from the Community Drug problem Service (CDPS), or Harm
Reduction Team (Low Threshold Methadone clinic) but most will be 
attending their General Practitioner for their prescribed drugs. A small 
number of HIV positive women drug users receive prescribed opiates from 
the Regional Infectious Diseases Unit (RIDU) at the Western General 
Hospital.
Substance Misuse in Pregnancy 72
Routine antenatal screening at booking 
At the booking appointment, the community midwife will also offer ‘routine
antenatal screening’. Blood samples are taken for: HIV, hepatitis B, 
rubella, syphilis, blood group and a full blood count.
Please note the following regarding blood borne viruses:
• Women who are currently injecting drugs or who have a history of 
injecting drug use may be at risk of HIV, hepatitis B and hepatitis C.
• The hepatitis B vaccine can be given safely in pregnancy and should be 
offered to all women who are likely to inject drugs in pregnancy or 
whose partner is an injecting drug user. 
• The Hepatitis C antibody test is not offered routinely as part of 
antenatal care in Lothian, however it should be offered to all pregnant 
women at risk.
• Many women who use drugs may not have a history of injecting 
themselves, but may have a partner who does.
• Non-drug using women may be at risk of blood borne virus infection if 
they have unprotected sex with an infected man. 
For more detailed information on antenatal testing for HIV, hepatitis B 
and C and the management of positive women and their babies see 
appendix 1.
Other screening and diagnostic tests 
Numerous screening and diagnostic procedures are offered during 
pregnancy. These are especially important for drug and alcohol using 
women who may be at increased risk of pregnancy complications. Drug use 
is associated with an increased risk of intrauterine growth restriction 
(IUGR) so care should be taken to assess fetal growth by clinical 
examination, ultrasound and antenatal fetal monitoring. Staff should be 
careful to explain the reasons for any additional tests sensitively to the 
woman.
Ultrasound scan is normally arranged for 10 – 14 weeks. It is important 
partly to confirm gestational age, but also to provide the mother with a 
positive experience of the hospital. Substance-misusing women often 
worry about fetal abnormality more than any other problem and feel guilty 
about the damage they may have caused their baby. In general, it is 
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usually possible to be quite reassuring (Johnstone 1998). Detailed fetal
anomaly scanning is not normally required as substance misuse is not 
associated with an increased risk of structural fetal abnormality. The only 
exceptions would be with heavy alcohol consumption (>8 units/day), cocaine 
or amphetamine use.
Attendance for fetal monitoring (cardiotocography or CTG) may 
sometimes be necessary for substance-misusing women, particularly if 
growth restriction (IUGR) is established. Please note however that there 
may be reduced activity (loss of variability and accelerations) following 
ingestion of opiates, benzodiazepines and alcohol. Repeat or extended 
monitoring is sometimes required. The biophysical profile is less affected 
and will usually be normal even after ingestion of drugs. Another fetal 
monitoring test, the umbilical artery doppler assessment, can identify 
vascular problems in the placenta, which can lead to distress or death. 
This test might be necessary for women who are heavy users of stimulant 
drugs (such as cocaine or amphetamines) or women in whom IUGR is 
demonstrated by ultrasound. 
Some women drug users (for instance those working in the sex industry) 
are at higher risk of sexually transmitted and other vaginal infections.
Because infections are a risk factor in pre-term labour and delivery it is 
important to detect and treat all infections in pregnancy. Screening for 
chlamydia, gonorrhoea, bacterial vaginosis and Group B streptococcus 
should be considered.
Some women (in particular HIV positive and immuno-compromised women) 
may also be at greater risk of cervical intraepithelial neoplasia (CIN) and 
may not have attended for routine cytological screening (cervical smears). 
Pregnancy can be a good opportunity to attract women into cytological 
surveillance, certainly in the 1
st
 and early 2
nd
 trimester.
Pregnancy complications 
Other complications can occur in substance-using women but not much 
more frequently than other women, with the exception of women using 
large amounts of stimulants, such as cocaine (Johnstone 1998).
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Pre-term labour is a particular problem that poses a difficult start to 
mothering and is a significant risk to the baby. It is more common in drug 
dependent women, particularly those using drugs intravenously or taking 
short-acting opiates (i.e. heroin). Very pre-term delivery is associated 
with increased mortality. Infections also account for some pre-term 
labour episodes so screening is advisable. Pregnant women should be 
advised to present themselves early if they think they are in pre-term 
labour so that an injection of steroids can be given to help mature the 
fetal lungs. 
Maternal health problems 
Good nutrition in pregnancy is important for the development of the baby. 
All pregnant women should be given advice about eating a healthy
balanced diet. Pregnant women are routinely tested for anaemia at their 
antenatal appointments and will be prescribed iron if necessary. They are 
advised to take folic acid for the first 12 weeks of pregnancy to prevent 
neural tube defects. Constipation is very common in pregnancy and can be 
exacerbated by opiate use, so women should be advised to increase their 
fibre intake and drink more water. 
Poor general health and drug use can lead to respiratory problems,
including chest infections and asthma. Repeated injections over years 
destroys peripheral veins, often leaving ‘track marks’ so venous access
may be limited even in women who stopped injecting drugs years before.
Good dental care in pregnancy is especially important. All pregnant women 
with substance misuse problems should be encouraged to attend their 
dentist for a check up so that they can get any necessary dental 
treatment and avoid dental decay and infections in pregnancy. Severe 
dental problems are commonly associated with opiate use. This is made 
worse by the high sugar content and acidity of methadone. Sugar free
methadone is available on prescription, but the acid content is similar to 
the normal preparation. Advise all women to brush their teeth with 
fluoride toothpaste before they take their methadone and rinse their 
mouth afterwards with water. Sugar free chewing gum will also help clear 
the methadone from their mouths. Women tend to suffer increased gum 
problems during pregnancy, which can show itself as bleeding gums. This 
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can be more serious in women with substance misuse problems and 
progress to acute and very painful infections.
There is a dental drop-in clinic at the Harm Reduction Team (HRT) in 
Spittal Street Centre on Mondays and Wednesdays (11am-1.30pm). This 
free dental service is available to all drug users who are attending the 
CDPS, HRT and Locality Clinics. Tele. 0131 537 8323 to make an 
appointment or advise the women to attend the drop-in clinic. 
Benefits and allowances 
All pregnant women should be given information on benefits and allowances
that are available during and after pregnancy. These include: 
 Entitlement to free NHS prescriptions throughout pregnancy and for 
one year after the birth of their baby 
 Entitlement to free NHS dental treatment throughout pregnancy and 
for one year after the birth of their baby 
 The ‘Sure Start’ Maternity Grant (which is currently worth £500 
and can be claimed from 29
th
 week of pregnancy). A midwife, health 
visitor or doctor can sign this form (which confirms that the woman 
has received health education and antenatal care).
 Entitlement to free milk tokens after the birth of their baby 
Further information on benefits is available from the Welfare Rights 
Advice Shop (see services list) and the Social Security booklet ‘Babies
and Children: A basic guide to benefits and tax credits for anyone 
expecting a baby or caring for children’ (BC1 2003). Tele. 0800 882200 
for a copy. 
Preparation for parenthood 
All pregnant women and their partners are offered ‘parent education’ and 
this normally starts at around 32 weeks gestation. Group and individual 
sessions are organised and run jointly by Midwives and Health Visitors. 
Parent education is especially important for women with substance misuse 
problems and for first time mothers and fathers. All parent education 
sessions are community-based. For further information contact the local 
Community Midwifery Team. Professionals should encourage parents to 
attend these sessions as many people with substance misuse problems 
have not had positive parenting role models and attendance is often poor.
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Risk assessment during pregnancy 
All professionals working with pregnant women with substance misuse 
problems should have a clear understanding of the concept of risk
assessment to ensure safety for mother and baby. Risk should be 
continuously assessed throughout the pregnancy, taking into account that 
risk status is dynamic and may change over time (Scottish Executive 
2001). See section on assessment, page 25. 
Significant risk factors that would warrant further assessment and 
intervention would include: 
 Poor obstetric and pregnancy outcome history 
 Poor maternal health / significant illness / HIV, Hepatitis C or B
 High alcohol consumption or alcohol dependence 
 Injecting drug use or chaotic illicit (non-prescribed) drug use 
 Neonate at risk of developing Neonatal Abstinence Syndrome (NAS), 
or previous baby with NAS 
 History of severe mental health problem (e.g. schizophrenia, bipolar 
disorder, postnatal depression / puerperal psychosis, eating disorder) 
 Domestic abuse
 Homelessness and insecure/ unsuitable/ unsafe accommodation 
 Other significant social problems (e.g. legal, financial, unsupported 
pregnancy, chaotic lifestyle)
 Existing children on ‘at risk’ register / accommodated by local 
authority
 Recorded history of previous parenting or child care concerns
Homelessness
Pregnant women who are homeless or in temporary accommodation can 
register with a GP at the Edinburgh Homeless Practice, either at the 
Access Point on Leith Street or at the Cowgate Clinic in the Grassmarket. 
The Access Point has social work and housing department staff who work 
in a multi-disciplinary team alongside health care staff. All pregnant 
homeless women are referred to the South East Edinburgh community 
midwifery team at Craigmillar Health Centre. The midwife will arrange to 
visit the woman at the clinic or in temporary accommodation. It is 
important that the woman finds suitable accommodation in time for her to 
prepare for the birth of her baby. Homelessness creates additional stress 
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for the women and can make attendance for antenatal care difficult. Good 
liaison and care planning are required to ensure agencies are working 
together. Pregnant women also need to engage early with the Health 
Visiting service who will encourage the family to move towards accessing 
mainstream services once they are in stable accommodation. For other 
services for homeless people see ‘services list’.
Not registered with a GP 
Pregnant women who are not registered with a General Practitioner should 
be encouraged to do so as soon as possible. If the woman experiences any 
difficulty registering with a GP then she should be advised to contact 
Primary Care Services to request a GP be ‘allocated’ to her. Requests must 
be made in writing. Advise the woman to complete the proforma letter 
(see appendix 6) and send to Lothian Health Primary Care Services. Tele. 
0131 537 8473 for enquiries. The process of being allocated a GP normally 
takes about one week. 
Domestic abuse 
Domestic abuse can have a harmful, sometimes even life-threatening, 
impact on the physical and mental wellbeing of both mother and baby and 
is a serious criminal, social and medical problem. Domestic abuse can 
include a wide range of physical (e.g. hitting, kicking, restraining), sexual
(including rape and coercion), psychological (verbal bullying, undermining, 
social isolation) and financial (e.g. withholding money) abuses. Domestic 
abuse is widespread and under reported and the level of repeat incidence 
is high. Conclusive evidence has demonstrated that pregnancy, far from 
being a time of peace and safety, may trigger or exacerbate male violence 
in the home (Royal College of Midwives 1997). Violence may also increase 
following the birth of a child or when a woman tries to end a relationship 
(Scottish Executive, March 2003). All midwives should sensitively enquire 
about domestic abuse as part of their antenatal risk assessment. Relevant 
addresses and telephone numbers should be made easily accessible to 
enable women to get help with or without the support and knowledge of 
health and social care staff. Women who disclose domestic abuse should 
be given advice and support on how and where to get help. Details of 
services that offer psychological support as well as refuge are included in 
the services list.
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Health care staff can refer to the Scottish Executive document 
‘Responding to Domestic Abuse: Guidelines for Health Care Workers in 
NHS Scotland’ (March 2003) for further guidance. All professionals can 
obtain free copies of the Scottish Executive booklet ‘Domestic Abuse: 
There is no excuse’ (Tele. 0131 244 3995).
Neonate at risk of Neonatal Abstinence Syndrome (NAS) 
It is important to discuss at an early stage with all drug dependent women 
the possibility of Neonatal Abstinence Syndrome (NAS). She needs to 
know that NAS is usually easily managed but the baby will need her 
support, understanding and patience. Having a baby who develops severe 
withdrawal symptoms can be very distressing for parents, but if properly 
looked after the baby will make a full recovery and will come to no short-
term developmental harm (Johnstone 1998). In Lothian, a parent
information leaflet called ‘Caring for a baby with drug withdrawal 
symptoms’ is available (see appendix 12). This leaflet should be given to all 
drug dependent women and their partners at around 32 weeks gestation. 
They should be advised to read the leaflet and discuss their birth plan 
and care of their baby with the midwife. For more detailed information 
see section on NAS, page 43.
Child care risk
Occasionally, a risk assessment will identify concerns about the ability of 
the woman (or her partner) to look after their (currently unborn) child. If 
this is the case, then it is important to address these concerns with the 
woman at an early stage. All professionals in contact with pregnant women 
have a responsibility to act if they believe that the baby’s safety or 
welfare will be at significant risk of harm. A pro-active and early
intervention approach is more likely to result in a positive outcome for 
both mother and baby.
Professionals should make themselves familiar with: 
z Edinburgh and the Lothian’s ‘Child Protection Guidelines’ (Nov 2002),
z ‘Getting Our Priorities Right: Good Practice Guidance for Working 
with Children and Families affected by Substance Misuse’ (Scottish 
Executive 2003), and
z ‘Hidden Harm: Responding to the needs of children of problem drug 
users’ (ACMD report 2003).
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These documents contain important information for professionals, 
including:
 The guiding principles of child protection 
 The legal framework on child protection
 Professional roles and responsibilities in relation to protecting the 
welfare of children 
 Guidance on information sharing and confidentiality 
 The signs and symptoms of physical abuse, neglect, non organic failure 
to thrive, emotional abuse and sexual abuse 
 The impact of parental problem drug use on infants and children 
 The referral process for dealing with child care concerns and child 
protection issues 
 A checklist of information to be collated concerning substance misuse 
and its impact on parenting 
 The practicalities of protecting and supporting the children of 
problem drug users 
 A helpful contact list of professionals who have expertise in child 
protection within Lothian 
For more detailed guidance on dealing with child care concerns see section 
‘Assessing and Managing Child Care Risk during Pregnancy’, page 95.
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Intrapartum care (labour and childbirth) 
The vast majority of labours and deliveries will be straightforward in drug 
and alcohol using women and thus their care will be similar to any other 
woman (Johnstone 1998). There are however, a few important factors to 
consider.
Currently, intrapartum care in Lothian is provided by labour suite midwives 
and community midwives who staff the labour suite on rotation. The 
pregnant woman may see a number of different midwives if she has 
several antenatal episodes in the labour suite (for instance for pre-term 
labour) and her key midwife in the community may not be the one who 
delivers her baby.
The Obstetrician and Paediatrician are kept informed during labour, but 
they are not the key professionals unless there are complications (for 
instance, pre-term delivery). 
Midwives delivering intrapartum care should make sure they read the 
woman’s hand held records and any other confidential or ‘sensitive’
information kept in the supplementary notes file held in admissions 
(R.I.E.). The antenatal liaison form (substance misuse) provides detailed 
information on the woman’s drug / alcohol use, medication, pharmacist and 
key professionals and services involved in her care (see appendix 9).
Maternity hospital policy 
The woman, her partner and family all need to understand the hospital 
priority for a safe pregnancy and childbirth experience. This means zero 
tolerance of illicit drug use on hospital premises, clear limits on the 
number and conduct of herself and any visitors, and zero tolerance for 
abusive, threatening or aggressive behaviour. If necessary, visitors will be 
removed from the building and barred from returning.
Substitute prescribed drugs are dispensed by the hospital pharmacy 
but only after the dose of medication has been checked with the 
prescribing doctor and any community prescriptions have been 
cancelled with the pharmacist. This means that hospital staff will need 
to know the name and telephone number of the prescribing doctor and 
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pharmacy. This information should be written clearly on the antenatal
liaison form (substance misuse). The woman should remember to take any 
supply of medication into hospital with her, as it will not be replaced if it 
has already been dispensed in the community. On discharge, the hospital 
will notify the prescribing doctor when the next dose of medication is due 
to be dispensed from the community.
Pain relief during childbirth 
Women who use drugs may be fearful of labour and childbirth and worry 
that they will not get adequate pain relief. It is very important that 
adequate pain relief is given and the midwife establishes a good rapport 
with the woman, offering reassurance and support when required. It is a 
good idea to discuss pain relief options in the antenatal period so that the 
woman feels confident that she will be well cared for and treated like any 
other woman in labour.
Prescribed medication should be dispensed as normal during labour. 
Substitution treatment with methadone or dihydrocodeine does not 
provide pain relief. Opioid receptors may be saturated so higher doses or 
more frequent injections of diamorphine are likely to be needed (Sparey & 
Wilkinshaw 1999). There is usually a low threshold for an epidural
anaesthesia and many drug dependent women opt for this pain 
management approach.
Caesarean section is no more likely than in the normal population and 
having a history of drug misuse should not be considered a 
contraindication to having a PCA pump (patient controlled analgesia pump) 
following caesarean section (Siney 1999). Post delivery pain relief should 
be the same as for every other woman, although higher doses may be 
required.
Complications of childbirth 
In women with a history of injecting drug use, venous access may be poor 
and antenatal referral to an anaesthetist may be required. Where labour 
is straightforward, no intravenous line is required. However, if it appears 
that there might be complications, it is sometimes better to establish an 
intravenous line electively shortly after admission, rather than be faced 
with the task in an emergency situation (Johnstone 1998). 
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There may be placental insufficiency in pregnancies of drug-using women, 
leading to an increased risk of intrapartum hypoxia, fetal distress and 
meconium staining (Department of Health 1999). Meconium aspiration is 
common and is associated with fetal distress secondary to periods of 
intra-uterine drug withdrawal. Some babies will be growth restricted so 
there should be careful surveillance during labour. Maternity staff should 
follow hospital guidelines for obstetric and neonate management for 
meconium staining.
High dose benzodiazepine use in the mother can result in the newborn 
showing signs of intoxication at birth that include: poor sucking, poor 
reflexes, hypotonia (low muscle tone), hypothermia (low body 
temperature), a feeble cry and low APGAR scores. Severely affected 
neonates may require vigorous resuscitation at birth because of 
respiratory depression. Women who are anxious about childbirth should be 
warned not to ‘self medicate’ with non-prescribed benzodiazepines (e.g. 
Valium®) before they admit themselves for delivery. 
Please note: Labour ward staff must not use naloxone (an opiate 
antagonist) to reverse opioid induced respiratory depression in neonates 
as this will induce an abrupt opiate withdrawal crisis. Use supportive 
measures or ventilation if necessary.
Postpartum care in hospital 
After delivery, the labour ward midwife should liaise with staff in the 
postnatal ward to ensure continuity of care. The key midwife in the 
community should also be informed of the delivery. This is particularly 
important if the woman has delivered pre-term. Maternity staff providing 
intrapartum care should complete the pregnancy outcome form 
(substance misuse) (see appendix 9).
All known drug dependent women are asked to stay in hospital for three 
days (72 hours) following the birth of their baby. This is because the 
baby needs to be observed for signs and symptoms of Neonatal
Abstinence Syndrome (NAS), which normally develop within this time 
period (see section on NAS for further information, page 43).
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Confinement in hospital can be a threatening experience for some drug-
using women (Mounteney 1999). Staff should take care to ensure privacy
by being discreet about the administration of any medications (e.g. 
methadone) so that the woman’s drug use is not exposed to other patients 
or visiting relatives who might not know about her drug use. 
Soon after delivery, mother and baby should be transferred to the 
postnatal ward where they can ‘room in’ together and have ‘skin-to-skin’
contact. Separating mother and baby should be avoided if at all possible. 
‘Skin-to-skin’ contact will help the baby relax and sleep, regulate their 
body temperature, steady their breathing, help with mother-infant 
bonding and will help get breastfeeding off to a good start.
Women who have a history of alcohol related problems (who remain in the 
postnatal ward) can be observed for maternal symptoms of alcohol
withdrawal (which typically occur around 48 hours post delivery), in which 
case appropriate medication may be required (Wright & Walker 2001). 
Ideally, discussion about the need for postnatal contraception should 
have been instigated in the antenatal period rather than at the post-
delivery meeting before discharge from hospital. Many women with 
substance misuse problems are not able to address their reproductive and 
sexual health care needs adequately. Planning contraception for the 
postnatal period involves considering ‘what, how and when?’ to start using 
hormonal treatments (e.g. combined oral contraceptive pill, progestogen-
only pill, ‘Depo-Provera®’, ‘Implanon®’ etc) or the coil. Advice on choices 
also varies depending on whether the woman is breastfeeding or not. 
Condoms are normally recommended for the first 48 hours post-delivery 
or for the first few weeks following delivery until hormonal contraception 
has been started. 
After 72 hours on the postnatal ward, mother and baby can be safely 
discharged home, provided the baby is well enough. On discharge, all 
women are given a ‘discharge pack’ which contains helpful information 
leaflets on caring for their baby.
In circumstances where the mother insists on taking an early discharge, 
she should be seen by the paediatrician and asked to sign a form that 
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states she is taking the baby home against medical advice. In rare cases, 
the mother may take her own discharge and leave the baby in hospital. If 
this happens, the baby will be transferred to the Neonatal Unit / Special 
Care Baby Unit (SCBU) for continued monitoring.
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Infant feeding 
Much confusion surrounds the issue of whether a woman should breast 
feed her baby when continuing to take drugs. Many women and their 
partners are concerned about breastfeeding whilst taking drugs or 
drinking alcohol and will ask for advice. Parents should be informed that 
the benefits of breastfeeding far outweigh the disadvantages, even with 
continued drug use. It is important to reassure the mother that the actual 
amount of most drugs passed to the baby through breast milk is minimal 
and will have little effect on the newborn baby (Johnstone 1998). The 
sometimes small effect on the baby may even help withdrawal symptoms, 
if they are present.
It is important that the woman is not given contradictory advice from 
different professionals, as nothing is more certain to reduce her 
confidence and to confuse her decision-making.
Breastfeeding
Department of Health (1999) guidance recommends that breastfeeding
should be encouraged in drug-using women. Mothers who are on 
prescribed drugs should therefore be encouraged to breast feed in the 
same way as other mothers. The exceptions to this would be if she were: 
• HIV positive (because of risk of transmission)
• using large quantities of stimulant drugs, such as cocaine, ‘crack’ or 
amphetamines (because of vasoconstriction effects) 
• drinking heavily (>8 units/day) or taking large amounts of non-
prescribed benzodiazepines (because of sedation effects).
Breastfeeding is best done immediately before taking medication and 
should be avoided for one to two hours after any dose of medication (i.e. 
the time of highest plasma concentrations). Medications are best taken as 
a single dose where possible and should be administered before the baby’s 
longest sleep period (SIGN ‘Postnatal Depression’ guideline 2003).
There is no evidence that Hepatitis C transmission occurs through 
breastfeeding so mothers who are Hepatitis C positive should be 
encouraged to breastfeed (Scottish Executive 2003).
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Women who are Hepatitis B positive can also safely breastfeed as soon as 
their newborn baby has had their first dose of immunoglobulin and Hep B 
vaccine (administered soon after birth).
Injecting drug use whilst breastfeeding should be discouraged because of 
the risk of mother-to-baby HIV transmission (see appendix 1 for further 
information on Blood Borne Viruses).
Ideally the woman should keep her drug use as stable as possible whilst 
breastfeeding. Ability to successfully breastfeed is in itself an indication 
of stability (Hepburn 1996). Breastfeeding can support the mother in 
feeling that she is positively comforting and caring for her baby and it can 
aid in the bonding process. Breastfeeding will also benefit the long-term 
health of both mother and baby.
The benefits of breastfeeding are outlined in the UNICEF leaflet 
‘Feeding Your New Baby’, which mothers-to-be should be given in the 
antenatal period. For more detailed information about breastfeeding see 
‘Breastfeeding: Off to a good start’, available from NHS Health Scotland 
(previously HEBS). 
Midwives can also offer a great deal of support and advice to mothers who 
wish to breastfeed their baby. For instance, they show the mother how to 
position their baby for feeding and how to make sure the baby attaches 
properly to the breast. They also teach mothers how to recognise when 
their baby is feeding properly and when not. Most areas throughout 
Lothian also have ‘breastfeeding support groups’ and antenatal 
breastfeeding workshops. Contact the local Community Midwifery Team or 
Health Visiting office for further information on these.
Weaning
The World Health Organisation (WHO 2001) recommends that babies 
should be exclusively breast fed until about 6 months of age in order to 
achieve optimal growth, development and health. After 6 months of age, 
the mother can introduce appropriate solid foods whilst continuing to 
breastfeed for up to 2 years or beyond.
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Formula (bottle) feeds are not a necessary part of a weaning diet. 
However, if a breastfeeding mother wishes to combine formula feeding 
with breastfeeding or to switch to formula feeding she should do this 
gradually, substituting one formula feed for one breast feed per day for 
several days, allowing her baby and her body to become accustomed to 
this. A second formula feed can then be introduced for another few days, 
then a third, fourth etc. Ideally, the weaning process should take several 
weeks, allowing a slow withdrawal for the baby.
Abrupt cessation of breastfeeding may result in the baby showing 
some signs and symptoms of drug withdrawal. Advise breastfeeding 
mothers who continue to take drugs to gradually introduce solids slowly 
into the breastfeeding schedule, reducing the frequency of breast feeds 
over a number of weeks.
Women with substance misuse problems should seek advice about weaning 
from their Health Visitor. Health care staff can seek advice from the 
Infant Feeding Advisors at the R.I.E. (Tele. 0131 242 2502) and Primary 
Care Trust (Tele. 0131 537 4262).
Bottle feeding 
Many women drug users choose to bottle feed rather than breast feed. 
Social and cultural beliefs and norms are powerful influences on decision 
making about early infant feeding. Parents should be supported to make an 
informed choice about how to feed their newborn baby. Having made their 
decision, they should be supported by all professionals involved. 
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Postnatal care 
The care of a pregnant woman who uses drugs or alcohol and the safe 
delivery of her baby is just the start of care. Continuing support in the 
postnatal period and for parenthood is essential if the ideal outcome 
of maintaining a healthy mother and child together is to be achieved.
After discharge from hospital, the baby is cared for at home by the 
mother and family, with advice and support from the Community Midwife
as well as other professionals and agencies involved with the family. The 
midwife will visit the family at home each day until the baby is 10 days old. 
Occasionally the midwife may need to continue visiting up until the baby is 
28 days old, depending on how well the baby is and how well the mother is 
coping. The Health Visitor normally visits after day 10 and should liaise 
with the midwife and GP before visiting the family. The Health Visitor will 
be a good source of information and support on motherhood and all 
aspects of health for the woman and her baby. When the baby is 6-8 
weeks old, the GP and Health Visitor will arrange a comprehensive 
postnatal examination of mother and baby.
Postnatal care should facilitate women and their partners to make an 
effective transition into parenthood. Professionals should give women and 
their partners an opportunity to reflect on their experiences of 
pregnancy and childbirth in the postnatal period as well as an opportunity 
to discuss the effects of parenthood on their relationships (Scottish 
Executive 2001). 
Soon after mother and baby are home, a case discussion meeting should 
be organised by the ‘lead professional’ to review the care plan and to 
decide whether an appropriate level of support is in place for the family 
(Department of Health 1999).
Postnatal depression 
Women drug users may be more at risk of postnatal depression and other 
mental health problems. Anxiety, depression and a history of sexual 
and/or physical abuse are commonly associated with drug and alcohol 
dependency. Identifying, screening and supporting women at risk of 
postnatal depression is very important. Untreated postnatal depression is 
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associated with detrimental effects on infant development. Postnatal 
depression is assessed using the Edinburgh Postnatal Depression Score
(EPDS) screening tool and augmented by a multi-disciplinary Integrated
Care Pathway (ICP). Health Visitors and GP’s are trained to use these 
tools to improve the care of women at risk. Staff should make themselves 
familiar with the new SIGN guideline (2003) ‘Postnatal Depression and 
Puerperal Psychosis’ (www.sign.ac.uk).
Sudden Infant Death Syndrome (SIDS) 
Maternal tobacco use, as well as drug and alcohol misuse are associated 
with an increased risk of Sudden Infant Death Syndrome (‘SIDS’ or ‘cot 
death’). All parents who use these drugs should be given advice about how 
to reduce the risk of cot death. The leaflet ‘Reducing the risk of cot 
death’ (produced by the Scottish Executive 2000) is included in the 
hospital ‘discharge pack’.
Risk of relapse 
In the postnatal period, increased drug and alcohol use is common. For 
women who have managed to reduce their intake during pregnancy or even 
come off drugs or alcohol, the risk of relapse to former levels of drug 
taking is high. There are a number of reasons for this, including: 
• feeling that it’s now OK to use again 
• relief at having a ‘normal’ baby 
• wanting to celebrate! 
• the stress of caring for a new born baby (perhaps with NAS)
• ‘baby blues’ or postnatal depression 
• poor support from partner or family 
• anxieties about motherhood 
It is important for professionals to acknowledge that relapse is 
common. Re-assessment of substance use and careful drug management is 
essential at this time, along with support to remain stable and to prevent 
relapse.
Ensuring the woman is engaged with a specialist drug and alcohol agency 
that can provide a relapse prevention service may be an important part of 
the postnatal care plan.
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Relapse prevention support work can include: 
 helping parents understand relapse as a process and as an event 
 raising awareness of ‘high-risk’ situations and factors that might lead 
to relapse 
 exploration of how to anticipate, avoid or cope with these high-risk 
situations
 acquisition of skills (cognitive and behavioural) to implement relapse 
prevention strategies
 anxiety and stress management education 
 confidence building and improving self–efficacy 
 strengthening existing positive coping strategies and other personal 
attributes
 life / social skills education (e.g. assertiveness, resistance and 
dissuasion skills, alternative activities to drug/alcohol use)
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Assessing and managing child care risk during pregnancy 
Many pregnant women who have substance misuse problems worry that 
they will be referred to social services or their baby will be taken into 
care purely because they use drugs. Raising this subject early and 
discussing their concerns openly will foster a more trusting relationship. 
It is important to reassure women that substance misuse, in itself, is 
not sufficient reason to assume inadequate parenting or child care. 
They need to know, however, that if there are specific concerns about the 
assessment and get involved, but that this policy is the same for everyone, 
whether or not they use drugs. This advice is mentioned in the information 
leaflet ‘Pregnant… and using drugs or alcohol?’ (see appendix 11).  
 
Many different factors affect the health and development of children. 
Parental drug and alcohol use is just one factor. Research evidence does 
not support the assumption that parental substance misuse will 
automatically lead to child neglect or abuse (Scottish Executive 2003). 
Indeed, a number of case controlled studies in Britain have found no 
significant differences in the health and development of children in drug-
using households compared to non-drug using households (Ross et al 1995, 
Burns et al 1996). Becoming ‘drug free’ should not be a requirement for 
parents to keep their children living with them. Parents who stop using 
drugs or control their drug intake are not necessarily better or safer 
parents. Some parents will have poor parenting skills for reasons other 
than their substance misuse as many risk factors also occur in non-drug 
using families (Scottish Executive 2003). 
 
However, a chaotic drug or alcohol using lifestyle may affect child safety 
and the child’s health and development in a number of ways and is always a 
factor to be considered. Infants, in particular, are vulnerable to the 
effects of physical and emotional neglect or injury which can have 
damaging effects on their long-term development.  
 
 
 
safety or welfare of the child then social work will need to do an 
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A number of childcare problems have been associated with parental 
substance misuse (Scottish Executive 2003, ACMD 2003). Some of these 
include:
• Inconsistent caring 
• Inadequate supervision 
• Lack of stimulation 
• Inadequate and unsafe accommodation 
• Social isolation and stigma 
• Exposure to violence and criminal behaviour 
• Emotional or physical neglect or abuse 
Resulting in… 
• Failure to thrive 
• Accidental injury 
• Emotional difficulties 
• Behavioural difficulties 
• Poor social development 
• Poor cognitive and educational attainment 
Professionals who are involved with children and families need to 
remember that good inter-agency communication and collaboration in the 
care process is essential. It is important to obtain consent from the 
woman early to share information with other professionals and agencies 
(see consent form in appendix 5). No professional, however, can guarantee 
absolute confidentiality as both statute and common law accepts that 
information may be shared in certain circumstances. 
Child care risk assessment should cover issues such as existing parenting 
skills, child safety, as well as the physical, cognitive, emotional and social 
development of children. Drug and alcohol specialist workers that lack 
child care and parenting expertise should consult with and involve other 
professionals and agencies who do have this expertise.
The Scottish Executive (2003) document ‘Getting Our Priorities Right: 
Good practice Guidance for working with Children and Families affected 
by Substance Misuse’, appendix II, includes a helpful checklist for 
collating information on substance misuse and its impact on parenting 
(download from www.scotland.gov.uk).
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 has a very chaotic lifestyle with multiple social problems and 
repeatedly fails to attend antenatal appointments 
 attends appointments but are repeatedly intoxicated or incapacitated 
from the effects of alcohol or drugs  
 has an inappropriate home environment which could be unsafe for a 
baby 
 lacks the necessary material possessions for caring for a baby 
 has been previously referred to social work regarding their parenting 
ability 
 has existing children on the child protection register 
 has had previous children accommodated by the local authority 
 has had previous children adopted 
 discloses domestic abuse 
 is socially isolated with no support network 
 
Child protection 
The welfare of the child is the paramount consideration. All 
professionals working with pregnant women and families affected by 
substance misuse should make themselves familiar with Edinburgh and the 
Lothian’s (Nov 2002) ‘Inter-agency Child Protection Guidelines’.  
 
 Refer to a non-statutory service that works with children and 
families affected by substance misuse (such as the Harbour Project 
or Aberlour Outreach Project). Substance-misusing parents see non-
statutory services as more acceptable and less ‘stigmatising’ than 
social work. Professionals who work in these services can offer 
intensive parenting support.  
 Discuss your concerns with the Midwife, Health Visitor or General 
Practitioner  
 Contact your designated senior staff member with responsibility for 
child protection to discuss your concerns 
 Contact your local duty social work service (Children & Families Team) 
to discuss your concerns and to seek their advice 
because the woman or her partner: 
consider taking one or more of the following actions: 
The assessment process (see pages 25-27 & 77-80) may highlight concerns
In line with these guidelines professionals who have concerns should
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 Report your concerns to the Children’s Reporter. Individuals and 
agencies have the right to make a referral to the children’s reporter 
irrespective of the views of the local authority.  
 Encourage the woman to approach social services herself for help and 
advice 
Early intervention strategies 
For families who are of ‘concern’ but not formally ‘at risk’, professionals 
should take the opportunity to engage with the parents and intervene 
early. A range of interventions can be helpful for pregnant women and 
vulnerable children and families. These include offering parenting support 
by: 
 
If there is a significant risk of harm to the baby’s health and 
development then professionals should take action and refer to social 
services. Significant harm may result from maltreatment or the absence 
of adequate care. The protection of children is an interagency 
responsibility, but social work has a statutory responsibility to assess risk 
and ensure that child protection plans are in place if necessary. The social 
work assessment, while acknowledging the needs and the rights of the 
parents, will focus primarily on the needs and welfare of the child. In 
some situations there will be conflict between the needs and wishes of 
the parents and the welfare of the child.  
 
Any referral or discussion with social services should be handled 
sensitively. It is important to stress to the woman that social work 
involvement is often positive and helpful. Whenever possible, social work 
has a duty to promote children’s upbringing by their families. Compulsory 
removal of children from their families is rare, even when agencies are 
worried about a child’s welfare (Scottish Executive 2003).  
 
Occasionally, social services will be sufficiently concerned about the 
future risk to an unborn child to warrant the implementation of child 
protection procedures and the calling of a child protection case 
conference to consider the need for registration and a child protection 
plan. If a child protection case conference is called, ideally it should be 
held 6-8 weeks before the estimated delivery date so that services can 
be put in place in time for the birth of the baby.  
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 Offering emotional support and an opportunity to talk about any 
stresses or worries 
 Discussing parenting roles and responsibilities 
 Developing the parents existing skills, attributes and resources
 Promoting a safer and more stable lifestyle 
 Teaching strategies to develop good parent/infant bonding 
 Offering or arranging practical support to the family 
 Teaching good play techniques and parent/child activities
 Discussing strategies for managing their children’s behaviour 
 Engaging them in activities where they can experience positive role 
modelling
 Helping parents develop routines, guidelines and boundaries with their 
children
Protective factors 
Professionals who provide care to pregnant women and their partners can 
ensure that ‘protective factors’ in child welfare are promoted by 
routinely discussing the following topics both before and after the baby is 
born:
 Drug safety issues in the home… safe storage of drugs, safe storage 
and disposal of injecting equipment, risks of ingestion of drugs and 
overdose, how to deal with medical emergencies etc 
 The importance of providing for all the child’s basic needs… food, 
clothes, warmth, personal hygiene, comfort, safety, stimulation, age-
appropriate activities etc 
 The importance of attending any child health appointments with the 
doctor and Health Visitor (Public Health Nurse) 
 The importance of providing appropriate supervision for their 
children… periods of intoxication and withdrawal may be a time when 
adequate supervision cannot be provided and parents will need to 
ensure that another responsible adult is available in these situations 
 Outlining potential problems… such as a chaotic substance-misusing 
lifestyle, other drug-using friends and households, procurement of 
drugs, violence, drug dealing, offending behaviour etc which may put 
the child at risk 
 The importance of establishing daily routines and making the home 
safe and secure for the child 
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Finally, it is important to remember that the majority of pregnant 
women and parents with substance misuse problems will provide 
adequate care for their children and most children will remain living 
with their birth parents.
Pregnancy is a special event in the life of a woman with substance 
misuse problems and provides professionals with an opportunity to 
offer treatment and care that might not otherwise be accepted. The 
philosophy of approach and principles of management should be broadly 
the same as for any other pregnant woman with special circumstances 
and needs.
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Services List 
Services providing maternity care in Lothian 
Maternity services in Lothian are part of the acute sector. Approximately 
6000 births per year are now delivered in Simpson’s Centre for 
Reproductive Health at the Royal Infirmary of Edinburgh, Little France. 
In West Lothian 2000 births per year are delivered in the Maternity Unit 
at St John’s Hospital, Livingston.
Maternity care is now essentially community based and midwife & GP
managed. Most Consultant Obstetricians run outreach clinics in community 
health centres throughout Lothian. Both Simpson’s Centre for 
Reproductive Health at the Royal Infirmary of Edinburgh and St John’s 
Hospital Maternity Unit run ‘high risk’ pregnancy clinics. 
Hospital maternity units in Lothian 
z The Simpson Centre for Reproductive Health, Royal Infirmary of 
Edinburgh, 51 Little France Crescent, Edinburgh EH16 4SA.
Tele. 0131 536 1000 
z Maternity Unit, St John’s Hospital, Howden Road West, Livingston, 
West Lothian EH54 6PP. 
Tele. 01506 419 666 
Midwives are specially trained in pregnancy, childbirth and postnatal care. 
They are usually the lead professional for women with ‘low risk’ 
pregnancies. The midwife undertakes a continuous risk assessment
throughout pregnancy and refers to other appropriate medical 
professionals if they detect deviations from the norm (Scottish Executive 
2001). They also have a significant role in health education and in 
supporting parents in the transition to parenthood. All pregnant women in 
Lothian are allocated a named midwife at booking. This will normally be a 
midwife attached to their GP surgery.
Obstetricians/Gynaecologists are experts in all aspects of pregnancy and 
childbirth. Obstetricians have expertise in treating complications of 
pregnancy and childbirth and offering specialist advice, screening and 
treatment. Women with a medium to high risk pregnancy will have their 
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care managed by an Obstetrician, with midwifery and GP support. 
Throughout Lothian, obstetricians see most women at their outreach 
clinics in the local community.
Neonatologists and Paediatricians have the responsibility for looking 
after the medical needs of all babies, including pre-term infants, babies 
who are ill (for instance with Neonatal Abstinence Syndrome), and babies 
with congenital abnormalities. They work closely with obstetricians, 
midwives and neonatal nurses to plan and provide care for newborn babies 
in partnership with the parents. Neonates who are ill are normally cared 
for in the Neonatal Unit at Simpson’s Centre for Reproductive Health at 
the Royal Infirmary or in the Special Care Baby Unit (SCBU) at the 
Maternity Unit at St John’s Hospital, Livingston.
Health Visitors are nurses who specialise in family and public health and 
are part of the primary health care team. They work alongside midwives to 
provide parent education and support during and after pregnancy. At the 
point when the midwifery care ends (normally 10 days after birth) the 
Health Visitor takes responsibility for the mother, baby and family and 
will visit in the immediate postnatal period, then follow-up the child until 
the age of 5 years. Health Visitors play a key role in supporting families 
with breastfeeding, postnatal depression, diet, exercise, child health and 
development, disease prevention, parenting, behaviour management, social 
and emotional issues. Health Visitors visit pregnant women before they 
give birth and get involved in their care at an early stage. Health Visitors 
will soon be changing their title to ‘Public Health Nurse’ in line with a 
move towards working with communities and groups to build their 
confidence in managing their own health.
General Practitioners have the responsibility for providing general 
medical care to the whole family and in most circumstances will confirm 
the pregnancy. GPs are experienced in caring for pregnant women and 
work closely with Community Midwives. Many jointly manage antenatal care
in Primary Care Health Centres. They also work closely with obstetricians 
and midwives in providing care to women with ‘high risk’ pregnancies. GP’s 
provide postnatal care to both mother and baby and work closely with 
Health Visitors. Many jointly manage ‘baby clinics’ with Health Visitors to 
monitor the health and development of children. In Lothian, most people 
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with a drug dependency who are on substitute drugs are managed by their 
GP and attend primary care for their prescription. General Practitioner’s 
will normally refer the pregnant woman to the community midwifery team 
and should provide details of any substance misuse, prescribed drugs or 
other risk factors on the referral letter or ‘antenatal liaison card’.
Pharmacists work in partnership with patients, doctors and other health 
care professionals to ensure medicines are used safely and to best effect. 
Community pharmacists are easily accessible to pregnant women. Many are 
in frequent contact with pregnant women who are drug dependent 
(especially those on prescription medicines), so can provide support and 
health care advice. Pharmacists provide a wide range of services including: 
dispensing of ‘substitute’ prescriptions, supervised self-administration of 
methadone, needle exchange schemes and general health promotion advice. 
Pharmacists are also involved with smoking cessation programs such as 
Want2Quit which can help pregnant women and their partners stop 
smoking.
Link Midwives and Nurses (Substance Misuse) 
In order to improve communication and care to pregnant women with drug 
and alcohol related problems in Lothian a named midwife in each 
community midwifery team in Edinburgh (and one each in East, Mid and 
West Lothian) as well as within the hospital midwifery department has 
been identified as a Link Midwife for Substance Misuse.
The role and remit of the Link Midwife (Substance Misuse) is: 
 To support other midwives within their area to provide good quality 
care to women with significant problems related to alcohol and drugs 
 To promote the implementation and use of the Substance Misuse in 
Pregnancy resource pack throughout Lothian
 To be a point of contact for other professionals involved in the care of 
substance-misusing women, offering information and advice where 
possible
 To liaise with Link Health Visitors for Substance Misuse, and other 
specialist drug and alcohol workers in their area 
 To ensure all the midwives in their area use the substance misuse 
‘liaison forms’ and collate them for data collection purposes 
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 To attend regular meetings of the Link Midwives and keep up-to-date 
with trends, research findings, policy and good practice in relation to 
drug use (including alcohol and tobacco) in pregnancy.
To contact your local Link Midwife for Substance Misuse see list in 
appendix 2.
Link Health Visitors (Substance Misuse) 
In order to improve the care of pregnant women, children and families 
affected by drug and alcohol related problems in Lothian a named Health 
Visitor in each LHCC (including East, Mid and West Lothian) has been 
identified as a Link Health Visitor for Substance Misuse.
The role and remit of the Link Health Visitor (Substance Misuse) is:
 To support other Health Visitors within their area to provide good 
quality care to children and families affected by substance misuse 
problems
 To promote the implementation and use of the Substance Misuse in 
Pregnancy resource pack throughout Lothian 
 To be a point of contact for other professionals involved in the care of 
pregnant women, children and families affected by substance misuse 
 To liaise with Link Midwives and specialist drug and alcohol service 
providers in their area to ensure channels of communication and 
referral are kept open 
 To attend regular meetings of the Link Health Visitors and keep up-to-
date with trends, research findings, policy and good practice in relation 
to substance misuse and child health. 
To contact your local Link Health Visitor for Substance Misuse see list in 
appendix 3.
Substance Misuse in Pregnancy 105
Drug services in Lothian 
Most specialist drug services in Lothian prioritise pregnant women and
their partners and will normally offer appointments within a few weeks 
from date of referral. Many also offer home visiting.
Lothian-wide drug services 
z Community Drug Problem Service (CDPS), The Spittal Street Centre, 
22-24 Spittal Street, Edinburgh EH3 9DU. 
Tele 0131 537 8343 
Health care service offering specialist assessment, substitute 
prescribing, drug stabilisation, supervision of methadone consumption, 
opiate detoxification, psychiatric assessment and drug management in 
pregnancy. Written referral required.
z Harm Reduction Team, The Exchange, Lady Lawson Street, Spittal 
Street Centre, Edinburgh EH3 9DU.
Tele 0131 537 8300
Offers needle exchange, advice about safer drug use, blood borne 
viruses and sexual health, and the low threshold methadone clinic for 
clients who continue to inject drugs. Offers choice of same sex 
worker. Telephone or self referral.
z Pharmacy Needle Exchanges 
There are approximately 20 pharmacies in Lothian currently 
participating in the needle exchange scheme. Contact Harm Reduction 
Team for an up-to-date list. Tele 0131 537 8300. *Please note that 
some local drug agencies also offer a needle exchange service – see 
list under ‘local drug services’.
z Simpson House Drug Project, 52 Queen Street, Edinburgh EH2 3NS 
Tele 0131 225 6028 
City centre drug agency offering drug counselling (individual, couple 
and family), counselling for emotional problems relating to drug use, 
support to families of drug users and prison visiting. Self referrals 
only.
z Scot-Pep (Scottish Prostitutes Education Project), 70 Newhaven Road, 
Edinburgh EH6 5QG 
Tele 0131 622 7550 
Service for women working in the sex industry who have drug related 
problems. Offers needle exchange, information, advice and support. 
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z Crew2000, 32 Cockburn Street, Edinburgh EH1 1PB 
Tele 0131 220 3404 
Young People’s (16-25 years) service offering information and one-to-
one peer support for anyone using stimulant or hallucinogenic drugs 
(e.g. amphetamines, ecstasy, cocaine, crack, LSD). 
Edinburgh-wide drug services 
z Aberlour Outreach Project, 7 Hay Road, Edinburgh EH16 4QE 
Tele 0131 669 4317 
Offers support to families affected by drug and /or alcohol misuse 
who have children under 12 years. Support for pregnant women and 
help with positive parenting. Home visiting offered.
z Harbour Project, c/o Family Service Unit, 18 West Pilton Park, Pilton, 
Edinburgh EH4 4EJ 
Tele 0131 552 0305 
Offers support to families affected by substance misuse. Outreach 
service provided. 
z Adult Resource Team Addictions (ARTA), Social Work Department, 
Building 4, 5-7 Regent Road, Edinburgh EH7 5BL 
Tele 0131 525 8040 
ARTA will assess, plan, co-ordinate and manage (for the first 16 
weeks) an action plan of services to meet the needs of drug-using 
adults. Written referral required.
z Community Care Resource Team (HIV/Drugs), Social Work 
Department, Building 4, 5-7 Regent Road, Edinburgh EH7 5BL 
Tele 0131 525 8040 
Specialist community care service for people with drug-related 
problems and/or HIV infection who have complex care needs. Also 
provides community care assessments for residential drug 
rehabilitation placements. 
z Hype, NCH Scotland, c/o Simpson House, 52 Queen Street, Edinburgh 
EH2 3NS 
Tele 0131 466 4600 
Service for young people (under 18 years) offering counselling, 
information, advice and support for those experiencing difficulties 
with drug, alcohol or volatile substance use. 
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Local drug services 
z Locality Clinics (Drug Problems) 
Many areas of Lothian have locality clinics, most of which offer 
assessment of drug users, advice about and initiation of prescribing 
and review of drug users already on treatment whose management is 
causing concern. These clinics are usually run by a doctor with 
experience of caring for drug users, a nurse from the CDPS, and a 
worker from the local voluntary drug agency. Written referral 
required.
z Each geographical area throughout Lothian has its own local drug 
service. Most accept self referrals and offer information, advice, 
needle exchange, support, counselling and home visiting. Some provide 
specific services to women and families affected by drug use. Contact 
them for further information. 
North West Edinburgh 
 North Edinburgh Drug Advice Centre (NEDAC), 10 Pennywell Court, 
Edinburgh EH4 4TZ. 
Tele 0131 332 2314 
North East Edinburgh 
 Turning Point (Leith), 3 Smith’s Place, Leith, Edinburgh EH6 8NT. 
Tel. 0131 554 7516 
South West Edinburgh 
 West Edinburgh Support Team (WEST), 12a Dumbryden Road, 
Edinburgh EH14 2AB. 
Tele 0131 442 2465 
South East Edinburgh 
 Castle Project, PO Box 922, Edinburgh EH16 4DU 
Tele. 0131 669 0068 
 Greater Liberton Drug Project, Gilmerton Community Centre, 4 Drum 
Street, Edinburgh EH17 8QQ 
Tele 0131 664 2839 
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East and Mid Lothian 
 Mid and East Lothian Drugs (MELD), 6a Newmills Road, Dalkeith, Mid 
Lothian EH22 1DU 
Tele 0131 660 3566 
 AXIS, Tynepark, Poldrate, Haddington, East Lothian EH41 4DA 
Tele 01368 865351 
West Lothian 
 West Lothian Drug and Alcohol Service (WLDAS), 43 Adelaide Street, 
Craigshill, Livingston, West Lothian EH54 5HQ 
Tele 01506 430 225 
 Drug Team (Social Work), Strathbrock Partnership Centre, 189a West 
Main Street, Broxburn, West Lothian EH52 5LH 
Tele 01506 775666 
Residential drug services 
z Links Project, Turning Point – Scotland, 5 Links Place, Leith, Edinburgh 
EH6 7EZ.
Tele 0131 553 2222 (Referrals) 
Residential unit for men and women who wish to detox, stabilise or 
reduce their drug use. Stay of up to 6 weeks. Self referrals only.
Clients from Mid, East and West Lothian require a community care 
assessment prior to admission.
z Brenda House, 7 Hay Drive, Edinburgh EH16 4QA. 
Tele 0131 669 6676 
Detoxification and rehabilitation unit for pregnant women and women 
with young children (under 12 years) who are drug or alcohol 
dependent. Community care funding required. Self or written referrals 
accepted.
z Midpoint Supported Accommodation (Turning Point), 9 Forrest Road, 
Edinburgh EH1 2QH. 
Tele 0131 226 5453 
Offers support for independent living, home visiting, practical and 
emotional support to women drug users who have their own tenancy. 
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Alcohol services in Lothian 
Most specialist alcohol services in Lothian prioritise pregnant women and 
will normally offer appointments within a few weeks from date of referral. 
Most also prioritise work with any pregnant woman’s partner who is 
affected by alcohol related problems too, so please make this clear when 
you refer.
Hospital
z Alcohol Problems Service (APS), 35 Morningside Park, Edinburgh EH10 
5HD.
Tele 0131 537 6557 
Offers specialist assessment, alcohol detoxification (in-patient and 
out-patient), psychiatric assessment and advice about management of 
alcohol use in pregnancy. Written referral required.
z Department of Psychological Medicine, Royal Infirmary of Edinburgh. 
Tele 0131 242 1396/1398 
Alcohol Liaison Nurses: Helene Leslie & Louise Learmonth 
Offers specialist assessment, advice and treatment regarding alcohol 
related problems to hospital in-patients. 
z Liaison Psychiatry Service, St John’s Hospital, Livingston, West 
Lothian.
Tele 01506 419 666 
Liaison Psychiatry Nurse, Pauline McManus 
Offers specialist assessment, advice and treatment regarding alcohol 
related problems to hospital in-patients. 
Community
z Alcohol Problems Service, Community Psychiatric Nursing Service, 
Royal Edinburgh Hospital. 
Specialist Community Psychiatric Nurses (CPN’s) for people with 
alcohol related problems are located in each LHCC area. Contact APS 
or GP surgery for further information. 
z Edinburgh and Lothian Council on Alcohol (ELCA), 2nd Floor, 40 
Shandwick Place, Edinburgh EH2 4RT. 
Tele 0131 225 8888 
Lothian-wide service offering one-to-one alcohol counselling. 
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z Libra, 4 Norton Park, Edinburgh EH7 5RS 
Tele 0131 661 0111 
Lothian-wide service offering one-to-one counselling and support 
groups for women affected by alcohol problems. 
z West Lothian Drug and Alcohol Service (WLDAS), 43 Adelaide Street, 
Craigshill, Livingston, West Lothian EH54 5HQ 
Tele 01506 430 225 
Residential
z Brenda House, 7 Hay Drive, Edinburgh EH16 4QA. 
Tele 0131 669 6676 
Detoxification and rehabilitation unit for pregnant women and women 
with young children (under 12 years) who have alcohol related 
problems. Community care funding required. Self or written referrals 
accepted.
Smoking cessation services in Lothian 
All areas throughout Lothian now have smoking cessation initiatives. For 
further information contact: 
• Fiona Moore, Smoking Cessation Co-ordinator (Pregnancy)
Tele. 0131 536 9414
• Jane Riddle, Smoking Cessation Co-ordinator (Primary Care)
Tele. 0131 536 9415 
West Lothian has a specialist midwife appointed to the ‘Stop for Life’
programme at the Smoking Cessation Clinic at St Johns Hospital, 
Livingston, West Lothian. 
Tele 01506 419 666 ext 3000 
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Other services in Lothian 
A variety of other services may be of help to pregnant women depending 
on their needs. Please refer to services and resource list in ‘Ready Steady 
Baby’ book as well as the following. 
General
z The Housing Advice Centre, 23 Waterloo Place, Edinburgh EH1 3BH 
Tele 0131 529 7368 
z Welfare Rights Team (Edinburgh Only), The Advice Shop, 85-87 South 
Bridge, Edinburgh EH1 1HN 
Tele 0131 225 1255 
HIV
z Genito-Urinary Medicine Department (GUM), Lauriston Building (Level 
4), Lauriston Place, Edinburgh EH3 9YW. 
Tele (Females) 0131 536 2104 
Offers HIV testing and care. HBV testing, STI testing and sexual 
health advice. Written or self referrals accepted. 
z Regional Infectious Diseases Unit (RIDU), Ward 41, Western General 
Hospital, Edinburgh EH4 2XU. 
Tele 0131 537 2820/2823 
Testing and care for blood borne viruses. GP referral for people 
infected with HIV, HCV or HBV. 
z Waverley Care, 58a Queen Street, Edinburgh EH2 3NS 
Tele 0131 226 2206 www.waverleycare.org
Includes Milestone House residential service, ‘Buddy’ service and day 
care service. 
z SOLAS, 2/4 Abbeymount, Edinburgh EH8 8EJ 
Tele 0131 661 0982 
Centre for support and information for people affected by HIV. 
Hepatitis
z Centre for Liver and Digestive Disorders (CLDD), Royal Infirmary of 
Edinburgh, Little France. 
Tele 0131 242 3063 
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Specialist health service centre for liver disease. Offers assessment 
and treatment for people infected with hepatitis. Written referral 
only.
z Capital C, 13 East Norton Place, Edinburgh EH7 5DR 
Tele 0131 478 7929 
Lothian-wide service offering support to people infected or affected 
by hepatitis C. Offers information, advice and practical support in 
attending hospital appointments. Written or self referral. 
Domestic abuse 
z Scottish Women’s Aid, Norton Park, 57 Albion Road, Edinburgh EH7 
5QY
Tele 0131 475 2372 
Advice, support and refuge to women who have been abused mentally, 
physically or sexually. Provides contact information for all local 
Women’s Aid groups throughout Lothian. 
z Space 44, 44 Montrose Terrace, Edinburgh EH7 5DL 
Tele 0131 652 0999 
 Advice, information, support and advocacy for women. Offers drop-in 
and crèche facilities. 
z Domestic abuse freephone helpline (10am – 12 midnight) 
Tele 0800 027 1234
Homelessness
z The Access Point (including the Edinburgh Homeless Practice) 
17 Leith Street, Edinburgh EH1 3AT 
Housing, Social Work and Health care services for homeless people.
Tele 0131 529 7747
z Streetwork, 14 Albany Street, Edinburgh EH1 3QB 
Tele 0131 476 3666 
Support, practical help and advocacy for homeless people.
z Homeless Outreach Project (HOP), 1A Grindlay Street Court, 
Edinburgh EH3 9AR.
Tele 0131 221 9099 
z Shelterline - Freephone number 
Information on emergency access to refuge services and general 
housing matters. 
Tele 0808 800 4444 
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Further help, information, useful addresses, websites 
All pregnant women in Lothian are given a copy of the NHS Health 
Scotland (formerly HEBS) book ‘Ready Steady Baby’.
Please refer to pages 151-155 for a list of helpful contacts.
Also refer to the Health Promotion Library Scotland, The Priory, Canaan 
Lane, Edinburgh EH10 4SG. Tele 0845 912 5442. www.hebs.com/library
Staff can also access the Library and Resource Centre, Lothian NHS 
Board, Deaconess House, 148 Pleasance, Edinburgh.
Tele 0131 536 9451
Pregnancy, childbirth, breastfeeding and child care 
z NHS Health Scotland,
Woodburn House, Canaan Lane, Edinburgh EH10 4SG.
Tele 0131 536 5500 
www.hebs.org
(2003) ‘Ready Steady Baby’
(1995) ‘The Breastfeeding Facts Pack’ 
z National Childbirth Trust (NCT),
Alexandra House, Oldham Terrace, London 
Tele 0870 444 8707
Breastfeeding helpline (Tele 0870 444 8708) 
www.nctpregnancyandbabycare.com
z Lawrence RA. (1999) ‘Breastfeeding: A Guide for the Medical 
Profession’, 5
th
 Edition, Mosby, St Louis. 
z SANDS (Stillbirth and Neonatal Death Society) 
Tele 0131 622 6263 
z Scottish Cot Death Trust,
Royal Hospital for Sick Children, Glasgow G3 8SJ.
Tele 0141 357 3946 
www.gla.ac.uk/departments/childhealth/SCDT/
z Lothian Health Council, 21 Torphichen Street, Edinburgh
(2000) ‘Women’s Views of Maternity Services in Lothian’
Tele 0131 229 6605 
www.lhc-online.org
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z Royal College of Obstetricians and Gynaecologists (RCOG) 
Guidelines on good practice 
www.rcog.org.uk
z Department of Child & Adolescent Health and Development (CAH), 
World Health Organisation, Geneva, Switzerland. 
www.who.int/child-adolescent-health
z Royal College of Psychiatrists 
Helpful leaflets & fact sheets on all aspects of mental health e.g. 
‘Postnatal depression – Help is at hand’
www.rcpsych.ac.uk/
Smoking, alcohol and drugs 
z National Drugs Helpline
Tele 0800 776600 
z Scottish Drugs Forum (SDF),
Shaftsbury House, 5 Waterloo Street, Glasgow G2 6AY.
Tele 0141 221 1175 
www.sdf.org.uk
z DrugScope, 32 Loman Street, London SE1 0EE 
Tele 020 7928 1211 
www.drugscope.org.uk
z ISD (Scotland) 
www.drugmisuse.isdscotland.org
z Substance Misuse Management in General Practice 
www.smmgp.demon.co.uk
z National Treatment Agency for Substance Misuse 
www.nta.nhs.uk
z Exchange: Tools for Harm Reduction
www.exchangesupplies.org
z Alcohol Focus Scotland (formally the Scottish Council on Alcohol),
166 Buchanan Street, Glasgow G1 2NH.
Tele 0141 572 6700 
www.alcohol-focus-scotland.org.uk
z Drinkwise, 2nd Floor, 166 Buchanan Street, Glasgow G1 2LW 
Tele 0141 572 6704 
www.drinkwise.co.uk
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z Alcohol Concern,
Waterbridge House, 32-36 Loman Street, London SE1 0EE. 
Tele 0207 922 8667 
www.alcoholconcern.org.uk
z Alcoholics Anonymous 
National Helpline. Tele 0845 769 7555 
www.aa-uk.org.uk
z Drinkline
National helpline. Tele 0800 917 8282 
z Down Your Drink 
Online programme for reducing drinking. 
www.downyourdrink.org
z ASH Scotland, 8 Fredrick Street, Edinburgh EH2 2HB.
Tele 225 4725 
www.ashscotland.org.uk
z Smokeline
A free helpline for people who want to give up smoking. 
Tele 0800 848484
z Children’s Liver Disease Foundation 
www.childliverdisease.org
z British Liver Trust, Ransomes Europark, Ipswich, England IP3 9QG. 
Tele 01473 276326 
www.britishlivertrust.org.uk
z Hepatitis C information site (prepared by NHS based doctors & 
nurses)
www.hepc.org.uk
z National AIDS Helpline (24 hours) 
0800 567 123 
z British HIV Association (BHIVA) 
www.bhiva.org
z Hepatitis C Resource Pack (NHS Lothian) 
Free pack containing information leaflets for patients as well as the 
Hepatitis C test proforma to guide pre and post test discussion with 
patients.
Copies available from the Library and Resource Centre, Deaconess 
House, 148 Pleasance, Edinburgh EH8 9RS. Tele 0131 536 9451 
Also available on NHS Lothian website www.nhslothian.scot.nhs.uk
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General
z Scottish Executive website 
www.scotland.gov.uk
z Scottish Health website 
www.show.scot.nhs.uk
z NHS 24 
Tele 08454 242424
www.nhs24.com
z NHS Helpline
Gives information about health services on freephone number. 
Tele 0800 224488 
Introduction
Key points
Setting the scene
Framework for care
Guidelines on good practice
References
Substance Misuse in Pregnancy 117
References
Abel EL, (1998) ‘Fetal Alcohol Syndrome’, Plenum Press, New York. 
ACMD (Advisory Council on the Misuse of Drugs) 2003 Report ‘Hidden Harm: 
Responding to the needs of children of problem drug users’, Home Office, London. 
Download from www.drugs.gov.uk
Alcohol Concern, (1997) ‘Brief Intervention’ Factsheet www.alcoholconcern.org.uk
British HIV Association (BHIVA) 2001, ‘Guidelines for the management of HIV 
infection in pregnant women and the prevention of mother-to-child transmission’, 
HIV Medicine, 2, 314-334. www.bhiva.org
Bradley KA, et al (1998) ‘Alcohol Screening questionnaires in women: A Critical 
Review’ JAMA; 280(2):pg.166-71. 
Burns EC, et al (1996) ‘The Health and development of children whose mothers are 
on methadone maintenance’, Child Abuse Review, 5:pg.113-122. 
Chang G, et al (1999) ‘Brief intervention for alcohol use in pregnancy: A 
randomised trial’, Addiction, 94(10):pg.1499-1508. 
Coghlan D, Milner M, Clarke T, Lambert I, McDermott C, McNally, Beckett M & 
Matthews T, (1999) ‘Neonatal Abstinence Syndrome’, Irish Medical Journal, 92 (1). 
Department of Health, (1999) ‘Drug Misuse and Dependence: Guidelines on Clinical 
Management’, Annex 5 ‘Pregnancy and Neonatal care’. www.doh.gov.uk/
Doberczak TM, Kandall SR & Wilets I, (1991) ‘Neonatal opiate abstinence 
syndrome in term and preterm infants’ Journal of Paediatrics, Vol.118, No.6, 
pp.933-37.
Drug Misuse Statistics Scotland, (2002) ‘Scottish Drug Misuse Database’, ISD, 
Edinburgh. www.drugmisuse.isdscotland.org
Edinburgh and the Lothian’s Child Protection Committee (November 2002) ‘Inter-
agency Child Protection Guidelines’.
Effective Interventions Unit, (2002) ‘Integrated Care for Drug Users’, Scottish 
Executive, Edinburgh. www.drugmisuse.isdscotland.org/eiu/eiu.htm
Substance Misuse in Pregnancy 118
Ford C, & Hepburn M, 1997, ‘Caring for the pregnant drug user’ in Beaumont. B, 
(Ed) ‘Care of drug users in general practice: a harm-minimization approach’,
HEBS (Health Education Board for Scotland), 2003, ‘Alcohol – Safe in Pregnancy?’
in ‘Ready Steady Baby’ book. 
www.hebs.scot.nhs.uk/readysteadybaby/pregnancy/health.htm
Hepburn M, 1996, ‘Drug Use in Pregnancy: Sex, Drugs and Facts’n’Fiction’, Druglink,
July/August issue. 
ISDD (Institute for the Study of Drug Dependence) 1999, ‘Drug Abuse Briefing’,
7th Edition, London. www.drugscope.org.uk
Johnstone F, 1998, ‘Pregnant Drug Users’ in Robertson, R (Ed) ‘Management of 
Drug Users in the Community: A Practical Handbook’, Arnold, London. 
Kandall SR, Doberczak TM, Jantunen M, & Stein J, 1999, ‘The methadone 
maintained pregnancy’, Clinics in Perinatology, 26 pp.173-183. 
Klee H, Jackson M, & Lewis S, (2002) ‘Drug Misuse and Motherhood’, Routledge, 
London.
Koren G, et al (1989) ‘Bias against the null hypothesis: the reproductive hazards of 
cocaine’, Lancet, 2 (8677) pg1440-1442. 
Lothian Primary Care NHS Trust, (2003) ‘Managing Drug Users in General 
Practice’, 4th Edition, Edinburgh.  
Macrory F, & Crosby S, (1995) ‘Special Care or Segregation?: The need for 
improvement in the provision of maternity services for drug-using women’, paper 
presented at the 6th International Conference on the Reduction of Drug Related 
Harm, Florence, Italy.  
McIntosh C, (2001) ‘The Care of Pregnant Drug and Alcohol Misusers in Lothian’,
Directorate of Public Health, Lothian Health, Edinburgh. 
Morrison C, (1999) in Siney. C (Ed) ‘Pregnancy and Drug Misuse’, Books for 
Midwives Press, Cheshire. 
Mounteney J, (1999) ‘Drugs pregnancy and Childcare: A Guide for Professionals’,
ISDD, London. 
Radcliffe Medical Press, Oxon. 
Substance Misuse in Pregnancy 119 
NICE (National Institute for Clinical Excellence), March 2002, ‘Guidance on the 
use of nicotine replacement therapy (NRT) and bupropion for smoking cessation’, 
www.nice.org.uk accessed on 1st June 2003.  
 
Plant M, (1997) ‘Women and Alcohol: A contemporary and historical perspective’, 
Free Association Books, London. 
 
 
Practical Handbook’, Arnold, London.  
 
Ross A, Raab G, Mok J, Gilkinson S, Hamilton B, & Johnstone F, (1995) ‘Maternal 
HIV infection, Drug Use, and Growth of uninfected children in their first 3 years’, 
Arch Dis Child. 73(6), pp490-495.  
 
Royal College of Midwives (1997) ‘Domestic Abuse in Pregnancy’ Position Paper 
No.19, RCM, London. www.rcm.org.uk/ 
 
SCIEH (Scottish Centre for Infection and Environmental Health) 2003, Weekly 
Report, 15th April 2003, Vol.37, No.2003/15. www.show.scot.nhs.uk/scieh/ 
 
SCODA/LGDF, (1997) ‘Drug Using Parents: Policy guidelines for inter-agency 
working’, LDGF. 
 
Scott G. (2003), Personal Communication, Consultant Physician, Department of 
Genito-Urinary Medicine, Royal Infirmary of Edinburgh. 
 
Scottish Executive (2001) ‘A Framework for Maternity Services in Scotland’’, 
Edinburgh. www.scotland.gov.uk 
 
Scottish Executive (2002) ‘Plan for Action on Alcohol Problems’, Edinburgh. 
www.scotland.gov.uk/health/alcoholproblems  
 
Scottish Executive (2003) ‘Getting Our Priorities Right: Good Practice Guidance 
for working with Children and Families affected by Substance Misuse’.  
Download from www.scotland.gov.uk  
  
Scottish Executive (March 2003) ‘Responding to Domestic Abuse: Guidelines for 
Health Care Workers in NHS Scotland’. Download from www.scotland.gov.uk 
 
Plant M, (2001) ‘FAS Info: Drinking in Pregnancy’, http://fas-info.uwe.ac.uk 
accessed on 5th April 2003. 
Robertson JR, Ed (1998), ‘Management of Drug Users in the Community: A 
Substance Misuse in Pregnancy 120
Shaw B, (1999) ‘Maternal Drug Use: Consequences for the Child’ in Siney. C (Ed) 
‘Pregnancy and Drug Misuse’, Books for Midwives Press, Cheshire. 
 
Shaw NJ, & McIvor L, (1994) ‘Neonatal abstinence syndrome after maternal 
methadone treatment’, Arch Dis Child, Vol.71, ppF203-F205. 
 
SIGN (Scottish Intercollegiate Guidelines Network) Guideline 2003 ‘The 
Management of Harmful Drinking and Alcohol Dependence in Primary Care: A 
National Clinical Guideline’, Scottish Intercollegiate Guidelines Network. 
www.sign.ac.uk  
 
SIGN (Scottish Intercollegiate Guidelines Network) Guideline 2003 ‘Postnatal 
Depression and Puerperal Psychosis’, Scottish Intercollegiate Guidelines Network. 
www.sign.ac.uk  
 
Siney C, (Ed) 1999 ‘Pregnancy and Drug Misuse’, Books for Midwives Press, 
Cheshire. 
 
Sparey C, & Wilkinshaw S, (1999) in Siney C, (Ed) ‘Pregnancy and Drug Misuse’, 
Books for Midwives Press, Cheshire. 
 
Taylor DJ, (2003) ‘Alcohol Consumption in Pregnancy’, Guidelines and Audit Sub-
Committee of the Royal College of Obstetricians and Gynaecologists. 
www.rcog.org.uk accessed on 1st June 2003.  
 
Ward J, Mattick RP, & Hall W, (1998) ‘Methadone Maintenance Therapy and Other 
Opioid Replacement Therapies’, Harwood Academic Publishers, New Jersey. 
 
Whittaker A, & McLeod J, 1998, in Robertson R, (Ed) ‘Management of Drug Users 
in the Community: A Practical Handbook’, Arnold, London. 
 
WHO (World Health Organisation), 2001 (28-30 March) ‘The Optimal Duration of 
Exclusive Breastfeeding. Report of an expert consultation’, Geneva, Switzerland. 
www.who.int/en/  
 
World Health Organisation, 1997 cited in Mounteney. J, 1999, ‘Drugs Pregnancy 
and Childcare: A Guide for Professionals’, ISDD, London. 
 
Wright A, & Walker J, (2001) ‘Drugs of Abuse in Pregnancy’, Best Practice and 
Research Clinical Obstetrics and Gynaecology, Vol. 15, No. 6, pp. 987-998 
 
Introduction
Key points
Setting the scene
Framework for care
Guidelines on good practicelossary
Substance Misuse in Pregnancy 121
Glossary
Antenatal care: care provided by professionals during pregnancy in order to 
detect, predict, prevent and manage problems in the woman or her unborn child. 
APGAR score: score measured at birth by observations of the babies health e.g. 
colour, tone, heart rate etc. 
Benzodiazepines: a class of drugs previously called ‘minor tranquillisers’ which 
reduce anxiety and have a sedative effect. 
Binge drinking: excessive amount of alcohol taken on any one occasion, usually 
twice the recommended daily amount (i.e. 6 units or more for women). 
Bio-physical profile assessment: use of ultrasound scanning to assess fetal well-
being.
Birth plan: a written record of a woman’s preferences for her care during 
pregnancy, labour and childbirth. 
Brief intervention: usually consists of a brief assessment of substance use, 
information and advice on risks associated with substance use and details of local 
services and other helpful resources. 
Caesarean Section: an operation where the baby is delivered through an incision 
through the abdomen and uterus. 
Care Pathways: structured multidisciplinary care plans which detail essential 
steps in the treatment and care of patients with a specific illness or condition. 
Child Protection Case Conference: a multi-disciplinary meeting convened by Social 
Work to assess the level of risk to children and to decide on what action needs to 
be taken, if any.
CNS depressant: a drug which acts on the central nervous system to suppress 
neural activity in the brain e.g. opioids and benzodiazepines. 
CNS stimulant: a drug which acts on the central nervous system to increase 
neural activity in the brain e.g. amphetamines, cocaine, nicotine. 
Conception: the act of becoming pregnant.
Congenital abnormalities: an anomaly present at birth.
Continuity of care: a situation where all professionals involved in delivery of care 
share common ways of working and a common philosophy so that the woman does 
not experience conflicting experience or advice. 
Detoxification: process by which a user withdraws from the effects of alcohol or 
drugs over a short period of time (i.e. 1 to 3 weeks), usually managed with 
medication.
Deprivation category: the Carstairs and Morris index is composed of 4 indicators 
judged to represent material disadvantage in the population. These include: 
overcrowding, male unemployment, social class 4 or 5 and no car. 
Drug/Alcohol Dependence: a syndrome characterised by a cluster of signs and 
symptoms including physical dependence (e.g. tolerance and withdrawal) and 
psychological dependence (e.g. compulsion, avoidance behaviour, disregard for 
harm).
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Drug/Alcohol related problem: refers to a whole spectrum of harm (physical, 
psychological, social) associated with substance use. 
Fetal: of the fetus or unborn child. 
Gestation: age of fetus since conception. 
‘High Risk’ pregnancy: pregnancy with increased likelihood of complications, 
usually managed by obstetrician. 
Harmful drinking: levels of drinking which cause physical or psychological harm 
Injecting paraphernalia: all the equipment used for injecting drugs e.g. spoon, 
filter etc 
Intoxication: a state where the individual has drunk or taken drugs sufficient to 
significantly impair functions such as speech, thinking, or ability to walk or drive. 
Intrapartum care: care provided during labour and childbirth. 
Intrauterine growth restriction (IUGR): previously known as intrauterine growth 
retardation.
In-utero: in the uterus or womb, unborn. 
Lead professional: the professional who will give a substantial part of the care 
personally and who is responsible for ensuring that the woman has access to care 
from other professionals as appropriate. 
LHCC: Local Health Care Co-operative, soon to be replaced by ‘Community Health 
Partnerships’.
‘Low risk’ pregnancy: normal pregnancy with few anticipated complications, usually 
managed by midwife
Midwifery team: a small team of midwives (normally based in the community) who 
share responsibility for care during pregnancy, childbirth and the postnatal period.
Neonatal period: first 28 days of a baby’s life. 
Obstetric: the branch of medicine and surgery that deals with pregnancy and 
childbirth.
Opiates: drugs derived from the opium poppy e.g. morphine, codeine. 
Opioids: includes both opiates and their synthetic analogues e.g. methadone, 
dihydrocodeine, pethidine.
Parity: the number of maternities to a woman (children born live or stillbirth 
after 24 weeks gestation).
Postnatal: after the birth. 
Postpartum care: care provided in the period following delivery. 
Polydrug use: the use of more than one drug at a time. 
Pre-term: premature baby born before 37 weeks gestation (a ‘full-term’ 
pregnancy lasts 40 weeks). 
Problem drug/alcohol use: tends to refer to drug use (dependent or recreational) 
which causes social, financial, health or legal problems. 
Recreational drug use: the occasional use of drugs for pleasure or leisure.
Reproductive health: health of the organs involved in the process of conception, 
pregnancy and childbirth. 
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Resuscitation: revival of someone who is in cardiac or respiratory failure or shock. 
Screening: mass examination of the population to detect specific illnesses or 
conditions.
Shared care: an agreed arrangement between a GP and an obstetrician / midwife 
/ paediatrician / or other health specialist over care for a woman. 
Social Inclusion: ensuring that everyone regardless of sex, wealth, race, religion, 
age, lifestyle and geographical position has the opportunity to live full and active 
lives free from injustice, discrimination and poverty. 
Stillbirth: baby born dead after 24 completed weeks of pregnancy. Stillbirths 
must be registered and the cause of death established before a certificate of 
stillbirth can be issued and a burial take place. 
Substance misuse: taken to mean the use of drugs or alcohol in a socially 
unacceptable, hazardous or harmful way. 
Teratogenic: causing fetal malformations or congenital birth defects. 
Tolerance: higher doses of drug are needed to maintain the same effect. 
Trimester: each period of three months in pregnancy (1
st
, 2
nd
 and 3
rd
 trimesters). 
Ultrasound scan: image created by use of sound waves, which can confirm 
pregnancy and determine fetal size and well-being. 
Umbilical artery Doppler: is a fetal monitoring assessment test.
Vertical transmission: transmission from mother to baby either in utero, during 
childbirth or through breastfeeding. 
Viral load: the amount of virus circulating in the blood. 
Volatile substances: refers to solvents and inhalants including aerosols. 
Withdrawal: the body’s reaction to the sudden absence of alcohol or a drug to 
which it has adapted. 
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INDEX
Alcohol, 37-38, 52-56, 84 
screening, 53-54, Appendix 7 
units, 38, 53 
Alcohol Problems Service (APS), 56 
Antenatal screening, 27, 69, 72-74, 91 
Assessment, 25-27, 67 
physical health needs, 25 
psychological needs, 26 
risk assessment, 12, 27, 70, 77-80, 95-99 
social needs, 26
substance misuse, 26, 57 
Blood borne viruses, 33, 58-59, 67-68, 72, Appendix 1 
Booking appointment, 53, 70-72 
Care pathway, 25, 69, 92, Appendix 4 
Child care risk, 12, 26-28, 67, 75, 77, 79-80, 95-99 
Community Drug Problem Service (CDPS), 59, 60-61, 66, 71 
Conception, 25, 35, 53, 55, 68 
Contraception, 65-67, 84 
Detoxification, 33, 40, 58 
alcohol, 55-56 
drugs, 60-62 
Drink/drug diary, 55-57, Appendix 8 
Drugs
amphetamines, 15, 31, 33, 41, 65, 73, 87 
antidepressants, 31 
barbiturates, 43 
benzodiazepines, 31-32, 39-40, 43-44, 50-51, 58, 60-62, 73, 83, 87 
cannabis, 15, 31, 39, 43, 51 
cocaine and ‘crack’, 40-41, 65, 73, 87 
dihydrocodeine, 31-32, 40, 60-62, 71, 82 
hallucinogens, 31, 42-43 
heroin, 15, 31-33, 37, 40, 44, 65, 74 
methadone, 31-32, 40, 44-45, 57-62, 65-66, 71, 74, 82, 84 
opioids, 31-33, 40, 43, 48, 50-51, 57-62, 65, 68, 71, 73-74, 82-83  
tobacco/smoking, 11-12, 15, 19, 25, 27, 31, 36-37, 39, 47, 51-52, 68, 70, 92 
volatile substances, 31, 42-43 
Evidence base, 18, 36, 51, 53, 59 
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Fetal Alcohol Syndrome (FAS), 38 
Fetal monitoring tests, 72-73 
Hand held records, 69, 71, 81 
Harm reduction, 7-8, 11, 21, 23, 27, 54, 58, 65,71 
Harm Reduction Team (HRT), 58, 66, 71,75 
Health Visitors, 28, 49, 75, 89, 91, 97, 99, Appendix 3 
Injecting drug use, 19, 25-27, 33, 40, 58-59, 68, 72, 74, 77, 82, 88, 99 
Intrauterine growth restriction (IUGR), 35, 37-40, 72-73, 83 
Liaison forms (Substance Misuse), 16, 70-71, 81-83, Appendix 9 
Low birth weight, 19, 35, 37-40 
Meconium staining, 83 
Midwives, 17, 25, 29, 36, 46, 48-49, 52-53, 55, 69, 75, 77-79, 81-83, 88, 91, 97,  
     Appendix 2 
Miscarriage, 37-41, 62 
Naloxone, 33, 48, 83 
Neonatal Abstinence Syndrome (NAS) 12, 19, 27, 35, 39-50, 60-62, 68, 70, 77,  
     79, 83, 87, Appendix 10, Appendix 12  
Neonatal Unit / Special Care Baby Unit (SCBU), 49, 85 
Nutrition, 16, 19-20, 25, 36, 38, 41, 65, 67, 74 
Obstetricians, 25, 41, 52, 54-56, 62, 69-70, 81 
Paediatricians, 25, 45-46, 49, 81, 84 
Placental abruption, 37, 40 
Pre-term labour and delivery, 19, 35, 37, 39-41, 45-46, 58, 62, 73-74, 81, 83 
Relapse, 13, 54, 56-57, 62, 92-93 
Reproductive health, 32, 65, 84 
Service user (patient) information leaflets, 8, 46, 79, 95, Appendix 11 & 12 
Stillbirth, 37, 39-41 
Substance-misusing partner, 12, 17-18, 22, 25-28, 36, 51-52, 67, 72, 92, 97, 99 
Substitute prescribing, 16, 26, 31, 39, 57-61, 70-71, 81-82, 87 
Sudden Infant Death Syndrome (SIDS), 19, 35, 37, 39-40, 92 
Teratogenic, 15, 35, 38-39, 41, 56 
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Appendices
1. Blood Borne Viruses 
2. Link Midwives (Substance Misuse)  
3. Link Health Visitors (Substance Misuse) 
4. Model Care Pathway 
5. Consent form for multi-disciplinary working 
6. GP allocation proforma letter 
7. T-ACE alcohol screening questionnaire  
8. Drug & Alcohol Diary 
9. Midwifery Liaison Forms (Substance Misuse) 
10. NAS assessment score chart 
11. Leaflet: Pregnant… and using alcohol or drugs?
12. Leaflet: Caring for a baby with drug withdrawal symptoms
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Blood Borne Viruses and Pregnancy
HIV, hepatitis B and hepatitis C are all blood borne viruses (BBV) that can 
be passed from mother-to-baby (vertical transmission).
Antenatal testing for HIV, HBV, HCV 
In Lothian, testing for HIV and hepatitis B has been part of routine
antenatal screening since December 1999. Testing for hepatitis C can be 
offered to those at risk, but is not part of the routine screening 
programme. The aim of testing women in pregnancy is to reduce the 
likelihood of mother-to-baby transmission and to improve and protect the 
health of both mother and baby.
All pregnant women in Lothian receive a copy of the leaflet ‘A Guide to 
Routine Blood Tests Offered During Pregnancy’ (NHS Health Scotland 
2003). At the booking appointment the midwife should ask the pregnant 
woman whether she has understood the leaflet. The reasons for antenatal 
screening and the benefits of each test are briefly discussed before 
informed consent is obtained. All tests are carried out unless the women 
specifically requests otherwise. Women can ‘opt out’ of any test, if they 
wish. The ‘opt out’ rate for the HIV and hepatitis B tests in Lothian is 
very low (<5%).
All negative results are communicated to the woman at her next antenatal 
appointment. Negative results are recorded in the woman’s ‘hand held’
records.
If an HIV antibody or Hepatitis B (HBsAg) test is positive the virologist 
reports the results in confidence to the designated lead Obstetrician and 
Midwife responsible for Blood Borne Viruses. The obstetrician/midwife 
recalls the woman so that she can be given the results in person and to 
retest. At this visit, support, treatment and care are discussed.
HIV (Human Immunodeficiency Virus)
HIV is the virus that causes AIDS (Acquired Immune Deficiency 
Syndrome). HIV can be passed from mother to baby during pregnancy 
(intrauterine), childbirth (intrapartum) and breastfeeding. The risk of 
transmission is related to maternal health, obstetric factors and infant 
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prematurity (BHIVA 2001). The majority of vertical transmission occurs 
during the intrapartum period. There is a close correlation between 
maternal viral load and risk of transmission: the higher the viral load the 
greater risk of transmission. Breastfeeding is also an important route of 
transmission. The additional risk of transmission through breastfeeding, 
over and above the intrauterine and intrapartum contribution, is 
estimated to be between 7-22% (BHIVA 2001). 
Without treatment, the transmission rate is approximately 15%-25%. The 
prevalence of HIV among pregnant women in Scotland has increased 
recently. In 2002, unlinked anonymous testing found a prevalence of 5.8 
per 10,000 population (SCIEH 2003). Without treatment, HIV-infected 
children develop chronic disease and about 20% develop AIDS or die in 
the first year of life. By the age of 6 years, about 25% will have died and 
most surviving children will have some illness because of their infection. 
The long-term picture is unknown, but all children with HIV benefit from 
early life-prolonging treatment (Scottish Executive 2002).
The aim of the antenatal screening programme is to reduce the number of 
babies born with HIV and to improve the health of infected women and 
their babies. Diagnosis in pregnancy means that women can be offered 
advice, treatment and interventions to reduce the likelihood of mother-
to-baby (vertical) transmission of the virus. If appropriate interventions 
are accepted, the risk of vertical transmission can be reduced to below 
2%.
The recommended interventions are set out in the British HIV Association 
(BHIVA) ‘Guidelines for the management of HIV infection in pregnant 
women and the prevention of mother-to-child transmission’ (2001).
Interventions include: 
 The use of antiretroviral drugs for both mother and baby 
 Careful obstetric management during pregnancy and delivery 
 Delivery by pre-labour caesarean section 
 Bottle feeding 
An expanded version of the BHIVA guidelines, with an appendix on safety 
and toxicity data is available on the BHIVA website: www.bhiva.org
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Management of HIV positive pregnant women 
The care offered to HIV positive pregnant women in Lothian is jointly 
managed by specialists from Midwifery, Obstetrics, HIV, Paediatrics, 
Primary Care and other services (e.g. social work, drug and HIV services). 
Health care staff should refer to the agreed management protocol and 
care pathway. The approach to treatment is individualised, according to 
the needs and choices of each mother. Good liaison is required between all 
professionals to ensure that the pregnancy and birth plan proceed 
appropriately and that the views and wishes of the woman are respected.
There are two scenarios in which HIV infection may be identified during 
pregnancy. The first is where HIV infection is diagnosed during 
pregnancy, normally at the antenatal clinic. The second is where a known 
HIV positive woman falls pregnant.
Antiretroviral drug therapy (ART) for the mother aims to reduce her viral 
load to ‘undetectable’. ART is given according to the mother’s HIV health 
status. Normally it is avoided in the 1
st
 trimester. If possible, treatment 
will be deferred until just before the 3
rd
 trimester (20-24 weeks) in 
order to reduce fetal exposure. Women who become pregnant whilst 
taking ART that is successfully suppressing viral load, will normally 
continue with their ART throughout pregnancy.
The recommended mode of delivery is also dependent on viral load. 
Caesarean section is recommended if the viral load result is >1000. If the 
viral load is <1000 (ideally <50 copies /ml) at term then vaginal delivery is 
considered an acceptable choice for the mother. The choice should be 
discussed with the mother. If a woman chooses to breastfeed despite the 
evidence (perhaps because of cultural reasons), then she should be 
advised to breastfeed exclusively. Exclusive breastfeeding has been 
shown to be safer than mixed breast and bottle feeding.
Antiretroviral drug therapy (ART) is normally given to the baby for the 
first 4 weeks. The paediatrician determines the choice of ART. Most 
neonates born to mothers known to have HIV will be exposed to ART in
utero. The possible adverse effects of ART to the fetus and developing 
child continue to be monitored. All women who receive ART in pregnancy 
are registered with the International Drug Registry and exposed infants 
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are followed up for at least 1 year. Dr Jacqueline Mok, (Community 
Paediatrician at the Royal Hospital for Sick Children), is responsible for 
the follow-up of all babies born to HIV positive mothers in Lothian. To 
date, no increased risk of birth defects or growth problems have been 
documented with AZT. However, much less is known about the safety of 
other anti-HIV drugs. All babies who have been exposed to ART are 
reported to the British Paediatric Surveillance Unit.
Dr Mok undertakes diagnosis of HIV infection in infants born to HIV 
positive mothers. All babies born to mothers infected with HIV will test 
HIV-antibody positive at birth due to the presence of maternal HIV 
antibodies. Babies who are not infected will become HIV antibody negative 
by 18 months of age. Other tests (using PCR techniques) are used to 
diagnose children by the age of 3 months.
All professionals supporting HIV infected pregnant women should be 
aware of the psychosocial issues that can impact on HIV treatment and 
care (BHIVA 2001). Women may need considerable help and support to 
come to terms with the implications of their diagnosis and the 
management of their infection.
Hepatitis B (HBV)
Hepatitis B is a virus which affects the liver and is highly infectious. It 
can be passed from mother to baby during childbirth (approximately 80%-
90% transmission rate from infectious ‘carrier’ mothers). People who 
remain chronically infected with hepatitis B (i.e. ‘carriers’) can remain well 
for many years and may not know they are infected. Babies who are 
infected are at risk of developing serious liver disease later in life.
Preventing HBV infection 
The high rate of mother-to-baby transmission can be largely prevented 
through immunisation. If the antenatal hepatitis B surface antigen test is 
positive, a vaccination programme is started at birth to enable the baby to 
develop immunity and to have a healthy life. The midwife delivering 
intrapartum care notifies the neonatal Paediatrician that the woman is in 
labour and ensures that the medications for the baby are in stock. Within 
12 hours of birth the baby receives immunoglobulin (which neutralises the 
virus) and the first vaccine dose in the postnatal ward. The baby can be 
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breast fed after these are given. The second dose of vaccine is given at 1 
month, third dose at 2 months and fourth dose at 12 months. Immunity 
checks are carried out at 14 months of age. The GP and Health Visitor are 
informed, as they are responsible for ensuring that the baby receives all 
the vaccines to complete the immunisation programme. The SIRS 
(Scottish Immunisation Recall System) database is notified to alert staff 
that administration of the vaccine is due. When the mother leaves 
hospital with her baby she is given a hepatitis B vaccination record card. 
Health care staff should refer to the ‘Management of Hepatitis B in 
Pregnancy’ protocol (available from Public Health). 
The Health Protection Team (Public Health) are also informed about any 
person with hepatitis B infection (HBsAg positive), as it is important to 
trace contacts. Sexual partners, children and other household contacts 
are offered testing and immunisation where appropriate.
The Centre for Liver and Digestive Disorders (CLDD) at the Royal 
Infirmary of Edinburgh (RIE) offers a service for patients who are 
chronic hepatitis B carriers (defined as those who are HBsAg positive for 
6 months or more). Newly diagnosed patients can also be referred to the 
Regional Infectious Diseases Unit (RIDU) for assessment.
Drug use and hepatitis B 
It is good practice to offer all women with a history of injecting drug use
(or a sexual partner with a history of drug use) full screening for HBV in 
pregnancy (i.e. the Ab test in addition to the Ag test). Women with no 
prior infection with HBV can be safely immunised during pregnancy 
(Scottish Executive 2003). Current sexual partners and existing children 
can also be immunised. Hepatitis B and Hepatitis A immunisation is 
recommended for any Hepatitis C positive or HIV positive woman (Scott 
2003).
General Practitioners, Midwives, Health Visitors and drug workers are all 
in a good position to raise the subject of Hepatitis B, and to recommend 
screening and immunisation. Immunisation can now be easily carried out in 
General Practice.
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Hepatitis C (HCV) 
Hepatitis C is a virus, which affects the liver and can be passed from 
mother to baby, either during pregnancy or childbirth, but not through 
breast feeding. The transmission rate is thought to be low (below 5%). 
People who are chronically infected with hepatitis C can remain well for 
many years and may not know they are infected. Babies who are infected 
are at risk of developing serious liver disease later in life. Unfortunately, 
there is no vaccine currently available for hepatitis C. Combination 
therapy drug treatment for hepatitis C (interferon alpha & ribavirin) is 
contraindicated during pregnancy and breastfeeding (because of 
foetotoxic and teratogenic effects) and in young babies and children. As 
yet, there are no proven interventions to prevent or reduce the risk of 
vertical transmission (except in the case of co-infection, see below). 
Breast feeding is encouraged as there is no evidence that HCV can be 
transmitted by this route. Universal screening of all pregnant women is 
therefore not recommended.
Identifying hepatitis C infection in pregnancy is still useful however, for a 
number of reasons: 
 the woman’s health can be monitored
 she can be given healthy lifestyle advice 
 she can be given advice to prevent further risk of exposure
 she can be immunised against hepatitis B and hepatitis A
 she can be given information on infection control in the home and 
elsewhere
 she can be referred for specialist treatment once the baby is 
delivered.
Antenatal testing is also useful because infected babies can be identified, 
they can be immunised against hepatitis B and their paediatric care can be 
managed appropriately. Dr Jacqueline Mok, Paediatrician at RHSC, is part 
of the European paediatric Hepatitis C Network and will see all infants 
born to mothers with HCV. Infants are monitored for signs and symptoms 
of hepatitis C during the first year of life. Blood tests are also carried 
out using PCR techniques.
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It is good practice therefore to offer the test to all pregnant women at
risk of HCV infection.
Risk factors for HCV include: 
 History of intravenous drug use, HIV or HBV infection 
 Recipients of blood or blood products prior to 1991 
 Sexual partner with a history of injecting drug use 
 Sexual partner known to have either HIV, HCV or HBV infection 
 Unsterile body piercing, tattoos, acupuncture etc
 Unsterile medical or dental procedures abroad 
Because testing for HCV during pregnancy is not part of routine 
screening, the midwife may want to refer the woman to her General 
Practitioner or other HCV testing site. All staff offering the test for 
HCV should follow the agreed testing procedure - see the ‘Hepatitis C 
Test Proforma’, which is included in the Hepatitis C Resource Pack
(Lothian Health 2002).
Mothers found to be HCV (PCR positive) are referred for specialist care 
by Obstetric, Paediatric and CLDD (Liver Unit) staff. Capital C is a 
voluntary organisation that offers support to people affected by hepatitis 
C (see ’services list’ for further details). The Children’s Liver Disease 
Foundation is an organisation that specialises in supporting children with 
liver disease (www.childliverdisease.org)
Co-infection (HIV & hepatitis) 
Co-infection with HIV, HCV and HBV can occur due to shared routes of 
transmission. Caesarean section reduces mother-to-baby transmission of 
HCV in mothers co-infected with HIV. C-section is therefore 
recommended even if there is no indication for a C-section related to HIV. 
Drug treatment for HIV disease does not affect the transmission of HCV. 
Ideally, all women at risk of blood borne viruses should be offered testing 
before they conceive. See services list for further information on 
available testing sites. 
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Health Care staff with a special interest in Blood Borne Viruses and 
Pregnancy
There are a number of health care staff who have a special role in the 
management of pregnant women with blood borne viruses in Lothian. These 
include:
• Dr Wang Liston (Obstetrician and Gynaecologist) and Fiona McNeilage 
(Midwife) follow up all positive women attending Simpson Centre for 
Reproductive Health at the Royal Infirmary of Edinburgh.
• Dr Gerry Beattie (Obstetrician and Gynaecologist) and Fiona McGuckin 
(Community Midwife) follow up all positive women in West Lothian at 
St John’s Hospital.
• Dr Jacqueline Mok (Paediatrician) at the Royal Hospital for Sick 
Children cares for all babies born to infected mothers.
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Link Midwives and Nurses (Substance Misuse) 
Simpson Centre for Reproductive Health, Royal Infirmary of Edinburgh, Edinburgh EH16 4SA 
Hospital staff 
Antenatal Clinic Fiona McNeilage (co-ordinator for link midwives/nurses) Tel. 242 2546 (22546) 
Neonatal Unit Angela Greco & Jane Anderson Tel. 242 2601 (22601) 
Postnatal Ward Fatima Goulter Tel. 242 1191 (21191) 
Labour Ward Gillian Fordyce Tel. 242 2542 (22542) 
Community midwifery staff 
East Lothian Linda Coull 
Community Midwives Office, Roodlands Hospital,
Haddington EH41 3PF 
536 8304
Midlothian Alison Bagan 
Community Midwives Office, Bonnyrigg Health Centre,
35-37 High Street, Bonnyrigg, EH19 4DA 
536 8949 
South-West
Edinburgh
Claire Stephen 
Community Midwives Office, Sighthill Health Centre,
Calder Road, Edinburgh EH11 4AU 
537 7116 
North-East
Edinburgh
Louise Croan & Gillian Reid
Community Midwives Office, Eastern General Hospital,
Seafield Road, Edinburgh EH6 7LN 
536 7345
North-West
Edinburgh
Jill Kelly 
Community Midwives Office, Pennywell Resource Centre,
31-33 Pennywell Road, Edinburgh, EH4 4PJ 
537 4251 
North-West
Edinburgh
Katy Ruggeri 
Community Midwives Office, North Lodge, Corstorphine
Hospital, 136 Corstorphine Road, Edinburgh EH12 6TT 
459 7257 
South-East
Edinburgh
Pauline Connolly 
Community Midwives Office, Craigmillar Medical Centre,
106 Niddrie Mains Road, Edinburgh, EH16 4DT 
536 9630 
South Central 
Edinburgh
Romana Shillinglaw 
Community Midwives Office, Tollcross Health Centre,
Ponton Street, Edinburgh EH3 9QQ 
536 9847 
Maternity Unit, St John’s Hospital, Livingston, West Lothian 
Deborah Stewart 
& Ruth Batten
Special Care Baby Unit, St John’s Hospital, Livingston 01506 419666  
ext 3097 
Community midwifery 
Fiona McGuckin Whitburn Health Centre, 1 Weaver’s Lane, Whitburn,
West Lothian, EH47 0SD 
01501 740719/297 
Mobile: 07740 841769 
Introduction
Key points
Setting the scene
Framework for care
Guidelines on good practice
 i
etting the scene
Framework for care
Guidelines on good practice
Appendix 3:
Link Health Visito s
(Substance Misuse)
   
Substance Misuse in Pregnancy: Appendix 3 
Link Health Visitors (Substance Misuse) 
South West Edinburgh LHCC Telephone no.
Val Waters & Fiona Bruce 
Whinpark Surgery, 6 Saughton Road, Edinburgh, EH11 3RA
455 5299
South East Edinburgh LHCC 
Wilma Laird 
Howdenhall Surgery, 57 Howdenhall Road, Edinburgh, EH16 6PL 
664 1004
Lisa Miller 
Southern Medical Centre, 322 Gilmerton Road, Edinburgh, EH17 7PR 
672 1168
Margo Hayes 
Craigmillar Medical Centre, 106 Niddrie Mains Rd, Edinburgh, EH16 4DT
536 9620
South Central Edinburgh LHCC
Linda Hornby
32 Lauriston Place, Edinburgh EH3 9EZ 
228 5873
Dee Mills 
Springwell Medical Centre, Ardmillan Terrace, Edinburgh, EH11 2JL
537 7451
North West Edinburgh LHCC 
Jane Henry 
Crewe Medical Centre, 135 Boswall Parkway, Edinburgh, EH5 2LY
552 1320
North East Edinburgh LHCC 
Jane Jackson & Louise Ferguson
Bellevue Medical Centre, 26 Huntingdon Place, Edinburgh EH7 4AT 
557 6585
East Lothian 
Margaret St Clair Gunn 
Prestonpans Health Centre, Preston Road, Prestonpans, East Lothian EH32 
9QS
01875 812979
Midlothian
Gillian Robertson & Anne MacDonald 
Dalkeith Medical Centre, St Andrew Street, Dalkeith, Mid Lothian EH22 1AP 
561 5510
West Lothian 
Susan Bell 
Murraygate Children’s Centre, 88 Murraygate Industrial Estate, Whitburn, 
West Lothian EH47 0LE 
Liz Henderson
Ashgrove Health Centre, Blackburn, West Lothian EH47 7LL 
01501 742388
01506 654965
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MODEL CARE PATHWAY: SUBSTANCE MISUSE IN PREGNANCY 
Pre-conceptual Care  Advice on reproductive health and contraception 
 Advice on sexual health 
 Advice on pregnancy care 
Confirmation of pregnancy  ‘Ready Steady Baby’ book 
 Woman to attend GP (e.g. health advice & folic acid) 
 Refer to Midwifery Team 
 Arrange scan 
12 weeks… Booking appointment 
Multidisciplinary
Assessment
 Follow antenatal ‘Care Pathway’ 
 Assessment of drug use (including tobacco and alcohol) 
 T-ACE (alcohol questionnaire) 
 Antenatal Liaison Form (Substance Misuse) 
 Leaflet ‘Pregnant… and using alcohol or drugs?’
 Refer to drug/alcohol specialist
 Blood Borne Virus testing – if positive, follow agreed protocol
 Risk assessment 
 Commence ‘infant feeding’ checklist 
 Consent form for multidisciplinary / multi-agency working 
 If woman does not attend booking – follow-up by Midwife
16 weeks… Antenatal appointment  Discuss and agree care plan 
 Discuss and agree management of drug/alcohol use 
 Identify ‘lead professional’ / ‘care co-ordinator’ 
 Give handheld records 
22 weeks… Antenatal appointment  Monitor drug/alcohol use 
 Monitor progress of care 
28 weeks… Antenatal appointment  Case discussion / care plan review meeting 
 Reassess social circumstances / risk 
 Discuss breastfeeding 
 Growth scan / fetal monitoring
32 weeks…
Antenatal appointment 
 Start preparation for parenthood 
 Discuss birth plan 
 Discuss NAS and give parent information leaflet 
 Child protection case conference (if needed) 
36 weeks… Antenatal appointment  Preparation for parenthood 
 Assess fetal growth 
 Discuss labour and delivery (include protocol re prescription) 
38 weeks… Antenatal appointment  Preparation for parenthood 
 Monitor drug/alcohol use – update antenatal liaison form 
Term…
(40 weeks) 
Childbirth  Pregnancy outcome liaison form 
 Neonatal Abstinence Syndrome (NAS) assessment and care 
 Discharge plan (include prescription arrangements) 
 Discharge pack – discuss info on SIDS (cot death) 
 Follow postnatal ‘Care Pathway’ 
10 days… Postnatal care  Continue multidisciplinary support / postnatal care plan 
 Continue NAS assessment and care (if required) 
 Monitor drug / alcohol use 
 Relapse prevention support 
 Midwife ends care (day 10 to 28) 
 Home visit by Health Visitor 
Implement care plan
Review care plan 
Review care plan
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Consent Form for Multi-disciplinary / Multi-agency Working 
Please read the following information before you sign this form. 
A number of different professionals and organisations may be involved in your care. To provide you with 
the best possible care and support we need to work together.
Normally we find it useful to share relevant information with each other and to ask each other for advice 
when we need it. We also need to agree a common ‘care plan’ with you and keep each other informed about 
the progress you are making. We also want to make sure that we don’t duplicate each others work, give you 
conflicting advice, or miss out on providing you with something that you might need.
Each different organisation has its own policy on confidentiality and keeps separate written records. 
Confidentiality can only be breached in exceptional circumstances so we need your consent before we can 
pass information to professionals who work in other organisations. If you complete this form you will be 
giving us permission to do this. 
I give my permission for the following professionals and organisations to share information regarding my 
care.
Name:
Organisation:
Name:
Organisation:
Name:
Organisation:
Name:
Organisation:
Name:
Organisation:
Name of client: …………………………………………………………………………………………………………………………………… 
Address: ……………………………………………………………………………………………………………………………………………… 
Date of Birth: ………………………………………………………………………… 
Signature: ………………………………………………………………………………
Date consent form signed: ………………………………………………… 
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The Administrator, Lothian Health 
Primary Care Services 
Stevenson House 
555 Gorgie Road 
Edinburgh, EH11 3LG 
Date:
Dear Sir/Madam, 
I am having difficulty in registering with a doctor. Could you please allocate me a GP as soon as 
possible.
I have detailed my particulars below. 
Name:  ………………………………………………………………………………………………………………………….  
Address: ………………………………………………………………………………………………………………………… 
…………………………………………………………………………………………………………………………
Date of Birth:………………………………………………………………………… 
Place of Birth:………………………………………………………………………… 
Last GP: …………………………………………………………………………… 
Address: …………………………………………………………………………………………………………………………… 
Thank you. 
Yours sincerely, 
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Antenatal screening questionnaire 
Alcohol use in pregnancy 
T-ACE
T (tolerance)  How many drinks does it take to make you feel high? 
Answer: ‘3 drinks or more’ scores 2 points 
A (annoyance) Have people annoyed you by criticising your drinking? 
Answer: ‘Yes’ scores 1 point 
C (cut down)  Have you ever felt you ought to cut down your drinking? 
Answer: ‘Yes’ scores 1 point 
E (eye-opener) Have you ever had a drink first thing in the morning to steady your nerves 
or to get rid of a hangover? 
Answer: ‘Yes’ scores 1 point 
Total Score _______ 
Date of test ___________ 
Lowest score possible = 0 
Highest score possible = 5 
A total score of two points or more will correctly identify most women whose drinking is hazardous, 
harmful or dependent.
See guidance on how to respond in ‘Substance Misuse in Pregnancy: A Resource Pack for Professionals in 
Lothian’.
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Drug and Alcohol Diary
Day Times Type of drug/drink taken Amount taken Where? Why? Effects? 
     
     
     
     
     
     
     
Name:                Date:
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Antenatal Liaison Form (Substance Misuse)    SM103 
Mother’s name: …………..……………………………………………………………….............................................................................. 
Date of birth: ………………………………………………… 
Address: ……………………………………………………………………….............................................................................................. 
Tele. ……………………….................……………………… 
------------------------------------------------------------------------ 
Postcode: EH _ _  / _ (only 1st number of 2nd part) Hospital Unit No .......................................... 
Mother’s age:……………………………………………………… Mother’s Chi No. ……………………………………… 
E.D.D: …………………………………………………………………… Parity: ............................................................... 
 Tele. No. 
GP: ................................................................................................................................. ........................................ 
Midwife: ...................................................................................................................... ........................................ 
Health Visitor: ........................................................................................................... ........................................ 
CDPS / APS worker: ................................................................................................. ........................................ 
Other drug / alcohol worker: ................................................................................. ........................................ 
Social Worker: ........................................................................................................... ........................................ 
Maternity Unit: .......................................................................................................... ........................................ 
Consultant Obstetrician: ......................................................................................... ........................................ 
Smoker?... Yes/No  If yes, number per day? ...................................... 
Prescribed medication at booking (drugs & dosage) 
.......................................................................................................................................................................................... 
.......................................................................................................................................................................................... 
Dispensing Arrangements?........................................................................................................................................ 
Pharmacy? ........................................................................................................ Tele: .............................................. 
Name of Prescriber? ..................................................................................... Tele: .............................................. 
 
Injecting drug use during pregnancy?… Yes/No If yes, please detail frequency ...............................…. 
If no, ever injected drugs in the past?… Yes/No 
Illicit (street) drug use since conception?  
(all drugs used, excluding those prescribed, enter average daily amounts taken in 1st trimester) 
Heroin ...............................................................…... Diazepam/Temazepam ......................................................... 
Dihydrocodeine .................................................... Other tranquillizers? ........................................................... 
Methadone .....................................................….... Amphetamines (‘speed’) ...................................................…. 
Other opiates?...............................................….... Cocaine / Crack ...................................................…............…. 
Cannabis ….......................................................….... Ecstasy .......................................................…………………......…. 
Solvents / Volatile substances ................................................................................................................................ 
Other drug use? .......................................................................................................................................................... 
Referred to Community Drug Problem Service (CDPS)? … Yes/No Attended?… Yes/No 
Outcome? ..............................................................................................................…………………………………………………….. 
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Alcohol use (tick average weekly consumption in 1st trimester)? 
0-14 units  15-21 units  22-28 units  29-35 units  36-42 units  over 42 units  
Pattern of alcohol use? (daily use?, weekend use? binge drinking? etc) ...................................................... 
......................................................................................................................................................................................... 
 
Referred to Alcohol Problems Service (APS)? ... Yes/No  Attended? ... Yes/No  
Outcome? ..............................................................................................................…………………………………………………….. 
 
History of drug/alcohol misuse in any previous pregnancies?… Yes/No   
If yes, outcome of previous pregnancies?………………………………………………………………………………………………………… 
……………………………………………………………………………………………………………………………………………………………………………………. 
 
Additional concerns? (e.g. not registered with GP, homeless, mental health problems, debts, legal 
problems, literacy problems, relationship difficulties, domestic abuse, sex industry worker etc)  
.......................................................................................................................................................................................... 
.......................................................................................................................................................................................... 
.......................................................................................................................................................................................... 
.......................................................................................................................................................................................... 
Child care concerns?... Yes/No Pre-birth child protection case conference held?... Yes/No 
Antenatal testing for Blood Borne Viruses? 
HIV  – test accepted/declined 
Hepatitis B  – test accepted/declined HBV immunised? ... Yes/No 
Hepatitis C  – test offered?… Yes/No If yes, accepted/declined? 
Referred to high risk clinic?… Yes/No   If yes, attended?… Yes/No 
Date of antenatal case discussion (around 28th week): .................................................................................... 
Professionals involved?………………………………………………………………………………………………………………………………………….. 
Drug / alcohol use of partner? (please detail illicit & prescribed drugs taken / alcohol units per wk)  
.......................................................................................................................................................................................... 
.......................................................................................................................................................................................... 
Partner’s HIV / hepatitis B / hepatitis C status (if known) ............................................................................ 
.......................................................................................................................................................................................... 
 
Date form completed: ................................................................................................................................................ 
Signature of key midwife: ........................................................................................................................................ 
 
Later changes to prescribed drugs? (record any medication/dose changes and date of change) 
.......................................................................................................................................................................................... 
.......................................................................................................................................................................................... 
.......................................................................................................................................................................................... 
Completed by: .............................................................................................................................................................. 
 
*Form SM103. Photocopy and send to Link Midwife (Substance Misuse). 
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Pregnancy Outcome Form (Substance Misuse)    SM203 
Mother’s name: ........................................................................……  Mother’s d.o.b.: …………………………………………… 
Baby’s name: ................................................................................. 
Address: ........................................................................................................................................................................ 
------------------------------------------------------------------------ 
Postcode: EH _ _  / _ (only 1st number of 2nd part) Mother’s Unit No .......................................... 
Baby’s SM number:……………………………………………………… Mother’s Chi No.:……………………………………….. 
Delivery date: ..........................................................……               Baby’s Chi No.:…………………………………………… 
Gestation: ...............................................................………. APGARs: ...........................................................……….. 
Birth weight: .............................................................….. Cord pH: …………………………………………………………………. 
Birth length: ................................................................... Head Circumference: …………………………………………… 
 
Labour ward (please give details… if none state ‘none’) 
Complications in labour? ............................................................................................................................................ 
Pain relief during labour? ......................................................................................................................................... 
Mode of delivery? ………………………………………………………………………………………………………………………………………………….. 
Complications of delivery? ........................................................................................................................................ 
Problems at birth? ...................................................................................................................................................... 
 
Postnatal ward 
Baby stayed for 72 hours observation?… Yes/No 
Neonatal withdrawal symptoms developed within 72 hours?… Yes/No 
If yes, severity… Mild /Moderate/ Severe  
Drug treatment administered? .......................................................................................................................……… 
Medication on discharge? …………………………………………………………………………………………………………………………………….. 
Breast or bottle feeding on discharge? …………………………………………………………………………………………………………… 
Other comments? ………………………………………………………………………………………………………………………………………………….. 
Postnatal ward discharge date: .....................................................................................................................……….. 
If mother HIV/Hepatitis C positive, baby referred for follow-up?...Yes/No   Bloods taken? Yes/No 
 
Neonatal Unit (RIE) / SCBU (West Lothian) 
Admission date: ........................................................................................................................................………………… 
Reason for admission: ........................................................................................................................................……… 
Neonatal withdrawal symptoms? None / Mild / Moderate /Severe  
Drug treatment administered? ..........................................................................................................................…… 
Medication on discharge?……………………………………………………………………………………………………………………………………… 
Breast or bottle feeding on discharge?…………………………………………………………………………………………………………… 
Other comments? ………………………………………………………………………………………………………………………………………………….. 
Neonatal Unit / SCBU discharge date:  ...........................................................................................................…… 
Toxicology Result: …………………………………………………………………………………………………………………………………………………. 
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Community 
Baby developed NAS symptoms after discharge from hospital?… Yes/No 
Baby readmitted?…  Neonatal Unit, RIE     SCBU, St John’s     
   RHSC     St John’s Children’s Ward   
Date of readmission: ………………………………………………………… 
 
Infant feeding at day 10?… Breast fed / Bottle fed 
Continued drug / alcohol use whilst breast feeding? (please detail) ................................….......................... 
.......................................................................................................................................................................................... 
 
 
Date of postnatal case discussion: ..................................................................................................................…… 
Professionals involved discussion?........................................................................................................................... 
……………………………………………………………………………………………………………………………………………………………………………………. 
……………………………………………………………………………………………………………………………………………………………………………………. 
Decisions made?........................................................................................................................................................... 
……………………………………………………………………………………………………………………………………………………………………………………. 
……………………………………………………………………………………………………………………………………………………………………………………. 
Child protection case conference held (post birth)?... Yes/No 
 
SIDS? (include details) .........................................................................................................................................…. 
 
Age of baby on last midwifery visit? ………………………………… days old   
Date of last midwifery visit? ……………………………………………………………. 
Name of midwife………………………………………………………………………………………. 
 
Details of Health Visitor 
Name: ............................................................................................................................................................................. 
Address: ........................................................................................................................................................................ 
.......................................................................................................................................................................................... 
Tele. ................................................... 
 
Form completed by: .................................................................................................................................................. 
Midwifery Team:…………………………………………………………………………………………………………………………………………………… 
Form completed on (date): ....................................................................................................................................... 
 
*Form SM203. Photocopy form and send to Link Midwife (Substance Misuse) after day 10. 
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Neonatal Abstinence Syndrome Assessment Score Chart   
Unit no: ...................................................................................... Please fill in score for each 4 hour period.
Name: .........................................................................................
Write score for each symptom and add together for total score.
If no symptoms enter score = 0
Insert date at beginning of each day and enter time at the beginning of each 4 hour period e.g. 23/06
Date of birth: .............................................................................   2 pm
SCORING
Birth weight: .............................................................................. Mild symptoms = 0-5
Moderate symptoms = 6-13 
Gestational age: ......................................................................... Severe symptoms = 14-21 
Information for parents... 
If baby has a seizure (fit), dial 999 for an ambulance. 
If baby has moderate to severe symptoms, seek advice and help from your midwife, GP or hospital. 
Date:
Time:
SYMPTOM: SCORE: 
Feeding  Not able to feed at all 
Demands hourly feeds 
Feeds very slowly (takes more
   than 30 minutes) 
4
2
2
Weight... from 
Day 7 onwards 
Loss
Same
Gain
4
2
0
Condition of 
bottom
Raw/broken skin 
Very red 
Mild red 
3
2
1
Resting/sleeping
after feeds 
Less than 1 hour 
1-2 hours 
2-3 hours 
5
3
1
Crying/
irritability
All the time 
Most of the time 
Only some of the time 
5
4
1
TOTAL SCORE 
Drug treatment 
Start time or change dose 
Comments
Information to help you and your baby
Pregnancy is a very special event for most
women. Knowing about tobacco, alcohol and drug
use can be important when you are pregnant.
This booklet is designed to give you some
information and advice to help you and your
baby stay as healthy as possible.
Pregnant… and using
alcohol or drugs?
You may be feeling worried about how your drug use might affect
your pregnancy and baby. Most women who use drugs and alcohol have
a normal pregnancy and a perfectly healthy baby. However, there are
risks associated with tobacco, alcohol and drug use.
Unfortunately, good evidence on the effects of drug/alcohol use during
pregnancy has been difficult to establish. What we do know however,
is that smoking tobacco in pregnancy is definitely harmful to your
baby and can affect your pregnancy in a number of ways. All mothers
who smoke should try to give up! Ask your GP, pharmacist or midwife
for help.
Using street drugs (like heroin) or being dependent on drugs (like
methadone or ‘valium’) can increase your chances of having a premature
birth and a low birth weight (small) baby. This in turn can lead to
other problems. The risk of cot death is also increased, particularly
if you smoke tobacco as well.
There is no good evidence to suggest that illicit (street) drugs alone
cause congenital birth defects. Heavy alcohol use, however, is
associated with birth defects and heavy cocaine use is associated
with a number of problems in pregnancy because the drug reduces
blood flow to the developing baby. Street drugs may contain impurities
and can put extra strain on your liver and kidneys, so it is better if
you can use only prescribed drugs when you are pregnant.
It is important to remember that there are many other things that
can affect your pregnancy at least as much as drugs. For instance,
the food you eat (your diet), your social circumstances and lifestyle,
and whether or not you get good antenatal (maternity) care. Drug use
can affect your appetite, weight, dental health, general health, mood
and ability to cope with everyday life.
Drug use in pregnancy
If you are using opiate drugs (e.g. methadone, heroin or DF118) try to
keep your drug use as stable as possible throughout your pregnancy.
This means taking the same amount of drug every day and avoiding
getting ‘stoned’ or taking extra, as far as you can.
If you experience morning sickness we normally recommend splitting
your daily dose into two lots (one dose in the morning and one at night).
Splitting up your dose will keep you and your baby more stable late in
pregnancy too.
Injecting drugs carries a lot more risks for you and your baby, especially
the risk of infections. It is also associated with premature labour and
delivery.  If you are injecting drugs you will be given help to stop or
cut down if you can. If you are dependent on heroin you will be advised
to take prescribed opiates instead (e.g. methadone). Seek help from
drug services… they will see you quickly.
Reducing……if you think you could manage to reduce your drug use a
bit then you would be supported to do so. Talk to your doctor first, so
you can do this sensibly. It is important to avoid relapsing when you
are reducing, so slow reductions are normally recommended. If you
are taking benzodiazepines (e.g. ‘valium’) you will be given help to reduce
these first.
Stopping……it is generally safe to stop using tobacco, cannabis (’hash’),
amphetamines (‘speed’), ecstasy, cocaine or ’crack’, solvents (‘gas’ and
‘glue’), ‘acid’ and other ‘designer’ drugs. We normally suggest stopping
all these drugs in pregnancy. If you cannot stop taking stimulant drugs
(cocaine/’crack’ or ‘speed’) then get help as soon as you can.
Some women who are dependent on opiates or benzodiazepines consider
stopping their drug use altogether. If you think you might want to do
this then you should speak with your doctor or specialist drug worker.
Do not suddenly stop taking opiates (methadone, DF118, heroin) or
benzodiazepines (e.g. valium) as this could be risky for you and your
Changing your drug use when pregnant
baby. If you want to come off, it is best done under medical supervision,
so that your baby can be monitored carefully and you can be given
support.
Alcohol……heavy drinking during pregnancy (including ‘binge’ drinking)
is associated with a number of pregnancy complications and birth
defects. If you are drinking more than 2 small drinks every day and
can’t stop or reduce your drinking, then talk to your doctor or midwife
who can arrange specialist help. If you are drinking heavily (more than
6 drinks a day) then you should get help straight away. Because we
don’t really know what is a ‘safe’ amount to drink in pregnancy we
recommend no more than one small drink per day, preferably none.
If you are taking drugs (e.g. opiates and benzodiazepines) most days
throughout your pregnancy and right up until the time of birth, your
baby will have been exposed to these drugs and may develop withdrawal
symptoms after birth. It is difficult to predict how each baby will
react. It depends on what drugs you have been taking, how much and
for how long. It also depends on the baby’s ability to clear the drugs
from their system.
If your baby does develop withdrawal symptoms, these are usually
easily managed and the baby will recover in time. Sometimes, however,
withdrawals can be quite severe and the baby will need special medical
and nursing care in hospital (in the ‘neonatal unit’ or ‘special care baby
unit’), perhaps for several weeks.
Your baby will be monitored closely for signs of withdrawal for at
least the first 3 days and you will be given advice on how to comfort
and care for your baby if withdrawal symptoms do develop.
Most babies are well enough to go home after 3 days but may need
some special attention from you, the Midwife, Health Visitor and GP
for some time afterwards (who will want to check on how well the
baby is feeding, sleeping and gaining weight).
Drugs and the newborn baby
When you are pregnant it is very important that you are checked
regularly and attend for all your scans and other tests. Women (and
their babies) who get regular antenatal checks tend to do better than
those who don’t. Midwives are there to help you and will try to answer
any questions and fears that you may have. When you see the midwife,
let them know about your drug and alcohol use so that you can be
offered the special care you and your baby need.
If you have a drug worker, tell them you are pregnant so that they
can help you with aspects of your drug use during pregnancy. You
might also need a social worker or welfare rights worker to help
with benefits or any other social problem (e.g. housing, debts, legal
problems etc).
Normally, the midwife will organise a meeting around the 28th week
(seven months) of your pregnancy to discuss how things are going and
to plan ahead for the arrival of your baby. You (and your partner if
you wish) would be asked to meet with professionals involved in your
care so that any support that you might need can be arranged well in
advance.
Your midwife will offer routine testing for HIV and hepatitis B at
your antenatal ‘booking’ appointment. These viral infections can pass
from mother to baby. Treatment can now greatly reduce the likelihood
of your baby getting these infections so it is important you get tested.
If you have injected drugs or had unprotected sex with anyone who
has, you could be at risk of HIV, hepatitis B and hepatitis C. Your
midwife or GP will normally offer testing for hepatitis C if you have
been at risk. If you are injecting drugs we recommend getting
immunised (vaccinated) for hepatitis B as well.
Antenatal care (before the birth)
HIV, hepatitis B and hepatitis C
Most women who use drugs or alcohol have a normal labour and a normal
delivery. The obstetrician and paediatrician will get involved if there
are any complications. Some women worry about whether or not they
will be given enough pain relief… you don’t need to. You will get to take
your prescribed drugs as normal in hospital and you will also be given
additional pain relief when you need it. It is important that hospital
staff know what drugs you are taking (including any street drugs), as
this will affect what pain relief is given (for instance there are some
drugs that don’t work with methadone, heroin and DF118).
You need to let hospital staff know the name and telephone number of
your pharmacist (chemist) and prescribing doctor. It is hospital policy
to cancel prescriptions before dispensing drugs in the maternity wards.
You should take all your medication into hospital with you and show it
to the staff. Be reassured that whilst you stay in hospital your privacy
will be maintained at all times.
You will be given lots of encouragement and help to breastfeed,
provided your drug use is fairly stable. The exception to this would be
if you were HIV positive or using large amounts of stimulants (e.g.
cocaine/’crack’) or street benzodiazepines (e.g. valium) or drinking
heavily. Only small amounts of drugs are passed to the baby through
breast milk and there is no evidence that hepatitis C is passed to the
baby through breastfeeding either. Breastfeeding has lots of benefits
for the long-term health and development of your baby. If you do
successfully breastfeed and continue to take drugs then you will be
advised to slowly wean the baby onto solids when the time is right.
Your Health Visitor will give you advice about this.
Labour and childbirth
Breastfeeding
After your baby is born you will be asked to stay in hospital for at
least 3 days (72 hours) so that your baby can be checked for withdrawal
symptoms. Following childbirth you might notice that your normal dose
of drug affects you more than normal. This is something to be careful
of as over-sedation (‘gouching’) may mean that you could accidentally
drop your baby or not hear them crying.
After you leave hospital with your baby, the midwife will visit you at
home. When your baby is 11 days old, your health visitor will visit and
will be a good source of information and support on motherhood and
all aspects of health for you and your baby. There will be baby clinics
at your local doctor’s surgery or health clinic where the development
of your child will be assessed. Some areas also have local parent and
child groups and breastfeeding support groups to go to as well.
It is important that you are clear about what is expected of you as a
mother and what services are available to help.
The time after the baby is born can be difficult for some mothers.
Tiredness and lack of sleep, as well as the ‘baby blues’ and other
stresses (like the baby still having some withdrawal symptoms) can
make it harder to look after your baby. This is normal and your
midwife, health visitor, doctor and drug worker are there to talk to
and offer support.
Postnatal care (after the birth)
Midwives are specially trained in pregnancy and childbirth.
Obstetricians are doctors who care for women in pregnancy and
childbirth. Neonatologists are doctors who care for newborn babies.
Paediatricians are doctors who care for children. Health Visitors are
specially trained in child and family health. All these health
professionals, along with your GP of course, may be involved in the
care of you and your baby.
Other services
Specialist drug and/or alcohol services may be able to offer you a lot
of help whilst you are pregnant and after your baby is born.  Ask your
doctor or midwife for advice about how to contact them. Specialist
services give priority to pregnant woman and will see you very quickly.
Some women worry that their baby may be ‘taken into care’ just because
they use drugs. Drug use in itself is not a reason to involve the Social
Work Department or to assume you cannot care for your baby. If
there is concern about the safety or welfare of your child however,
Social Work may need to do an assessment and get involved. This is
the same policy for everyone, whether or not they use drugs.
In Lothian, we have a good system of health and social care that works
well with people who use drugs or alcohol. Everyone is interested in
the well-being of you and your baby and want to make your experience
of pregnancy and childbirth a happy one. Please feel free to talk to
professionals. They are there to help.
Midwifery care staff
Getting support
It is very important that as many people as possible can offer you
support throughout your pregnancy and beyond. Show this booklet to
your partner and any other person (family or friends) who will be
supporting you. There are a lot of myths about drug use in pregnancy
and a lot of bad feelings towards mothers who use drugs so it is
important you get reliable information and have a positive experience.
If your partner also has problems related to drugs or alcohol then
they can get help from services at the same time as you, if they are
not already doing so. Tell them to speak to the midwife or their GP.
Telephone number
My Midwife is
My Obstetrician is
My Maternity Hospital is
My Pharmacist is
My Health Visitor is
My Drug / Alcohol Worker is
My Social Worker is
Other workers involved in my care
Helpful numbers
Notes
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Caring for a baby with
drug withdrawal symptoms
Information for parents
Drug use and newborn babies
This leaflet provides you with information and advice that will help
you prepare for the arrival of your baby. Hopefully after reading this,
you will feel reassured and confident that your baby can be well cared
for and that you can do a lot to help.
If there is anything in this leaflet that you don’t understand or would
like to talk about further, please speak with your midwife or other
health care professional involved in your care.
Most drugs (including tobacco and alcohol) that you take when you are
pregnant pass through the placenta and are absorbed by your baby.
If a mother is dependent (or ‘addicted’) to certain drugs the baby will
be born dependent on these too and can develop what is known as
‘Neonatal Abstinence Syndrome’. This is a condition where the baby
shows signs and symptoms of withdrawal. It occurs often with opiate
drugs (e.g. methadone, DF118 or heroin) and benzodiazepine drugs
(e.g. valium or temazepam). At birth, the baby’s drug supply stops and
the baby goes through a period of withdrawal. Baby withdrawal
symptoms can be similar to how adults feel when they suddenly stop
taking drugs or go ‘cold turkey’.
Baby withdrawal symptoms can include things like:
• high-pitched crying
• irritability and restlessness
• tremor (shakiness)
• feeding difficulties (the baby is often keen to feed but cannot
suck or swallow properly)
• sleeping difficulties (the baby cannot settle or sleep after a feed)
• vomiting and/or diarrhoea
• fever
• a sore bottom (due to frequent dirty nappies)
Occasionally, babies have convulsions (fits) but this is very rare.
Most babies who have been exposed to drugs before birth will have
some symptoms after birth. Some babies experience only mild
withdrawal symptoms and require no more than the usual care that all
babies need. Other babies however, can have severe symptoms where
they cannot feed or sleep properly and they lose weight rather than
gain weight. These babies usually need medical treatment, including
special nursing care and sometimes calming drugs to help them recover.
Unfortunately, there is no way of telling exactly how a baby will react
as there are many different factors that affect withdrawal symptoms
in babies. The amount of drugs you are taking is only one factor so we
like to prepare all parents just in case.
What we can say is that drug withdrawal in babies is now fairly common,
so you are not alone. Midwives and other maternity staff as well as
Health Visitors and GPs have experience in looking after babies and
can offer some good advice and help to parents.
Mothers who are dependent on drugs are asked to stay in hospital
with their baby for at least 3 days (72 hours). This is because most
withdrawal symptoms in babies appear within this time period.
Benzodiazepines (e.g. valium and temazepam) however, can take longer
to leave the baby’s system and withdrawal signs may not show up for a
week or so.
In the postnatal ward you will be encouraged to breastfeed and ‘bond’
with your baby. The nurse or midwife will use a special score chart to
assess the condition of your baby. You will be shown how to use the
chart so you can help the nurses with this.
Most babies are well enough to go home after 3 days where they can
be cared for by their parents, with the help and support of the
midwife, health visitor and GP. The baby needs to feed well enough
and the baby will be checked to see if it is putting on enough weight.
Caring for your baby
Parents are encouraged to keep a close eye on their baby and use the
special score chart.
If the baby has severe withdrawal symptoms they would be admitted
to the ‘neonatal unit’ or ‘special care baby unit’. Here they can get
‘tube’ feeds and calming medicine if necessary. Treatment aims to
reduce the baby’s distress and to get the baby feeding and sleeping
as normally as possible. Babies usually stay in the neonatal unit for
about 10-14 days, but occasionally for much longer.
Most admissions to the neonatal unit happen when the baby is still in
hospital after birth, but babies are also admitted from home if
problems become worse later on. Babies older than 2 weeks are
admitted to the Royal Hospital for Sick Children (RHSC) or the
Children’s Ward at St John’s Hospital. If the baby’s problems get
worse at home then it is better to admit the baby earlier rather than
later. This is why we are keen to offer parents extra help at home and
to see how the baby is doing.
We appreciate that babies with withdrawal symptoms are difficult to
look after and they can require a lot of patience and may be difficult
to feed and settle. Some babies can be irritable for months, but
symptoms gradually improve with time.
You will have been given this leaflet because your baby may be at risk
of developing withdrawal symptoms. Experience has shown us that there
are many things that you can do to help calm and comfort your baby.
Here are some suggestions:
• make sure your baby is kept in very quiet and calm surroundings,
no bright lights or loud sounds that might upset your baby
• make sure no one smokes near your baby, keep the air fresh but
warm
• hold your baby as much as you can, the baby will cry less and feed
better if they have ‘skin-to-skin’ contact
• use a dummy or pacifier (‘soothers’)… unless you are breastfeeding
• move and handle your baby very gently; try giving them a gentle
massage
• change your baby’s clothes frequently, especially if they sweat a
lot
• avoid getting your baby too hot
• regularly check and change your baby’s nappy
• use a barrier cream around the baby’s bottom area to help prevent
any skin damage
• feed your baby on demand, frequent small feeds are normally
better
• keep a record of all the feeds your baby takes so that the Midwife
or Health Visitor can check whether your baby is feeding well
enough and putting on enough weight
• if your baby has a convulsion (fit), dial 999 and ask for an
ambulance to take your child to the Royal Hospital for Sick
Children.
Things parents can do to help
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All mothers are encouraged to breastfeed their babies and are given
help to do so, including mothers who are dependent on drugs. In fact,
breastfeeding can sometimes help with your baby’s withdrawal
symptoms. Only very small amounts of drugs are passed to the baby
through breast milk. The benefits of breastfeeding are so great that
they outweigh worries about continued drug use. The only exceptions
to this would be: if the mother were HIV positive (or ‘at risk’ of
infection whilst breastfeeding); if she were drinking heavily, taking
large amounts of stimulant drugs (e.g. cocaine, crack or ‘speed’) or
street benzodiazepines (e.g. valium).
It is important to remember that most women who use drugs
have a normal pregnancy, a normal delivery and a normal full
term baby. Babies born with drug withdrawal symptoms will
recover in time.
We hope that this leaflet has given you enough information to help
you prepare for the arrival of your baby. We know that it can be
difficult to have a baby with withdrawal symptoms and that many
mums feel guilty and ‘to blame’. Remember that we are always here to
provide you with support and to talk to you about any worries or
questions that you may have. Please feel free to speak with your
midwife or other health care professional about the information in
this leaflet.
Breastfeeding and drug use
